Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051179 | 0.00000 | 2.57894 | 370 | 655 | 5950 | localization |
| GO:0002376 | 0.00000 | 2.79085 | 166 | 359 | 2664 | immune system process |
| GO:0006928 | 0.00000 | 2.99141 | 125 | 295 | 2014 | movement of cell or subcellular component |
| GO:0032879 | 0.00000 | 2.65098 | 177 | 366 | 2835 | regulation of localization |
| GO:0048870 | 0.00000 | 3.15833 | 99 | 249 | 1595 | cell motility |
| GO:0051674 | 0.00000 | 3.15833 | 99 | 249 | 1595 | localization of cell |
| GO:0022610 | 0.00000 | 3.38496 | 82 | 219 | 1310 | biological adhesion |
| GO:0007155 | 0.00000 | 3.38119 | 81 | 217 | 1298 | cell adhesion |
| GO:0048518 | 0.00000 | 2.16833 | 384 | 616 | 6171 | positive regulation of biological process |
| GO:0016477 | 0.00000 | 3.21551 | 90 | 231 | 1447 | cell migration |
| GO:0040011 | 0.00000 | 2.94041 | 113 | 266 | 1817 | locomotion |
| GO:0051234 | 0.00000 | 2.23805 | 283 | 489 | 4538 | establishment of localization |
| GO:0006810 | 0.00000 | 2.22714 | 274 | 475 | 4398 | transport |
| GO:0048583 | 0.00000 | 2.28799 | 242 | 435 | 3883 | regulation of response to stimulus |
| GO:0048731 | 0.00000 | 2.16848 | 295 | 498 | 4746 | system development |
| GO:0002682 | 0.00000 | 2.99499 | 92 | 223 | 1473 | regulation of immune system process |
| GO:0048856 | 0.00000 | 2.06820 | 366 | 577 | 5871 | anatomical structure development |
| GO:0006955 | 0.00000 | 2.83796 | 103 | 238 | 1652 | immune response |
| GO:0032502 | 0.00000 | 2.03389 | 390 | 602 | 6258 | developmental process |
| GO:0065007 | 0.00000 | 1.99117 | 755 | 978 | 12135 | biological regulation |
| GO:0048522 | 0.00000 | 2.02501 | 340 | 538 | 5469 | positive regulation of cellular process |
| GO:0007275 | 0.00000 | 2.01015 | 334 | 527 | 5362 | multicellular organism development |
| GO:0035556 | 0.00000 | 2.35647 | 162 | 314 | 2608 | intracellular signal transduction |
| GO:0001775 | 0.00000 | 3.13531 | 68 | 176 | 1098 | cell activation |
| GO:0051049 | 0.00000 | 2.53008 | 121 | 254 | 1946 | regulation of transport |
| GO:0050789 | 0.00000 | 1.89949 | 717 | 929 | 11520 | regulation of biological process |
| GO:0051270 | 0.00000 | 3.17257 | 64 | 167 | 1028 | regulation of cellular component movement |
| GO:0050896 | 0.00000 | 1.87951 | 593 | 805 | 9531 | response to stimulus |
| GO:0009653 | 0.00000 | 2.27975 | 171 | 321 | 2744 | anatomical structure morphogenesis |
| GO:0030154 | 0.00000 | 2.06206 | 263 | 437 | 4218 | cell differentiation |
| GO:0002684 | 0.00000 | 3.10813 | 67 | 171 | 1072 | positive regulation of immune system process |
| GO:0045321 | 0.00000 | 3.20295 | 62 | 163 | 994 | leukocyte activation |
| GO:2000145 | 0.00000 | 3.27073 | 58 | 157 | 939 | regulation of cell motility |
| GO:0051239 | 0.00000 | 2.17765 | 202 | 361 | 3248 | regulation of multicellular organismal process |
| GO:0002252 | 0.00000 | 3.34239 | 55 | 150 | 879 | immune effector process |
| GO:0030155 | 0.00000 | 3.73232 | 43 | 129 | 686 | regulation of cell adhesion |
| GO:0048869 | 0.00000 | 2.02718 | 277 | 452 | 4443 | cellular developmental process |
| GO:0048584 | 0.00000 | 2.35701 | 143 | 280 | 2294 | positive regulation of response to stimulus |
| GO:0030334 | 0.00000 | 3.28180 | 56 | 150 | 892 | regulation of cell migration |
| GO:0050900 | 0.00000 | 5.27206 | 21 | 85 | 340 | leukocyte migration |
| GO:0040012 | 0.00000 | 3.05909 | 63 | 161 | 1018 | regulation of locomotion |
| GO:0010646 | 0.00000 | 2.10174 | 208 | 361 | 3338 | regulation of cell communication |
| GO:0009966 | 0.00000 | 2.19246 | 173 | 316 | 2780 | regulation of signal transduction |
| GO:0023051 | 0.00000 | 2.09239 | 209 | 362 | 3360 | regulation of signaling |
| GO:0050776 | 0.00000 | 3.17542 | 56 | 148 | 903 | regulation of immune response |
| GO:0048513 | 0.00000 | 2.07079 | 218 | 373 | 3504 | animal organ development |
| GO:0006952 | 0.00000 | 2.55412 | 100 | 214 | 1601 | defense response |
| GO:0006954 | 0.00000 | 3.50938 | 43 | 124 | 691 | inflammatory response |
| GO:0098609 | 0.00000 | 3.44029 | 45 | 127 | 720 | cell-cell adhesion |
| GO:0035239 | 0.00000 | 3.11061 | 56 | 146 | 905 | tube morphogenesis |
| GO:0048523 | 0.00000 | 1.92416 | 292 | 458 | 4687 | negative regulation of cellular process |
| GO:0007166 | 0.00000 | 2.20365 | 155 | 288 | 2497 | cell surface receptor signaling pathway |
| GO:0008283 | 0.00000 | 2.33654 | 124 | 245 | 1994 | cell proliferation |
| GO:0065009 | 0.00000 | 2.19383 | 154 | 285 | 2477 | regulation of molecular function |
| GO:0035295 | 0.00000 | 2.80280 | 70 | 165 | 1122 | tube development |
| GO:0051240 | 0.00000 | 2.34078 | 120 | 238 | 1929 | positive regulation of multicellular organismal process |
| GO:0051272 | 0.00000 | 3.68856 | 36 | 109 | 580 | positive regulation of cellular component movement |
| GO:0048519 | 0.00000 | 1.86238 | 329 | 497 | 5278 | negative regulation of biological process |
| GO:0007154 | 0.00000 | 1.80583 | 414 | 593 | 6648 | cell communication |
| GO:0007010 | 0.00000 | 2.64874 | 81 | 182 | 1305 | cytoskeleton organization |
| GO:0023052 | 0.00000 | 1.80650 | 410 | 588 | 6579 | signaling |
| GO:0042127 | 0.00000 | 2.44754 | 103 | 213 | 1649 | regulation of cell proliferation |
| GO:0050793 | 0.00000 | 2.12292 | 169 | 303 | 2721 | regulation of developmental process |
| GO:0006950 | 0.00000 | 1.98580 | 227 | 375 | 3640 | response to stress |
| GO:2000147 | 0.00000 | 3.70764 | 35 | 106 | 561 | positive regulation of cell motility |
| GO:0044093 | 0.00000 | 2.54289 | 89 | 192 | 1429 | positive regulation of molecular function |
| GO:0040017 | 0.00000 | 3.58729 | 37 | 109 | 593 | positive regulation of locomotion |
| GO:0046903 | 0.00000 | 2.67251 | 76 | 173 | 1227 | secretion |
| GO:0016043 | 0.00000 | 1.80855 | 379 | 551 | 6083 | cellular component organization |
| GO:0002521 | 0.00000 | 3.65835 | 35 | 106 | 567 | leukocyte differentiation |
| GO:0002520 | 0.00000 | 2.84451 | 64 | 154 | 1030 | immune system development |
| GO:0009605 | 0.00000 | 2.14179 | 157 | 284 | 2515 | response to external stimulus |
| GO:0050790 | 0.00000 | 2.33892 | 112 | 224 | 1807 | regulation of catalytic activity |
| GO:0032940 | 0.00000 | 2.78395 | 67 | 157 | 1070 | secretion by cell |
| GO:0030335 | 0.00000 | 3.70675 | 34 | 102 | 539 | positive regulation of cell migration |
| GO:0050794 | 0.00000 | 1.74128 | 671 | 857 | 10774 | regulation of cellular process |
| GO:0001816 | 0.00000 | 3.17686 | 47 | 125 | 755 | cytokine production |
| GO:0002366 | 0.00000 | 5.29795 | 17 | 68 | 269 | leukocyte activation involved in immune response |
| GO:0001817 | 0.00000 | 3.28701 | 42 | 116 | 679 | regulation of cytokine production |
| GO:0002263 | 0.00000 | 5.19362 | 17 | 68 | 273 | cell activation involved in immune response |
| GO:0007165 | 0.00000 | 1.77539 | 375 | 541 | 6028 | signal transduction |
| GO:0001944 | 0.00000 | 3.12641 | 47 | 123 | 752 | vasculature development |
| GO:0072358 | 0.00000 | 3.09341 | 48 | 124 | 765 | cardiovascular system development |
| GO:0010562 | 0.00000 | 2.67808 | 69 | 158 | 1112 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 2.67808 | 69 | 158 | 1112 | positive regulation of phosphate metabolic process |
| GO:0001568 | 0.00000 | 3.16571 | 45 | 119 | 719 | blood vessel development |
| GO:0046649 | 0.00000 | 2.95647 | 52 | 131 | 841 | lymphocyte activation |
| GO:0071840 | 0.00000 | 1.75297 | 390 | 555 | 6266 | cellular component organization or biogenesis |
| GO:0048514 | 0.00000 | 3.33971 | 39 | 108 | 622 | blood vessel morphogenesis |
| GO:0030029 | 0.00000 | 3.09117 | 46 | 121 | 746 | actin filament-based process |
| GO:0043085 | 0.00000 | 2.70532 | 65 | 151 | 1051 | positive regulation of catalytic activity |
| GO:0045785 | 0.00000 | 4.04630 | 26 | 84 | 411 | positive regulation of cell adhesion |
| GO:0022603 | 0.00000 | 2.67403 | 67 | 153 | 1076 | regulation of anatomical structure morphogenesis |
| GO:0009893 | 0.00000 | 1.92243 | 217 | 353 | 3486 | positive regulation of metabolic process |
| GO:0048534 | 0.00000 | 2.77373 | 61 | 143 | 972 | hematopoietic or lymphoid organ development |
| GO:2000026 | 0.00000 | 2.14516 | 136 | 250 | 2184 | regulation of multicellular organismal development |
| GO:0042221 | 0.00000 | 1.85417 | 257 | 401 | 4136 | response to chemical |
| GO:0009987 | 0.00000 | 1.83430 | 984 | 1143 | 15803 | cellular process |
| GO:0009888 | 0.00000 | 2.19779 | 122 | 230 | 1956 | tissue development |
| GO:0042327 | 0.00000 | 2.68403 | 65 | 149 | 1043 | positive regulation of phosphorylation |
| GO:0030097 | 0.00000 | 2.80300 | 57 | 137 | 921 | hemopoiesis |
| GO:0002697 | 0.00000 | 3.93626 | 26 | 84 | 420 | regulation of immune effector process |
| GO:0051716 | 0.00000 | 1.69808 | 486 | 656 | 7810 | cellular response to stimulus |
| GO:0098657 | 0.00000 | 2.85636 | 54 | 132 | 872 | import into cell |
| GO:0030595 | 0.00000 | 5.76288 | 13 | 57 | 211 | leukocyte chemotaxis |
| GO:0048646 | 0.00000 | 2.57276 | 72 | 159 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:0006811 | 0.00000 | 2.32235 | 97 | 195 | 1565 | ion transport |
| GO:0032101 | 0.00000 | 2.97348 | 48 | 121 | 770 | regulation of response to external stimulus |
| GO:0007159 | 0.00000 | 4.48334 | 20 | 71 | 319 | leukocyte cell-cell adhesion |
| GO:0051050 | 0.00000 | 2.61429 | 67 | 151 | 1081 | positive regulation of transport |
| GO:0042110 | 0.00000 | 3.58976 | 31 | 91 | 491 | T cell activation |
| GO:0065008 | 0.00000 | 1.83507 | 252 | 391 | 4051 | regulation of biological quality |
| GO:0050778 | 0.00000 | 2.98802 | 47 | 118 | 747 | positive regulation of immune response |
| GO:0033036 | 0.00000 | 1.95745 | 181 | 303 | 2901 | macromolecule localization |
| GO:0051247 | 0.00000 | 2.26909 | 102 | 200 | 1639 | positive regulation of protein metabolic process |
| GO:0030036 | 0.00000 | 3.12372 | 41 | 109 | 663 | actin cytoskeleton organization |
| GO:0070887 | 0.00000 | 1.93545 | 188 | 312 | 3023 | cellular response to chemical stimulus |
| GO:0060429 | 0.00000 | 2.51235 | 73 | 158 | 1172 | epithelium development |
| GO:0022407 | 0.00000 | 3.92551 | 25 | 79 | 395 | regulation of cell-cell adhesion |
| GO:0072359 | 0.00000 | 2.52678 | 71 | 155 | 1143 | circulatory system development |
| GO:1902531 | 0.00000 | 2.22554 | 106 | 205 | 1710 | regulation of intracellular signal transduction |
| GO:0060326 | 0.00000 | 4.51276 | 19 | 67 | 299 | cell chemotaxis |
| GO:0001934 | 0.00000 | 2.64295 | 62 | 140 | 989 | positive regulation of protein phosphorylation |
| GO:0002443 | 0.00000 | 3.44911 | 32 | 91 | 507 | leukocyte mediated immunity |
| GO:0010604 | 0.00000 | 1.88919 | 200 | 324 | 3212 | positive regulation of macromolecule metabolic process |
| GO:0051094 | 0.00000 | 2.27376 | 96 | 189 | 1540 | positive regulation of developmental process |
| GO:0002703 | 0.00000 | 4.91925 | 16 | 60 | 250 | regulation of leukocyte mediated immunity |
| GO:0006897 | 0.00000 | 2.91982 | 46 | 115 | 741 | endocytosis |
| GO:0051128 | 0.00000 | 1.97588 | 159 | 272 | 2558 | regulation of cellular component organization |
| GO:0030100 | 0.00000 | 4.44923 | 18 | 65 | 293 | regulation of endocytosis |
| GO:0002250 | 0.00000 | 3.19219 | 36 | 98 | 583 | adaptive immune response |
| GO:0002790 | 0.00000 | 3.03950 | 41 | 105 | 652 | peptide secretion |
| GO:0031325 | 0.00000 | 1.87268 | 199 | 321 | 3201 | positive regulation of cellular metabolic process |
| GO:0048468 | 0.00000 | 1.98503 | 150 | 258 | 2406 | cell development |
| GO:0097529 | 0.00000 | 5.34307 | 13 | 53 | 207 | myeloid leukocyte migration |
| GO:0002274 | 0.00000 | 5.20925 | 13 | 54 | 215 | myeloid leukocyte activation |
| GO:0009967 | 0.00000 | 2.24417 | 94 | 183 | 1504 | positive regulation of signal transduction |
| GO:0050764 | 0.00000 | 8.38474 | 7 | 37 | 105 | regulation of phagocytosis |
| GO:0071702 | 0.00000 | 1.94752 | 156 | 264 | 2505 | organic substance transport |
| GO:0051246 | 0.00000 | 1.91405 | 167 | 278 | 2687 | regulation of protein metabolic process |
| GO:1902533 | 0.00000 | 2.52160 | 63 | 137 | 1005 | positive regulation of intracellular signal transduction |
| GO:0050865 | 0.00000 | 2.89025 | 43 | 107 | 693 | regulation of cell activation |
| GO:0016192 | 0.00000 | 2.21791 | 93 | 181 | 1501 | vesicle-mediated transport |
| GO:0051046 | 0.00000 | 2.60441 | 57 | 128 | 911 | regulation of secretion |
| GO:0060627 | 0.00000 | 3.12529 | 35 | 94 | 568 | regulation of vesicle-mediated transport |
| GO:0019220 | 0.00000 | 2.14025 | 105 | 197 | 1692 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00000 | 2.13871 | 105 | 197 | 1693 | regulation of phosphorus metabolic process |
| GO:0006468 | 0.00000 | 2.09599 | 113 | 207 | 1815 | protein phosphorylation |
| GO:1903530 | 0.00000 | 2.68182 | 52 | 120 | 831 | regulation of secretion by cell |
| GO:0042330 | 0.00000 | 3.04171 | 37 | 97 | 600 | taxis |
| GO:0032270 | 0.00000 | 2.19458 | 95 | 183 | 1532 | positive regulation of cellular protein metabolic process |
| GO:0051173 | 0.00000 | 1.84533 | 191 | 305 | 3061 | positive regulation of nitrogen compound metabolic process |
| GO:0009306 | 0.00000 | 3.01106 | 38 | 97 | 605 | protein secretion |
| GO:0006935 | 0.00000 | 3.02041 | 37 | 96 | 597 | chemotaxis |
| GO:0002699 | 0.00000 | 4.48626 | 16 | 58 | 259 | positive regulation of immune effector process |
| GO:1901342 | 0.00000 | 3.88767 | 21 | 68 | 341 | regulation of vasculature development |
| GO:0042325 | 0.00000 | 2.17741 | 95 | 182 | 1533 | regulation of phosphorylation |
| GO:0032989 | 0.00000 | 2.33699 | 75 | 154 | 1211 | cellular component morphogenesis |
| GO:0008219 | 0.00000 | 2.00883 | 129 | 226 | 2065 | cell death |
| GO:0001525 | 0.00000 | 3.20911 | 32 | 87 | 513 | angiogenesis |
| GO:0002694 | 0.00000 | 2.89330 | 41 | 101 | 652 | regulation of leukocyte activation |
| GO:0006793 | 0.00000 | 1.84242 | 184 | 295 | 2955 | phosphorus metabolic process |
| GO:0031401 | 0.00000 | 2.32002 | 75 | 153 | 1210 | positive regulation of protein modification process |
| GO:0016310 | 0.00000 | 1.97237 | 135 | 233 | 2166 | phosphorylation |
| GO:0000902 | 0.00000 | 2.38805 | 68 | 143 | 1100 | cell morphogenesis |
| GO:0002791 | 0.00000 | 3.13569 | 33 | 88 | 529 | regulation of peptide secretion |
| GO:0002822 | 0.00000 | 5.26941 | 12 | 48 | 189 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032501 | 0.00000 | 1.58981 | 513 | 663 | 8233 | multicellular organismal process |
| GO:0006796 | 0.00000 | 1.83385 | 183 | 292 | 2933 | phosphate-containing compound metabolic process |
| GO:0001819 | 0.00000 | 3.34416 | 28 | 79 | 449 | positive regulation of cytokine production |
| GO:0012501 | 0.00000 | 2.02204 | 119 | 211 | 1908 | programmed cell death |
| GO:0042592 | 0.00000 | 2.02419 | 117 | 209 | 1887 | homeostatic process |
| GO:0001932 | 0.00000 | 2.19041 | 88 | 169 | 1410 | regulation of protein phosphorylation |
| GO:0043410 | 0.00000 | 3.11762 | 32 | 86 | 519 | positive regulation of MAPK cascade |
| GO:0006915 | 0.00000 | 2.02510 | 116 | 207 | 1867 | apoptotic process |
| GO:0070661 | 0.00000 | 3.80689 | 21 | 65 | 331 | leukocyte proliferation |
| GO:0008284 | 0.00000 | 2.43282 | 61 | 129 | 972 | positive regulation of cell proliferation |
| GO:0002819 | 0.00000 | 4.86206 | 13 | 49 | 205 | regulation of adaptive immune response |
| GO:0030855 | 0.00000 | 2.85125 | 39 | 96 | 626 | epithelial cell differentiation |
| GO:0050663 | 0.00000 | 4.40823 | 15 | 54 | 244 | cytokine secretion |
| GO:0008104 | 0.00000 | 1.85984 | 161 | 262 | 2578 | protein localization |
| GO:0050708 | 0.00000 | 3.14918 | 31 | 82 | 490 | regulation of protein secretion |
| GO:0043067 | 0.00000 | 2.10951 | 96 | 178 | 1537 | regulation of programmed cell death |
| GO:0010647 | 0.00000 | 2.00399 | 115 | 204 | 1854 | positive regulation of cell communication |
| GO:1903037 | 0.00000 | 4.02105 | 18 | 59 | 287 | regulation of leukocyte cell-cell adhesion |
| GO:0010941 | 0.00000 | 2.05269 | 105 | 190 | 1685 | regulation of cell death |
| GO:0031589 | 0.00000 | 3.69437 | 21 | 65 | 339 | cell-substrate adhesion |
| GO:0002285 | 0.00000 | 4.97821 | 12 | 47 | 193 | lymphocyte activation involved in immune response |
| GO:0033674 | 0.00000 | 3.16262 | 30 | 80 | 476 | positive regulation of kinase activity |
| GO:0002687 | 0.00000 | 5.92965 | 9 | 40 | 144 | positive regulation of leukocyte migration |
| GO:0045765 | 0.00000 | 3.85550 | 19 | 61 | 307 | regulation of angiogenesis |
| GO:0030098 | 0.00000 | 3.41957 | 25 | 71 | 395 | lymphocyte differentiation |
| GO:0031323 | 0.00000 | 1.62331 | 336 | 466 | 5401 | regulation of cellular metabolic process |
| GO:0031399 | 0.00000 | 2.01355 | 110 | 195 | 1760 | regulation of protein modification process |
| GO:0045595 | 0.00000 | 1.97100 | 119 | 207 | 1909 | regulation of cell differentiation |
| GO:0023056 | 0.00000 | 1.98345 | 116 | 203 | 1860 | positive regulation of signaling |
| GO:0045807 | 0.00000 | 5.18657 | 11 | 44 | 175 | positive regulation of endocytosis |
| GO:0042981 | 0.00000 | 2.08339 | 94 | 174 | 1516 | regulation of apoptotic process |
| GO:0002064 | 0.00000 | 4.23355 | 15 | 53 | 247 | epithelial cell development |
| GO:0002460 | 0.00000 | 3.20076 | 27 | 75 | 441 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032268 | 0.00000 | 1.83938 | 155 | 252 | 2494 | regulation of cellular protein metabolic process |
| GO:0046651 | 0.00000 | 3.75865 | 19 | 60 | 308 | lymphocyte proliferation |
| GO:0019222 | 0.00000 | 1.58798 | 371 | 501 | 5953 | regulation of metabolic process |
| GO:0022409 | 0.00000 | 4.23886 | 15 | 52 | 242 | positive regulation of cell-cell adhesion |
| GO:0045087 | 0.00000 | 2.47502 | 52 | 114 | 842 | innate immune response |
| GO:0045597 | 0.00000 | 2.26991 | 68 | 137 | 1097 | positive regulation of cell differentiation |
| GO:0032943 | 0.00000 | 3.72823 | 19 | 60 | 310 | mononuclear cell proliferation |
| GO:0050863 | 0.00000 | 3.73908 | 19 | 59 | 304 | regulation of T cell activation |
| GO:0070663 | 0.00000 | 4.22160 | 15 | 51 | 238 | regulation of leukocyte proliferation |
| GO:0008285 | 0.00000 | 2.64336 | 42 | 98 | 681 | negative regulation of cell proliferation |
| GO:0031347 | 0.00000 | 2.70399 | 40 | 94 | 640 | regulation of defense response |
| GO:0051241 | 0.00000 | 2.11506 | 84 | 157 | 1343 | negative regulation of multicellular organismal process |
| GO:0002683 | 0.00000 | 3.03734 | 29 | 77 | 473 | negative regulation of immune system process |
| GO:0002685 | 0.00000 | 4.58420 | 13 | 46 | 201 | regulation of leukocyte migration |
| GO:0030030 | 0.00000 | 2.02365 | 98 | 176 | 1572 | cell projection organization |
| GO:0050670 | 0.00000 | 4.30557 | 14 | 49 | 225 | regulation of lymphocyte proliferation |
| GO:0070374 | 0.00000 | 4.36465 | 14 | 48 | 218 | positive regulation of ERK1 and ERK2 cascade |
| GO:0034097 | 0.00000 | 2.29502 | 63 | 127 | 1004 | response to cytokine |
| GO:0002706 | 0.00000 | 4.63179 | 12 | 45 | 195 | regulation of lymphocyte mediated immunity |
| GO:0032944 | 0.00000 | 4.25680 | 14 | 49 | 227 | regulation of mononuclear cell proliferation |
| GO:0032103 | 0.00000 | 3.61950 | 19 | 59 | 312 | positive regulation of response to external stimulus |
| GO:1904018 | 0.00000 | 4.49653 | 13 | 46 | 204 | positive regulation of vasculature development |
| GO:0050707 | 0.00000 | 4.37438 | 13 | 47 | 213 | regulation of cytokine secretion |
| GO:0070371 | 0.00000 | 3.54180 | 20 | 60 | 323 | ERK1 and ERK2 cascade |
| GO:0051347 | 0.00000 | 2.81477 | 34 | 84 | 551 | positive regulation of transferase activity |
| GO:0002449 | 0.00000 | 3.12540 | 26 | 71 | 425 | lymphocyte mediated immunity |
| GO:0090087 | 0.00000 | 2.50914 | 47 | 103 | 749 | regulation of peptide transport |
| GO:0045860 | 0.00000 | 3.06602 | 27 | 72 | 438 | positive regulation of protein kinase activity |
| GO:0050766 | 0.00000 | 8.26946 | 5 | 27 | 77 | positive regulation of phagocytosis |
| GO:1903039 | 0.00000 | 4.39564 | 13 | 45 | 203 | positive regulation of leukocyte cell-cell adhesion |
| GO:1903532 | 0.00000 | 2.94655 | 29 | 75 | 472 | positive regulation of secretion by cell |
| GO:0002793 | 0.00000 | 3.43597 | 21 | 60 | 331 | positive regulation of peptide secretion |
| GO:0030001 | 0.00000 | 2.37765 | 52 | 110 | 839 | metal ion transport |
| GO:0070372 | 0.00000 | 3.54852 | 19 | 57 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0023014 | 0.00000 | 2.39592 | 50 | 107 | 810 | signal transduction by protein phosphorylation |
| GO:0060099 | 0.00000 | 42.57722 | 1 | 14 | 19 | regulation of phagocytosis, engulfment |
| GO:0051047 | 0.00000 | 2.79509 | 33 | 80 | 527 | positive regulation of secretion |
| GO:0080090 | 0.00000 | 1.56602 | 327 | 444 | 5248 | regulation of primary metabolic process |
| GO:0006909 | 0.00000 | 3.37294 | 21 | 60 | 336 | phagocytosis |
| GO:0097530 | 0.00000 | 5.22097 | 9 | 37 | 146 | granulocyte migration |
| GO:0010033 | 0.00000 | 1.69851 | 191 | 288 | 3070 | response to organic substance |
| GO:0018108 | 0.00000 | 3.44533 | 20 | 58 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0050714 | 0.00000 | 3.52673 | 19 | 56 | 302 | positive regulation of protein secretion |
| GO:0120036 | 0.00000 | 1.97696 | 95 | 168 | 1526 | plasma membrane bounded cell projection organization |
| GO:1990266 | 0.00000 | 5.89142 | 7 | 33 | 119 | neutrophil migration |
| GO:0051223 | 0.00000 | 2.49134 | 44 | 97 | 708 | regulation of protein transport |
| GO:0051336 | 0.00000 | 2.23345 | 61 | 122 | 985 | regulation of hydrolase activity |
| GO:0080134 | 0.00000 | 2.04161 | 83 | 152 | 1337 | regulation of response to stress |
| GO:0018212 | 0.00000 | 3.40570 | 20 | 58 | 322 | peptidyl-tyrosine modification |
| GO:0060255 | 0.00000 | 1.55000 | 342 | 459 | 5486 | regulation of macromolecule metabolic process |
| GO:0007264 | 0.00000 | 2.85139 | 30 | 75 | 485 | small GTPase mediated signal transduction |
| GO:0007399 | 0.00000 | 1.77996 | 145 | 231 | 2333 | nervous system development |
| GO:0050715 | 0.00000 | 5.03522 | 9 | 37 | 150 | positive regulation of cytokine secretion |
| GO:0032880 | 0.00000 | 2.18424 | 65 | 126 | 1038 | regulation of protein localization |
| GO:0048585 | 0.00000 | 1.94504 | 98 | 171 | 1576 | negative regulation of response to stimulus |
| GO:1905153 | 0.00000 | 35.47939 | 1 | 14 | 20 | regulation of membrane invagination |
| GO:0043549 | 0.00000 | 2.44073 | 45 | 98 | 728 | regulation of kinase activity |
| GO:0070201 | 0.00000 | 2.42386 | 46 | 99 | 740 | regulation of establishment of protein localization |
| GO:0071310 | 0.00000 | 1.75803 | 151 | 238 | 2433 | cellular response to organic substance |
| GO:0051171 | 0.00000 | 1.55466 | 318 | 431 | 5104 | regulation of nitrogen compound metabolic process |
| GO:0002705 | 0.00000 | 4.52774 | 11 | 40 | 176 | positive regulation of leukocyte mediated immunity |
| GO:0071705 | 0.00000 | 1.79785 | 133 | 214 | 2133 | nitrogen compound transport |
| GO:0000165 | 0.00000 | 2.34425 | 49 | 103 | 793 | MAPK cascade |
| GO:0048878 | 0.00000 | 2.07676 | 74 | 137 | 1182 | chemical homeostasis |
| GO:0001906 | 0.00000 | 4.42940 | 11 | 40 | 179 | cell killing |
| GO:0050870 | 0.00000 | 4.32414 | 12 | 41 | 187 | positive regulation of T cell activation |
| GO:0043269 | 0.00000 | 2.39446 | 46 | 97 | 732 | regulation of ion transport |
| GO:0022008 | 0.00000 | 1.85924 | 111 | 185 | 1778 | neurogenesis |
| GO:0042098 | 0.00000 | 4.08996 | 13 | 43 | 205 | T cell proliferation |
| GO:0007265 | 0.00000 | 2.94550 | 26 | 66 | 414 | Ras protein signal transduction |
| GO:0051249 | 0.00000 | 2.62687 | 35 | 80 | 555 | regulation of lymphocyte activation |
| GO:0006812 | 0.00000 | 2.09693 | 69 | 129 | 1101 | cation transport |
| GO:0051222 | 0.00000 | 2.87927 | 27 | 68 | 435 | positive regulation of protein transport |
| GO:1902105 | 0.00000 | 3.40050 | 18 | 53 | 294 | regulation of leukocyte differentiation |
| GO:0002456 | 0.00000 | 5.06773 | 9 | 34 | 137 | T cell mediated immunity |
| GO:0002573 | 0.00000 | 3.94275 | 13 | 44 | 216 | myeloid leukocyte differentiation |
| GO:0051056 | 0.00000 | 3.60279 | 16 | 49 | 259 | regulation of small GTPase mediated signal transduction |
| GO:0045184 | 0.00000 | 1.82646 | 116 | 190 | 1856 | establishment of protein localization |
| GO:0051338 | 0.00000 | 2.26754 | 52 | 105 | 832 | regulation of transferase activity |
| GO:0045766 | 0.00000 | 4.24494 | 12 | 40 | 185 | positive regulation of angiogenesis |
| GO:0051345 | 0.00000 | 2.68437 | 32 | 75 | 510 | positive regulation of hydrolase activity |
| GO:0051130 | 0.00000 | 1.99144 | 80 | 144 | 1290 | positive regulation of cellular component organization |
| GO:0046578 | 0.00000 | 3.79075 | 14 | 45 | 228 | regulation of Ras protein signal transduction |
| GO:0050866 | 0.00000 | 4.01698 | 13 | 42 | 203 | negative regulation of cell activation |
| GO:0043408 | 0.00000 | 2.34519 | 46 | 96 | 737 | regulation of MAPK cascade |
| GO:0060100 | 0.00000 | 45.55687 | 1 | 12 | 16 | positive regulation of phagocytosis, engulfment |
| GO:1905155 | 0.00000 | 45.55687 | 1 | 12 | 16 | positive regulation of membrane invagination |
| GO:0002275 | 0.00000 | 6.74091 | 5 | 26 | 85 | myeloid cell activation involved in immune response |
| GO:1904951 | 0.00000 | 2.78469 | 28 | 69 | 454 | positive regulation of establishment of protein localization |
| GO:0001909 | 0.00000 | 4.87738 | 9 | 34 | 141 | leukocyte mediated cytotoxicity |
| GO:0050920 | 0.00000 | 3.89605 | 13 | 43 | 213 | regulation of chemotaxis |
| GO:0015833 | 0.00000 | 1.82300 | 112 | 184 | 1797 | peptide transport |
| GO:0007162 | 0.00000 | 3.38093 | 18 | 51 | 284 | negative regulation of cell adhesion |
| GO:0019221 | 0.00000 | 3.10614 | 21 | 57 | 341 | cytokine-mediated signaling pathway |
| GO:0050801 | 0.00000 | 2.25227 | 51 | 102 | 812 | ion homeostasis |
| GO:0051707 | 0.00000 | 2.02217 | 73 | 133 | 1172 | response to other organism |
| GO:0030593 | 0.00000 | 5.95354 | 6 | 28 | 100 | neutrophil chemotaxis |
| GO:0009607 | 0.00000 | 2.00552 | 75 | 136 | 1208 | response to biotic stimulus |
| GO:0042063 | 0.00000 | 3.17388 | 20 | 55 | 323 | gliogenesis |
| GO:0043207 | 0.00000 | 2.01809 | 73 | 133 | 1174 | response to external biotic stimulus |
| GO:0002709 | 0.00000 | 6.16641 | 6 | 27 | 94 | regulation of T cell mediated immunity |
| GO:0043299 | 0.00000 | 7.63678 | 4 | 23 | 69 | leukocyte degranulation |
| GO:0045859 | 0.00000 | 2.39410 | 41 | 88 | 662 | regulation of protein kinase activity |
| GO:0045216 | 0.00000 | 4.70075 | 9 | 34 | 145 | cell-cell junction organization |
| GO:0071621 | 0.00000 | 5.16468 | 8 | 31 | 123 | granulocyte chemotaxis |
| GO:0002253 | 0.00000 | 2.58719 | 33 | 75 | 526 | activation of immune response |
| GO:0055085 | 0.00000 | 1.96638 | 79 | 140 | 1266 | transmembrane transport |
| GO:0042886 | 0.00000 | 1.79889 | 113 | 184 | 1817 | amide transport |
| GO:0006820 | 0.00000 | 2.53922 | 34 | 77 | 549 | anion transport |
| GO:0050731 | 0.00000 | 3.96923 | 12 | 40 | 195 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0098771 | 0.00000 | 2.28233 | 46 | 95 | 746 | inorganic ion homeostasis |
| GO:0002444 | 0.00000 | 5.90132 | 6 | 27 | 97 | myeloid leukocyte mediated immunity |
| GO:0000904 | 0.00000 | 2.22425 | 50 | 100 | 804 | cell morphogenesis involved in differentiation |
| GO:0001763 | 0.00000 | 3.55549 | 15 | 45 | 240 | morphogenesis of a branching structure |
| GO:0030031 | 0.00000 | 2.60806 | 31 | 72 | 501 | cell projection assembly |
| GO:0046631 | 0.00000 | 4.40359 | 10 | 35 | 157 | alpha-beta T cell activation |
| GO:0030099 | 0.00000 | 2.83342 | 25 | 62 | 401 | myeloid cell differentiation |
| GO:0001818 | 0.00000 | 3.41793 | 16 | 47 | 259 | negative regulation of cytokine production |
| GO:0051641 | 0.00000 | 1.66196 | 161 | 242 | 2592 | cellular localization |
| GO:0002695 | 0.00000 | 4.05511 | 11 | 38 | 182 | negative regulation of leukocyte activation |
| GO:0030217 | 0.00000 | 3.34949 | 17 | 48 | 269 | T cell differentiation |
| GO:0002286 | 0.00000 | 5.28609 | 7 | 29 | 113 | T cell activation involved in immune response |
| GO:0015711 | 0.00000 | 2.77311 | 26 | 63 | 415 | organic anion transport |
| GO:0051093 | 0.00000 | 2.02493 | 67 | 122 | 1070 | negative regulation of developmental process |
| GO:1903706 | 0.00000 | 2.78336 | 25 | 62 | 407 | regulation of hemopoiesis |
| GO:0032675 | 0.00000 | 4.38311 | 10 | 34 | 153 | regulation of interleukin-6 production |
| GO:0007169 | 0.00000 | 2.47757 | 34 | 76 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0032635 | 0.00000 | 4.22924 | 10 | 35 | 162 | interleukin-6 production |
| GO:0061138 | 0.00000 | 3.61003 | 14 | 42 | 221 | morphogenesis of a branching epithelium |
| GO:0007015 | 0.00000 | 2.78571 | 25 | 61 | 400 | actin filament organization |
| GO:0032642 | 0.00000 | 6.06472 | 5 | 25 | 88 | regulation of chemokine production |
| GO:0050867 | 0.00000 | 2.63727 | 29 | 67 | 461 | positive regulation of cell activation |
| GO:0032722 | 0.00000 | 7.62746 | 4 | 21 | 63 | positive regulation of chemokine production |
| GO:0043069 | 0.00000 | 2.08090 | 58 | 110 | 939 | negative regulation of programmed cell death |
| GO:0002824 | 0.00000 | 4.54132 | 9 | 32 | 140 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0071345 | 0.00000 | 2.09572 | 56 | 107 | 907 | cellular response to cytokine stimulus |
| GO:0048871 | 0.00000 | 2.56715 | 30 | 69 | 486 | multicellular organismal homeostasis |
| GO:0006887 | 0.00000 | 2.82930 | 23 | 58 | 375 | exocytosis |
| GO:0071902 | 0.00000 | 3.20300 | 17 | 48 | 279 | positive regulation of protein serine/threonine kinase activity |
| GO:0015031 | 0.00000 | 1.77125 | 109 | 175 | 1746 | protein transport |
| GO:0046634 | 0.00000 | 5.36311 | 6 | 27 | 104 | regulation of alpha-beta T cell activation |
| GO:0001667 | 0.00000 | 2.73649 | 25 | 61 | 406 | ameboidal-type cell migration |
| GO:0043547 | 0.00000 | 3.58209 | 14 | 41 | 217 | positive regulation of GTPase activity |
| GO:0051091 | 0.00000 | 3.38637 | 15 | 44 | 244 | positive regulation of DNA-binding transcription factor activity |
| GO:0034220 | 0.00000 | 2.10328 | 55 | 104 | 878 | ion transmembrane transport |
| GO:0033627 | 0.00000 | 7.28008 | 4 | 21 | 65 | cell adhesion mediated by integrin |
| GO:0045123 | 0.00000 | 7.28008 | 4 | 21 | 65 | cellular extravasation |
| GO:0050730 | 0.00000 | 3.26503 | 16 | 46 | 263 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0055065 | 0.00000 | 2.28692 | 41 | 85 | 664 | metal ion homeostasis |
| GO:0055080 | 0.00000 | 2.21483 | 46 | 91 | 732 | cation homeostasis |
| GO:0031349 | 0.00000 | 2.81455 | 23 | 57 | 370 | positive regulation of defense response |
| GO:0032602 | 0.00000 | 5.70160 | 6 | 25 | 92 | chemokine production |
| GO:0022607 | 0.00000 | 1.60488 | 175 | 254 | 2807 | cellular component assembly |
| GO:0032970 | 0.00000 | 2.73140 | 24 | 59 | 393 | regulation of actin filament-based process |
| GO:0042129 | 0.00000 | 3.97715 | 11 | 35 | 170 | regulation of T cell proliferation |
| GO:0050727 | 0.00000 | 2.84072 | 22 | 55 | 354 | regulation of inflammatory response |
| GO:0051051 | 0.00000 | 2.42656 | 34 | 73 | 540 | negative regulation of transport |
| GO:0002696 | 0.00000 | 2.59413 | 28 | 64 | 446 | positive regulation of leukocyte activation |
| GO:0002821 | 0.00000 | 4.26352 | 9 | 32 | 147 | positive regulation of adaptive immune response |
| GO:0002009 | 0.00000 | 2.39857 | 34 | 74 | 553 | morphogenesis of an epithelium |
| GO:0051090 | 0.00000 | 2.70670 | 25 | 59 | 396 | regulation of DNA-binding transcription factor activity |
| GO:0072507 | 0.00000 | 2.44762 | 32 | 71 | 521 | divalent inorganic cation homeostasis |
| GO:0019932 | 0.00000 | 2.62839 | 27 | 62 | 427 | second-messenger-mediated signaling |
| GO:0042035 | 0.00000 | 5.03493 | 7 | 27 | 109 | regulation of cytokine biosynthetic process |
| GO:0050921 | 0.00000 | 4.35576 | 9 | 31 | 140 | positive regulation of chemotaxis |
| GO:0043066 | 0.00000 | 2.03494 | 57 | 106 | 921 | negative regulation of apoptotic process |
| GO:0120192 | 0.00000 | 9.24192 | 3 | 17 | 45 | tight junction assembly |
| GO:0090132 | 0.00000 | 3.08011 | 18 | 47 | 282 | epithelium migration |
| GO:1903555 | 0.00000 | 3.94907 | 10 | 34 | 166 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0045576 | 0.00000 | 6.67218 | 4 | 21 | 69 | mast cell activation |
| GO:0002688 | 0.00000 | 4.91459 | 7 | 27 | 111 | regulation of leukocyte chemotaxis |
| GO:0072511 | 0.00000 | 2.49906 | 30 | 66 | 475 | divalent inorganic cation transport |
| GO:0090130 | 0.00000 | 3.05384 | 18 | 47 | 284 | tissue migration |
| GO:0035023 | 0.00000 | 4.37355 | 8 | 30 | 135 | regulation of Rho protein signal transduction |
| GO:0043406 | 0.00000 | 3.41400 | 14 | 40 | 220 | positive regulation of MAP kinase activity |
| GO:1902107 | 0.00000 | 3.88977 | 10 | 34 | 168 | positive regulation of leukocyte differentiation |
| GO:0048017 | 0.00000 | 3.98192 | 10 | 33 | 160 | inositol lipid-mediated signaling |
| GO:0050673 | 0.00000 | 2.59135 | 26 | 61 | 425 | epithelial cell proliferation |
| GO:0120031 | 0.00000 | 2.46501 | 30 | 67 | 488 | plasma membrane bounded cell projection assembly |
| GO:0032956 | 0.00000 | 2.80968 | 21 | 53 | 344 | regulation of actin cytoskeleton organization |
| GO:0051250 | 0.00000 | 4.08493 | 9 | 32 | 152 | negative regulation of lymphocyte activation |
| GO:0060548 | 0.00000 | 1.94887 | 65 | 116 | 1049 | negative regulation of cell death |
| GO:0007266 | 0.00000 | 3.59366 | 12 | 37 | 195 | Rho protein signal transduction |
| GO:0048729 | 0.00000 | 2.20358 | 42 | 84 | 677 | tissue morphogenesis |
| GO:0001936 | 0.00000 | 4.43704 | 8 | 29 | 129 | regulation of endothelial cell proliferation |
| GO:0022408 | 0.00000 | 3.65721 | 12 | 36 | 187 | negative regulation of cell-cell adhesion |
| GO:0071706 | 0.00000 | 3.83221 | 11 | 34 | 170 | tumor necrosis factor superfamily cytokine production |
| GO:0098542 | 0.00000 | 2.21022 | 42 | 83 | 667 | defense response to other organism |
| GO:0070838 | 0.00000 | 2.47173 | 29 | 65 | 472 | divalent metal ion transport |
| GO:0010631 | 0.00000 | 3.02544 | 17 | 46 | 280 | epithelial cell migration |
| GO:0007167 | 0.00000 | 2.02181 | 55 | 102 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0010959 | 0.00000 | 2.56856 | 26 | 60 | 421 | regulation of metal ion transport |
| GO:0002764 | 0.00000 | 2.48163 | 29 | 64 | 463 | immune response-regulating signaling pathway |
| GO:0055082 | 0.00000 | 2.07174 | 50 | 95 | 810 | cellular chemical homeostasis |
| GO:0046942 | 0.00000 | 2.92149 | 19 | 48 | 301 | carboxylic acid transport |
| GO:0031532 | 0.00000 | 5.02432 | 6 | 25 | 101 | actin cytoskeleton reorganization |
| GO:0072503 | 0.00000 | 2.41240 | 31 | 67 | 497 | cellular divalent inorganic cation homeostasis |
| GO:0006816 | 0.00000 | 2.55417 | 26 | 60 | 423 | calcium ion transport |
| GO:0015849 | 0.00000 | 2.90986 | 19 | 48 | 302 | organic acid transport |
| GO:0002690 | 0.00000 | 5.48439 | 5 | 23 | 87 | positive regulation of leukocyte chemotaxis |
| GO:0048015 | 0.00000 | 3.92062 | 10 | 32 | 157 | phosphatidylinositol-mediated signaling |
| GO:0034330 | 0.00000 | 3.11812 | 16 | 43 | 255 | cell junction organization |
| GO:0006801 | 0.00000 | 6.48541 | 4 | 20 | 67 | superoxide metabolic process |
| GO:0042107 | 0.00000 | 4.41403 | 8 | 28 | 125 | cytokine metabolic process |
| GO:0055074 | 0.00000 | 2.41476 | 30 | 66 | 489 | calcium ion homeostasis |
| GO:0042108 | 0.00000 | 6.04134 | 5 | 21 | 74 | positive regulation of cytokine biosynthetic process |
| GO:0048699 | 0.00000 | 1.71976 | 104 | 164 | 1672 | generation of neurons |
| GO:0043087 | 0.00000 | 2.91689 | 18 | 47 | 295 | regulation of GTPase activity |
| GO:0006996 | 0.00000 | 1.50337 | 222 | 303 | 3568 | organelle organization |
| GO:0010648 | 0.00000 | 1.81237 | 81 | 135 | 1306 | negative regulation of cell communication |
| GO:0051271 | 0.00000 | 2.82616 | 20 | 49 | 316 | negative regulation of cellular component movement |
| GO:0097435 | 0.00000 | 2.15704 | 42 | 83 | 681 | supramolecular fiber organization |
| GO:0010573 | 0.00000 | 11.19732 | 2 | 14 | 33 | vascular endothelial growth factor production |
| GO:0007204 | 0.00000 | 2.78043 | 20 | 50 | 327 | positive regulation of cytosolic calcium ion concentration |
| GO:0070830 | 0.00000 | 8.69219 | 3 | 16 | 44 | bicellular tight junction assembly |
| GO:0023057 | 0.00000 | 1.80585 | 82 | 135 | 1310 | negative regulation of signaling |
| GO:0010942 | 0.00000 | 2.13684 | 43 | 84 | 695 | positive regulation of cell death |
| GO:0120193 | 0.00000 | 7.83983 | 3 | 17 | 50 | tight junction organization |
| GO:0019725 | 0.00000 | 1.96599 | 58 | 104 | 930 | cellular homeostasis |
| GO:0050671 | 0.00000 | 4.14543 | 8 | 29 | 136 | positive regulation of lymphocyte proliferation |
| GO:0051092 | 0.00000 | 4.28102 | 8 | 28 | 128 | positive regulation of NF-kappaB transcription factor activity |
| GO:0060562 | 0.00000 | 2.61029 | 24 | 55 | 380 | epithelial tube morphogenesis |
| GO:0070665 | 0.00000 | 3.99140 | 9 | 30 | 145 | positive regulation of leukocyte proliferation |
| GO:0042089 | 0.00000 | 4.38974 | 8 | 27 | 121 | cytokine biosynthetic process |
| GO:0006873 | 0.00000 | 2.15983 | 41 | 80 | 655 | cellular ion homeostasis |
| GO:0032946 | 0.00000 | 4.06899 | 9 | 29 | 138 | positive regulation of mononuclear cell proliferation |
| GO:0032680 | 0.00000 | 3.71151 | 10 | 32 | 164 | regulation of tumor necrosis factor production |
| GO:0031341 | 0.00000 | 4.15575 | 8 | 28 | 131 | regulation of cell killing |
| GO:0045055 | 0.00000 | 3.01471 | 16 | 42 | 256 | regulated exocytosis |
| GO:0002700 | 0.00000 | 3.88938 | 9 | 30 | 148 | regulation of production of molecular mediator of immune response |
| GO:0006874 | 0.00000 | 2.37437 | 29 | 63 | 473 | cellular calcium ion homeostasis |
| GO:0060284 | 0.00000 | 1.85717 | 68 | 116 | 1093 | regulation of cell development |
| GO:0001910 | 0.00000 | 4.54414 | 7 | 25 | 109 | regulation of leukocyte mediated cytotoxicity |
| GO:0050678 | 0.00000 | 2.61782 | 22 | 52 | 358 | regulation of epithelial cell proliferation |
| GO:0032640 | 0.00000 | 3.62853 | 10 | 32 | 167 | tumor necrosis factor production |
| GO:0045088 | 0.00000 | 2.83503 | 18 | 45 | 289 | regulation of innate immune response |
| GO:0010876 | 0.00000 | 2.57611 | 23 | 53 | 370 | lipid localization |
| GO:0044085 | 0.00000 | 1.51308 | 189 | 262 | 3041 | cellular component biogenesis |
| GO:0001894 | 0.00000 | 3.10036 | 14 | 39 | 232 | tissue homeostasis |
| GO:0001935 | 0.00000 | 3.88963 | 9 | 29 | 143 | endothelial cell proliferation |
| GO:0046330 | 0.00000 | 3.88963 | 9 | 29 | 143 | positive regulation of JNK cascade |
| GO:0010574 | 0.00000 | 10.96799 | 2 | 13 | 31 | regulation of vascular endothelial growth factor production |
| GO:0003158 | 0.00000 | 4.26979 | 7 | 26 | 119 | endothelium development |
| GO:0002708 | 0.00000 | 3.85563 | 9 | 29 | 144 | positive regulation of lymphocyte mediated immunity |
| GO:0009617 | 0.00000 | 1.93087 | 56 | 100 | 907 | response to bacterium |
| GO:1901343 | 0.00000 | 4.08418 | 8 | 27 | 128 | negative regulation of vasculature development |
| GO:0044092 | 0.00000 | 1.87705 | 63 | 108 | 1006 | negative regulation of molecular function |
| GO:0042554 | 0.00000 | 9.24826 | 2 | 14 | 37 | superoxide anion generation |
| GO:0072676 | 0.00000 | 4.74107 | 6 | 23 | 97 | lymphocyte migration |
| GO:1903708 | 0.00000 | 3.20757 | 13 | 36 | 208 | positive regulation of hemopoiesis |
| GO:0009611 | 0.00000 | 2.29394 | 31 | 64 | 495 | response to wounding |
| GO:0042102 | 0.00000 | 4.67764 | 6 | 23 | 98 | positive regulation of T cell proliferation |
| GO:0030888 | 0.00000 | 5.78661 | 4 | 19 | 69 | regulation of B cell proliferation |
| GO:0045619 | 0.00000 | 3.39054 | 11 | 33 | 182 | regulation of lymphocyte differentiation |
| GO:0009891 | 0.00000 | 1.61437 | 121 | 180 | 1943 | positive regulation of biosynthetic process |
| GO:0031328 | 0.00000 | 1.62065 | 118 | 177 | 1903 | positive regulation of cellular biosynthetic process |
| GO:0032945 | 0.00000 | 5.08006 | 5 | 21 | 84 | negative regulation of mononuclear cell proliferation |
| GO:0050672 | 0.00000 | 5.08006 | 5 | 21 | 84 | negative regulation of lymphocyte proliferation |
| GO:0072593 | 0.00000 | 2.77005 | 18 | 44 | 288 | reactive oxygen species metabolic process |
| GO:0010810 | 0.00000 | 3.15214 | 13 | 36 | 211 | regulation of cell-substrate adhesion |
| GO:0048771 | 0.00000 | 3.27438 | 12 | 34 | 193 | tissue remodeling |
| GO:0048754 | 0.00000 | 3.34532 | 11 | 33 | 184 | branching morphogenesis of an epithelial tube |
| GO:0010720 | 0.00000 | 2.08045 | 41 | 78 | 659 | positive regulation of cell development |
| GO:0043068 | 0.00000 | 2.09829 | 40 | 76 | 637 | positive regulation of programmed cell death |
| GO:0050777 | 0.00000 | 3.58387 | 10 | 30 | 158 | negative regulation of immune response |
| GO:2000181 | 0.00000 | 4.19324 | 7 | 25 | 116 | negative regulation of blood vessel morphogenesis |
| GO:0044087 | 0.00000 | 1.87800 | 59 | 102 | 948 | regulation of cellular component biogenesis |
| GO:0002292 | 0.00000 | 5.56353 | 4 | 19 | 71 | T cell differentiation involved in immune response |
| GO:0008360 | 0.00000 | 3.66342 | 9 | 29 | 150 | regulation of cell shape |
| GO:0042116 | 0.00000 | 4.72388 | 6 | 22 | 93 | macrophage activation |
| GO:0051817 | 0.00000 | 4.72388 | 6 | 22 | 93 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0010628 | 0.00000 | 1.59929 | 123 | 182 | 1981 | positive regulation of gene expression |
| GO:0006875 | 0.00000 | 2.14927 | 36 | 71 | 582 | cellular metal ion homeostasis |
| GO:0040013 | 0.00000 | 2.59885 | 21 | 48 | 332 | negative regulation of locomotion |
| GO:0071900 | 0.00000 | 2.37463 | 27 | 57 | 427 | regulation of protein serine/threonine kinase activity |
| GO:0034446 | 0.00000 | 4.49711 | 6 | 23 | 101 | substrate adhesion-dependent cell spreading |
| GO:2000379 | 0.00000 | 4.30782 | 7 | 24 | 109 | positive regulation of reactive oxygen species metabolic process |
| GO:0051924 | 0.00000 | 2.80291 | 17 | 42 | 272 | regulation of calcium ion transport |
| GO:0030003 | 0.00000 | 2.08304 | 40 | 76 | 641 | cellular cation homeostasis |
| GO:0002757 | 0.00000 | 2.32701 | 28 | 59 | 450 | immune response-activating signal transduction |
| GO:0002886 | 0.00000 | 5.82868 | 4 | 18 | 65 | regulation of myeloid leukocyte mediated immunity |
| GO:0090322 | 0.00000 | 9.39984 | 2 | 13 | 34 | regulation of superoxide metabolic process |
| GO:0010712 | 0.00000 | 6.75811 | 3 | 16 | 52 | regulation of collagen metabolic process |
| GO:0043065 | 0.00000 | 2.08442 | 39 | 75 | 632 | positive regulation of apoptotic process |
| GO:0098660 | 0.00000 | 2.05956 | 41 | 77 | 656 | inorganic ion transmembrane transport |
| GO:0002693 | 0.00000 | 12.83510 | 1 | 11 | 24 | positive regulation of cellular extravasation |
| GO:0003382 | 0.00000 | 7.35416 | 3 | 15 | 46 | epithelial cell morphogenesis |
| GO:0014065 | 0.00000 | 3.93014 | 8 | 26 | 127 | phosphatidylinositol 3-kinase signaling |
| GO:0051851 | 0.00000 | 5.35698 | 5 | 19 | 73 | modification by host of symbiont morphology or physiology |
| GO:0032874 | 0.00000 | 3.38642 | 11 | 31 | 171 | positive regulation of stress-activated MAPK cascade |
| GO:0070664 | 0.00000 | 4.77589 | 5 | 21 | 88 | negative regulation of leukocyte proliferation |
| GO:0061900 | 0.00000 | 6.57515 | 3 | 16 | 53 | glial cell activation |
| GO:0019216 | 0.00000 | 2.54437 | 21 | 48 | 338 | regulation of lipid metabolic process |
| GO:0034762 | 0.00000 | 2.13706 | 35 | 69 | 568 | regulation of transmembrane transport |
| GO:0070304 | 0.00000 | 3.36224 | 11 | 31 | 172 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0022604 | 0.00000 | 2.19125 | 33 | 65 | 523 | regulation of cell morphogenesis |
| GO:0009968 | 0.00000 | 1.75994 | 73 | 119 | 1175 | negative regulation of signal transduction |
| GO:0070633 | 0.00000 | 15.16028 | 1 | 10 | 20 | transepithelial transport |
| GO:0007229 | 0.00000 | 4.70544 | 6 | 21 | 89 | integrin-mediated signaling pathway |
| GO:0009887 | 0.00000 | 1.78583 | 68 | 112 | 1090 | animal organ morphogenesis |
| GO:0043297 | 0.00000 | 6.40183 | 3 | 16 | 54 | apical junction assembly |
| GO:0010575 | 0.00000 | 11.91776 | 2 | 11 | 25 | positive regulation of vascular endothelial growth factor production |
| GO:0042113 | 0.00000 | 2.36841 | 25 | 54 | 405 | B cell activation |
| GO:0090066 | 0.00000 | 2.13077 | 35 | 68 | 561 | regulation of anatomical structure size |
| GO:0048608 | 0.00000 | 2.28592 | 28 | 58 | 449 | reproductive structure development |
| GO:0051704 | 0.00000 | 1.52841 | 149 | 210 | 2389 | multi-organism process |
| GO:0045834 | 0.00000 | 3.46196 | 10 | 29 | 157 | positive regulation of lipid metabolic process |
| GO:0071674 | 0.00000 | 4.83475 | 5 | 20 | 83 | mononuclear cell migration |
| GO:0030183 | 0.00000 | 3.53460 | 9 | 28 | 149 | B cell differentiation |
| GO:0032755 | 0.00000 | 4.35458 | 6 | 22 | 99 | positive regulation of interleukin-6 production |
| GO:0007043 | 0.00000 | 4.17473 | 7 | 23 | 107 | cell-cell junction assembly |
| GO:0046635 | 0.00000 | 5.37054 | 4 | 18 | 69 | positive regulation of alpha-beta T cell activation |
| GO:0061458 | 0.00000 | 2.26235 | 28 | 58 | 453 | reproductive system development |
| GO:0006464 | 0.00000 | 1.44226 | 215 | 285 | 3453 | cellular protein modification process |
| GO:0036211 | 0.00000 | 1.44226 | 215 | 285 | 3453 | protein modification process |
| GO:0015718 | 0.00000 | 3.50547 | 9 | 28 | 150 | monocarboxylic acid transport |
| GO:0098662 | 0.00000 | 2.05727 | 38 | 72 | 613 | inorganic cation transmembrane transport |
| GO:0048872 | 0.00000 | 2.55893 | 20 | 45 | 315 | homeostasis of number of cells |
| GO:0032102 | 0.00000 | 2.49831 | 21 | 47 | 336 | negative regulation of response to external stimulus |
| GO:0045621 | 0.00000 | 4.12542 | 7 | 23 | 108 | positive regulation of lymphocyte differentiation |
| GO:0035710 | 0.00000 | 4.29856 | 6 | 22 | 100 | CD4-positive, alpha-beta T cell activation |
| GO:0010632 | 0.00000 | 2.91676 | 14 | 36 | 225 | regulation of epithelial cell migration |
| GO:0043405 | 0.00000 | 2.61831 | 18 | 43 | 295 | regulation of MAP kinase activity |
| GO:0035821 | 0.00000 | 3.38221 | 10 | 29 | 160 | modification of morphology or physiology of other organism |
| GO:0042093 | 0.00000 | 5.62086 | 4 | 17 | 63 | T-helper cell differentiation |
| GO:0002698 | 0.00000 | 3.67422 | 8 | 26 | 134 | negative regulation of immune effector process |
| GO:0007017 | 0.00000 | 1.92839 | 47 | 84 | 759 | microtubule-based process |
| GO:0043542 | 0.00000 | 3.05949 | 12 | 33 | 198 | endothelial cell migration |
| GO:0051649 | 0.00000 | 1.57212 | 119 | 173 | 1906 | establishment of localization in cell |
| GO:0002711 | 0.00000 | 5.16740 | 4 | 18 | 71 | positive regulation of T cell mediated immunity |
| GO:0014068 | 0.00000 | 5.16740 | 4 | 18 | 71 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0098655 | 0.00000 | 1.97218 | 43 | 78 | 690 | cation transmembrane transport |
| GO:0001776 | 0.00000 | 4.03021 | 7 | 23 | 110 | leukocyte homeostasis |
| GO:0002294 | 0.00000 | 5.50101 | 4 | 17 | 64 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0002367 | 0.00000 | 4.19071 | 6 | 22 | 102 | cytokine production involved in immune response |
| GO:0030336 | 0.00000 | 2.68927 | 17 | 40 | 268 | negative regulation of cell migration |
| GO:0051251 | 0.00000 | 2.33833 | 25 | 52 | 394 | positive regulation of lymphocyte activation |
| GO:1901700 | 0.00000 | 1.62274 | 99 | 149 | 1589 | response to oxygen-containing compound |
| GO:0019722 | 0.00000 | 2.97281 | 13 | 34 | 209 | calcium-mediated signaling |
| GO:0040007 | 0.00000 | 1.75354 | 68 | 111 | 1097 | growth |
| GO:0051702 | 0.00000 | 4.81995 | 5 | 19 | 79 | interaction with symbiont |
| GO:2000377 | 0.00000 | 3.02257 | 12 | 33 | 200 | regulation of reactive oxygen species metabolic process |
| GO:0010001 | 0.00000 | 2.80516 | 15 | 37 | 239 | glial cell differentiation |
| GO:0051480 | 0.00000 | 2.37190 | 23 | 50 | 374 | regulation of cytosolic calcium ion concentration |
| GO:0002221 | 0.00000 | 3.57442 | 9 | 26 | 137 | pattern recognition receptor signaling pathway |
| GO:0034341 | 0.00000 | 3.57442 | 9 | 26 | 137 | response to interferon-gamma |
| GO:0002293 | 0.00000 | 5.38616 | 4 | 17 | 65 | alpha-beta T cell differentiation involved in immune response |
| GO:0150076 | 0.00000 | 5.38616 | 4 | 17 | 65 | neuroinflammatory response |
| GO:0072678 | 0.00000 | 5.79106 | 4 | 16 | 58 | T cell migration |
| GO:0032535 | 0.00000 | 2.31768 | 25 | 52 | 397 | regulation of cellular component size |
| GO:2000146 | 0.00000 | 2.61908 | 17 | 41 | 281 | negative regulation of cell motility |
| GO:0001774 | 0.00000 | 6.85909 | 3 | 14 | 45 | microglial cell activation |
| GO:0002269 | 0.00000 | 6.85909 | 3 | 14 | 45 | leukocyte activation involved in inflammatory response |
| GO:0002888 | 0.00000 | 6.85909 | 3 | 14 | 45 | positive regulation of myeloid leukocyte mediated immunity |
| GO:0032965 | 0.00000 | 6.85909 | 3 | 14 | 45 | regulation of collagen biosynthetic process |
| GO:0016525 | 0.00000 | 3.93928 | 7 | 23 | 112 | negative regulation of angiogenesis |
| GO:0046632 | 0.00000 | 3.93928 | 7 | 23 | 112 | alpha-beta T cell differentiation |
| GO:0002691 | 0.00000 | 8.67072 | 2 | 12 | 33 | regulation of cellular extravasation |
| GO:0009889 | 0.00000 | 1.42269 | 221 | 289 | 3542 | regulation of biosynthetic process |
| GO:0032612 | 0.00000 | 4.08812 | 6 | 22 | 104 | interleukin-1 production |
| GO:0014066 | 0.00000 | 4.26489 | 6 | 21 | 96 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0010692 | 0.00000 | 35.31154 | 1 | 7 | 10 | regulation of alkaline phosphatase activity |
| GO:0002291 | 0.00000 | 90.74635 | 0 | 6 | 7 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0002287 | 0.00000 | 5.27600 | 4 | 17 | 66 | alpha-beta T cell activation involved in immune response |
| GO:0050767 | 0.00000 | 1.79441 | 60 | 99 | 956 | regulation of neurogenesis |
| GO:0002758 | 0.00000 | 3.51084 | 9 | 26 | 139 | innate immune response-activating signal transduction |
| GO:0014015 | 0.00000 | 4.41312 | 6 | 20 | 89 | positive regulation of gliogenesis |
| GO:0060341 | 0.00000 | 1.79006 | 60 | 99 | 958 | regulation of cellular localization |
| GO:1903038 | 0.00000 | 3.59736 | 8 | 25 | 131 | negative regulation of leukocyte cell-cell adhesion |
| GO:1901564 | 0.00000 | 1.33819 | 388 | 470 | 6234 | organonitrogen compound metabolic process |
| GO:0048589 | 0.00000 | 1.87527 | 49 | 85 | 787 | developmental growth |
| GO:0031326 | 0.00000 | 1.41970 | 216 | 283 | 3470 | regulation of cellular biosynthetic process |
| GO:1902624 | 0.00000 | 8.27622 | 2 | 12 | 34 | positive regulation of neutrophil migration |
| GO:0001885 | 0.00000 | 5.17024 | 4 | 17 | 67 | endothelial cell development |
| GO:0051493 | 0.00000 | 2.08163 | 33 | 64 | 538 | regulation of cytoskeleton organization |
| GO:0034113 | 0.00000 | 5.99752 | 3 | 15 | 53 | heterotypic cell-cell adhesion |
| GO:0007267 | 0.00000 | 1.60108 | 99 | 148 | 1596 | cell-cell signaling |
| GO:0033043 | 0.00000 | 1.68301 | 77 | 121 | 1242 | regulation of organelle organization |
| GO:0022612 | 0.00000 | 3.35027 | 9 | 27 | 150 | gland morphogenesis |
| GO:0045580 | 0.00000 | 3.35027 | 9 | 27 | 150 | regulation of T cell differentiation |
| GO:0010557 | 0.00000 | 1.56437 | 112 | 163 | 1799 | positive regulation of macromolecule biosynthetic process |
| GO:0048010 | 0.00000 | 6.44279 | 3 | 14 | 47 | vascular endothelial growth factor receptor signaling pathway |
| GO:0048002 | 0.00000 | 5.06863 | 4 | 17 | 68 | antigen processing and presentation of peptide antigen |
| GO:0006869 | 0.00000 | 2.42256 | 21 | 45 | 330 | lipid transport |
| GO:0050729 | 0.00000 | 3.41956 | 9 | 26 | 142 | positive regulation of inflammatory response |
| GO:0032964 | 0.00000 | 5.84346 | 3 | 15 | 54 | collagen biosynthetic process |
| GO:0046890 | 0.00000 | 3.14088 | 11 | 29 | 170 | regulation of lipid biosynthetic process |
| GO:0002761 | 0.00000 | 3.62272 | 8 | 24 | 125 | regulation of myeloid leukocyte differentiation |
| GO:0032656 | 0.00000 | 13.63475 | 1 | 9 | 19 | regulation of interleukin-13 production |
| GO:0002702 | 0.00000 | 4.04820 | 6 | 21 | 100 | positive regulation of production of molecular mediator of immune response |
| GO:0031343 | 0.00000 | 4.04820 | 6 | 21 | 100 | positive regulation of cell killing |
| GO:0034103 | 0.00000 | 4.44816 | 5 | 19 | 84 | regulation of tissue remodeling |
| GO:0032928 | 0.00000 | 10.82678 | 1 | 10 | 24 | regulation of superoxide anion generation |
| GO:0031098 | 0.00000 | 2.52336 | 18 | 41 | 290 | stress-activated protein kinase signaling cascade |
| GO:0051960 | 0.00000 | 1.72558 | 67 | 107 | 1071 | regulation of nervous system development |
| GO:0050769 | 0.00000 | 2.01423 | 36 | 67 | 580 | positive regulation of neurogenesis |
| GO:0043303 | 0.00000 | 6.25301 | 3 | 14 | 48 | mast cell degranulation |
| GO:0043412 | 0.00000 | 1.40256 | 226 | 293 | 3634 | macromolecule modification |
| GO:0018193 | 0.00000 | 1.70009 | 71 | 112 | 1137 | peptidyl-amino acid modification |
| GO:0002237 | 0.00000 | 2.29404 | 23 | 49 | 377 | response to molecule of bacterial origin |
| GO:0034765 | 0.00000 | 2.12519 | 30 | 58 | 478 | regulation of ion transmembrane transport |
| GO:0045596 | 0.00000 | 1.84270 | 50 | 85 | 799 | negative regulation of cell differentiation |
| GO:0010811 | 0.00000 | 3.55205 | 8 | 24 | 127 | positive regulation of cell-substrate adhesion |
| GO:0043129 | 0.00000 | 17.30430 | 1 | 8 | 15 | surfactant homeostasis |
| GO:0019882 | 0.00000 | 3.80833 | 7 | 22 | 110 | antigen processing and presentation |
| GO:0007417 | 0.00000 | 1.79124 | 55 | 92 | 888 | central nervous system development |
| GO:0050868 | 0.00000 | 3.65087 | 7 | 23 | 119 | negative regulation of T cell activation |
| GO:0002218 | 0.00000 | 3.14258 | 10 | 28 | 164 | activation of innate immune response |
| GO:0002260 | 0.00000 | 4.56307 | 5 | 18 | 78 | lymphocyte homeostasis |
| GO:0043507 | 0.00000 | 4.56307 | 5 | 18 | 78 | positive regulation of JUN kinase activity |
| GO:0002279 | 0.00000 | 6.07407 | 3 | 14 | 49 | mast cell activation involved in immune response |
| GO:0002448 | 0.00000 | 6.07407 | 3 | 14 | 49 | mast cell mediated immunity |
| GO:0043300 | 0.00000 | 6.07407 | 3 | 14 | 49 | regulation of leukocyte degranulation |
| GO:0006898 | 0.00000 | 2.76557 | 14 | 34 | 222 | receptor-mediated endocytosis |
| GO:0045089 | 0.00000 | 2.71764 | 14 | 35 | 232 | positive regulation of innate immune response |
| GO:0002704 | 0.00000 | 5.55791 | 3 | 15 | 56 | negative regulation of leukocyte mediated immunity |
| GO:0072006 | 0.00000 | 3.30497 | 9 | 26 | 146 | nephron development |
| GO:0048568 | 0.00000 | 2.09223 | 31 | 59 | 493 | embryonic organ development |
| GO:0021782 | 0.00000 | 3.76536 | 7 | 22 | 111 | glial cell development |
| GO:0071677 | 0.00000 | 10.10453 | 2 | 10 | 25 | positive regulation of mononuclear cell migration |
| GO:0002224 | 0.00000 | 3.89955 | 6 | 21 | 103 | toll-like receptor signaling pathway |
| GO:0042060 | 0.00000 | 2.30417 | 22 | 47 | 360 | wound healing |
| GO:0045582 | 0.00000 | 4.05895 | 6 | 20 | 95 | positive regulation of T cell differentiation |
| GO:0007018 | 0.00000 | 2.53041 | 17 | 39 | 275 | microtubule-based movement |
| GO:2000514 | 0.00000 | 5.06578 | 4 | 16 | 64 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0032715 | 0.00000 | 5.90508 | 3 | 14 | 50 | negative regulation of interleukin-6 production |
| GO:0033003 | 0.00000 | 5.90508 | 3 | 14 | 50 | regulation of mast cell activation |
| GO:0043254 | 0.00000 | 2.13519 | 28 | 55 | 451 | regulation of protein complex assembly |
| GO:0034329 | 0.00000 | 2.81016 | 13 | 32 | 206 | cell junction assembly |
| GO:0030182 | 0.00000 | 1.58915 | 93 | 138 | 1494 | neuron differentiation |
| GO:0050918 | 0.00000 | 6.36471 | 3 | 13 | 44 | positive chemotaxis |
| GO:0044089 | 0.00000 | 2.02239 | 33 | 62 | 534 | positive regulation of cellular component biogenesis |
| GO:0032835 | 0.00000 | 5.29891 | 4 | 15 | 58 | glomerulus development |
| GO:0090196 | 0.00000 | 15.14057 | 1 | 8 | 16 | regulation of chemokine secretion |
| GO:0043367 | 0.00000 | 4.34518 | 5 | 18 | 81 | CD4-positive, alpha-beta T cell differentiation |
| GO:0032147 | 0.00000 | 2.59755 | 15 | 36 | 248 | activation of protein kinase activity |
| GO:2000403 | 0.00000 | 7.00166 | 2 | 12 | 38 | positive regulation of lymphocyte migration |
| GO:0048732 | 0.00000 | 2.09471 | 29 | 56 | 467 | gland development |
| GO:0030162 | 0.00000 | 1.86089 | 45 | 77 | 716 | regulation of proteolysis |
| GO:0045446 | 0.00000 | 3.76140 | 7 | 21 | 106 | endothelial cell differentiation |
| GO:0042535 | 0.00000 | 11.36125 | 1 | 9 | 21 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0044057 | 0.00000 | 1.95183 | 37 | 67 | 596 | regulation of system process |
| GO:0032623 | 0.00000 | 4.86270 | 4 | 16 | 66 | interleukin-2 production |
| GO:0050679 | 0.00000 | 2.81836 | 12 | 31 | 199 | positive regulation of epithelial cell proliferation |
| GO:0031175 | 0.00000 | 1.68439 | 67 | 106 | 1083 | neuron projection development |
| GO:0002718 | 0.00000 | 4.27709 | 5 | 18 | 82 | regulation of cytokine production involved in immune response |
| GO:0090287 | 0.00000 | 2.49585 | 17 | 38 | 271 | regulation of cellular response to growth factor stimulus |
| GO:0046777 | 0.00000 | 2.61062 | 15 | 35 | 240 | protein autophosphorylation |
| GO:0031348 | 0.00000 | 2.69680 | 14 | 33 | 220 | negative regulation of defense response |
| GO:0043900 | 0.00000 | 2.19869 | 24 | 49 | 391 | regulation of multi-organism process |
| GO:0010634 | 0.00000 | 3.22974 | 9 | 25 | 143 | positive regulation of epithelial cell migration |
| GO:1903557 | 0.00000 | 3.85272 | 6 | 20 | 99 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0001938 | 0.00000 | 4.01441 | 6 | 19 | 91 | positive regulation of endothelial cell proliferation |
| GO:0032652 | 0.00000 | 4.01441 | 6 | 19 | 91 | regulation of interleukin-1 production |
| GO:0048305 | 0.00000 | 8.91494 | 2 | 10 | 27 | immunoglobulin secretion |
| GO:0035725 | 0.00000 | 3.67459 | 7 | 21 | 108 | sodium ion transmembrane transport |
| GO:0046850 | 0.00000 | 5.06294 | 4 | 15 | 60 | regulation of bone remodeling |
| GO:0051656 | 0.00000 | 2.06399 | 29 | 56 | 473 | establishment of organelle localization |
| GO:0002707 | 0.00000 | 5.97842 | 3 | 13 | 46 | negative regulation of lymphocyte mediated immunity |
| GO:0001578 | 0.00000 | 3.80439 | 6 | 20 | 100 | microtubule bundle formation |
| GO:0051962 | 0.00000 | 1.88744 | 41 | 71 | 651 | positive regulation of nervous system development |
| GO:0045862 | 0.00000 | 2.31158 | 20 | 43 | 328 | positive regulation of proteolysis |
| GO:0048875 | 0.00000 | 13.45767 | 1 | 8 | 17 | chemical homeostasis within a tissue |
| GO:0090195 | 0.00000 | 13.45767 | 1 | 8 | 17 | chemokine secretion |
| GO:0032616 | 0.00000 | 10.48682 | 1 | 9 | 22 | interleukin-13 production |
| GO:0045624 | 0.00000 | 10.48682 | 1 | 9 | 22 | positive regulation of T-helper cell differentiation |
| GO:0001913 | 0.00000 | 4.37974 | 5 | 17 | 76 | T cell mediated cytotoxicity |
| GO:1903307 | 0.00000 | 4.95265 | 4 | 15 | 61 | positive regulation of regulated secretory pathway |
| GO:0007160 | 0.00000 | 2.73627 | 13 | 31 | 204 | cell-matrix adhesion |
| GO:0001914 | 0.00000 | 5.31359 | 3 | 14 | 54 | regulation of T cell mediated cytotoxicity |
| GO:0051640 | 0.00000 | 1.91759 | 37 | 66 | 596 | organelle localization |
| GO:0031334 | 0.00000 | 2.53568 | 15 | 35 | 246 | positive regulation of protein complex assembly |
| GO:0002831 | 0.00000 | 3.12327 | 9 | 25 | 147 | regulation of response to biotic stimulus |
| GO:0060271 | 0.00000 | 2.36398 | 19 | 40 | 299 | cilium assembly |
| GO:0050830 | 0.00000 | 3.30492 | 8 | 23 | 129 | defense response to Gram-positive bacterium |
| GO:0010594 | 0.00000 | 3.02591 | 10 | 26 | 157 | regulation of endothelial cell migration |
| GO:0051235 | 0.00000 | 2.29704 | 20 | 42 | 322 | maintenance of location |
| GO:0001912 | 0.00000 | 4.02475 | 5 | 18 | 86 | positive regulation of leukocyte mediated cytotoxicity |
| GO:0032611 | 0.00000 | 4.02475 | 5 | 18 | 86 | interleukin-1 beta production |
| GO:0033628 | 0.00000 | 6.27649 | 3 | 12 | 41 | regulation of cell adhesion mediated by integrin |
| GO:0042130 | 0.00000 | 4.50167 | 4 | 16 | 70 | negative regulation of T cell proliferation |
| GO:1990868 | 0.00000 | 4.50167 | 4 | 16 | 70 | response to chemokine |
| GO:1990869 | 0.00000 | 4.50167 | 4 | 16 | 70 | cellular response to chemokine |
| GO:0002548 | 0.00000 | 5.18375 | 3 | 14 | 55 | monocyte chemotaxis |
| GO:0070925 | 0.00000 | 1.77375 | 50 | 82 | 796 | organelle assembly |
| GO:0042100 | 0.00001 | 3.51242 | 7 | 21 | 112 | B cell proliferation |
| GO:0002440 | 0.00001 | 2.23954 | 21 | 44 | 345 | production of molecular mediator of immune response |
| GO:0033993 | 0.00001 | 1.75850 | 51 | 84 | 822 | response to lipid |
| GO:0060560 | 0.00001 | 2.42844 | 17 | 37 | 270 | developmental growth involved in morphogenesis |
| GO:1903556 | 0.00001 | 4.74585 | 4 | 15 | 63 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:2000249 | 0.00001 | 6.94883 | 2 | 11 | 35 | regulation of actin cytoskeleton reorganization |
| GO:0046328 | 0.00001 | 2.78299 | 12 | 29 | 188 | regulation of JNK cascade |
| GO:0002526 | 0.00001 | 3.34947 | 8 | 22 | 122 | acute inflammatory response |
| GO:0008015 | 0.00001 | 2.00990 | 30 | 56 | 484 | blood circulation |
| GO:0060249 | 0.00001 | 2.13957 | 24 | 48 | 392 | anatomical structure homeostasis |
| GO:0001659 | 0.00001 | 2.82844 | 11 | 28 | 179 | temperature homeostasis |
| GO:0120162 | 0.00001 | 3.75286 | 6 | 19 | 96 | positive regulation of cold-induced thermogenesis |
| GO:1902622 | 0.00001 | 6.06699 | 3 | 12 | 42 | regulation of neutrophil migration |
| GO:0032496 | 0.00001 | 2.19585 | 22 | 45 | 359 | response to lipopolysaccharide |
| GO:0060541 | 0.00001 | 2.47641 | 16 | 35 | 251 | respiratory system development |
| GO:1904062 | 0.00001 | 2.20976 | 22 | 44 | 349 | regulation of cation transmembrane transport |
| GO:0002312 | 0.00001 | 4.10091 | 5 | 17 | 80 | B cell activation involved in immune response |
| GO:0023061 | 0.00001 | 1.95421 | 33 | 59 | 523 | signal release |
| GO:2000516 | 0.00001 | 6.67057 | 2 | 11 | 36 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0072677 | 0.00001 | 9.08774 | 1 | 9 | 24 | eosinophil migration |
| GO:0042533 | 0.00001 | 7.57666 | 2 | 10 | 30 | tumor necrosis factor biosynthetic process |
| GO:0042534 | 0.00001 | 7.57666 | 2 | 10 | 30 | regulation of tumor necrosis factor biosynthetic process |
| GO:0043372 | 0.00001 | 7.57666 | 2 | 10 | 30 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0043086 | 0.00001 | 1.81863 | 42 | 72 | 682 | negative regulation of catalytic activity |
| GO:0071675 | 0.00001 | 5.33112 | 3 | 13 | 50 | regulation of mononuclear cell migration |
| GO:0043277 | 0.00001 | 5.87101 | 3 | 12 | 43 | apoptotic cell clearance |
| GO:0032736 | 0.00001 | 15.13074 | 1 | 7 | 14 | positive regulation of interleukin-13 production |
| GO:0070486 | 0.00001 | 15.13074 | 1 | 7 | 14 | leukocyte aggregation |
| GO:0007254 | 0.00001 | 2.66164 | 13 | 30 | 202 | JNK cascade |
| GO:0098742 | 0.00001 | 2.66164 | 13 | 30 | 202 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0032760 | 0.00001 | 3.65752 | 6 | 19 | 98 | positive regulation of tumor necrosis factor production |
| GO:0038061 | 0.00001 | 3.49716 | 7 | 20 | 107 | NIK/NF-kappaB signaling |
| GO:0002040 | 0.00001 | 3.36391 | 7 | 21 | 116 | sprouting angiogenesis |
| GO:0017157 | 0.00001 | 2.47332 | 15 | 34 | 244 | regulation of exocytosis |
| GO:0032663 | 0.00001 | 4.82965 | 4 | 14 | 58 | regulation of interleukin-2 production |
| GO:0045921 | 0.00001 | 3.61163 | 6 | 19 | 99 | positive regulation of exocytosis |
| GO:0052547 | 0.00001 | 2.07528 | 26 | 49 | 411 | regulation of peptidase activity |
| GO:0001782 | 0.00001 | 6.41372 | 2 | 11 | 37 | B cell homeostasis |
| GO:0042092 | 0.00001 | 6.41372 | 2 | 11 | 37 | type 2 immune response |
| GO:0030316 | 0.00001 | 3.45726 | 7 | 20 | 108 | osteoclast differentiation |
| GO:0031324 | 0.00001 | 1.42044 | 152 | 203 | 2449 | negative regulation of cellular metabolic process |
| GO:0010556 | 0.00001 | 1.36634 | 206 | 263 | 3311 | regulation of macromolecule biosynthetic process |
| GO:0045893 | 0.00001 | 1.52476 | 96 | 137 | 1536 | positive regulation of transcription, DNA-templated |
| GO:0009991 | 0.00001 | 2.08414 | 25 | 48 | 401 | response to extracellular stimulus |
| GO:0045637 | 0.00001 | 2.57138 | 13 | 31 | 215 | regulation of myeloid cell differentiation |
| GO:0051403 | 0.00001 | 2.40881 | 16 | 35 | 257 | stress-activated MAPK cascade |
| GO:0043302 | 0.00001 | 7.21553 | 2 | 10 | 31 | positive regulation of leukocyte degranulation |
| GO:0090023 | 0.00001 | 8.51937 | 2 | 9 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0003013 | 0.00001 | 1.95853 | 31 | 56 | 495 | circulatory system process |
| GO:0008152 | 0.00001 | 1.26071 | 653 | 731 | 10485 | metabolic process |
| GO:2000401 | 0.00001 | 4.72211 | 4 | 14 | 59 | regulation of lymphocyte migration |
| GO:0032418 | 0.00001 | 4.11923 | 5 | 16 | 75 | lysosome localization |
| GO:1990845 | 0.00001 | 2.90748 | 10 | 25 | 156 | adaptive thermogenesis |
| GO:0000226 | 0.00001 | 1.88348 | 35 | 62 | 568 | microtubule cytoskeleton organization |
| GO:1903508 | 0.00001 | 1.52011 | 96 | 137 | 1540 | positive regulation of nucleic acid-templated transcription |
| GO:0051607 | 0.00001 | 2.50509 | 14 | 32 | 227 | defense response to virus |
| GO:1902680 | 0.00001 | 1.51895 | 96 | 137 | 1541 | positive regulation of RNA biosynthetic process |
| GO:0010468 | 0.00001 | 1.33985 | 240 | 300 | 3860 | regulation of gene expression |
| GO:0030851 | 0.00001 | 6.17589 | 2 | 11 | 38 | granulocyte differentiation |
| GO:1901222 | 0.00001 | 3.52322 | 6 | 19 | 101 | regulation of NIK/NF-kappaB signaling |
| GO:2001141 | 0.00001 | 1.38953 | 174 | 227 | 2801 | regulation of RNA biosynthetic process |
| GO:0040008 | 0.00001 | 1.77304 | 45 | 74 | 717 | regulation of growth |
| GO:0061028 | 0.00001 | 5.51469 | 3 | 12 | 45 | establishment of endothelial barrier |
| GO:0002523 | 0.00001 | 10.09186 | 1 | 8 | 20 | leukocyte migration involved in inflammatory response |
| GO:0033630 | 0.00001 | 10.09186 | 1 | 8 | 20 | positive regulation of cell adhesion mediated by integrin |
| GO:0035082 | 0.00001 | 4.29714 | 4 | 15 | 68 | axoneme assembly |
| GO:0046637 | 0.00001 | 4.29714 | 4 | 15 | 68 | regulation of alpha-beta T cell differentiation |
| GO:0090197 | 0.00001 | 13.23879 | 1 | 7 | 15 | positive regulation of chemokine secretion |
| GO:0043506 | 0.00001 | 3.64793 | 6 | 18 | 93 | regulation of JUN kinase activity |
| GO:0019218 | 0.00002 | 3.48061 | 6 | 19 | 102 | regulation of steroid metabolic process |
| GO:0019538 | 0.00002 | 1.29748 | 333 | 399 | 5344 | protein metabolic process |
| GO:0002446 | 0.00002 | 6.88723 | 2 | 10 | 32 | neutrophil mediated immunity |
| GO:0002486 | 0.00002 | 6.88723 | 2 | 10 | 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
| GO:0030947 | 0.00002 | 6.88723 | 2 | 10 | 32 | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0051048 | 0.00002 | 2.36573 | 16 | 35 | 261 | negative regulation of secretion |
| GO:0044782 | 0.00002 | 2.19313 | 20 | 41 | 327 | cilium organization |
| GO:0002720 | 0.00002 | 4.93060 | 3 | 13 | 53 | positive regulation of cytokine production involved in immune response |
| GO:0032774 | 0.00002 | 1.37899 | 180 | 233 | 2896 | RNA biosynthetic process |
| GO:0009620 | 0.00002 | 5.95505 | 2 | 11 | 39 | response to fungus |
| GO:0050798 | 0.00002 | 5.35224 | 3 | 12 | 46 | activated T cell proliferation |
| GO:0001889 | 0.00002 | 3.19498 | 8 | 21 | 121 | liver development |
| GO:1903034 | 0.00002 | 2.70744 | 11 | 27 | 179 | regulation of response to wounding |
| GO:0045630 | 0.00002 | 37.78299 | 0 | 5 | 7 | positive regulation of T-helper 2 cell differentiation |
| GO:0001892 | 0.00002 | 3.30633 | 7 | 20 | 112 | embryonic placenta development |
| GO:0014013 | 0.00002 | 2.90057 | 9 | 24 | 150 | regulation of gliogenesis |
| GO:0006814 | 0.00002 | 2.52824 | 13 | 30 | 211 | sodium ion transport |
| GO:0006629 | 0.00002 | 1.56002 | 78 | 115 | 1258 | lipid metabolic process |
| GO:0032872 | 0.00002 | 2.44190 | 14 | 32 | 232 | regulation of stress-activated MAPK cascade |
| GO:1904019 | 0.00002 | 3.27063 | 7 | 20 | 113 | epithelial cell apoptotic process |
| GO:0002476 | 0.00002 | 6.58749 | 2 | 10 | 33 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
| GO:0002484 | 0.00002 | 6.58749 | 2 | 10 | 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway |
| GO:1903506 | 0.00002 | 1.37928 | 174 | 225 | 2792 | regulation of nucleic acid-templated transcription |
| GO:0032720 | 0.00002 | 4.42636 | 4 | 14 | 62 | negative regulation of tumor necrosis factor production |
| GO:0003341 | 0.00002 | 4.14050 | 4 | 15 | 70 | cilium movement |
| GO:0032930 | 0.00002 | 9.31513 | 1 | 8 | 21 | positive regulation of superoxide anion generation |
| GO:0002820 | 0.00002 | 5.19908 | 3 | 12 | 47 | negative regulation of adaptive immune response |
| GO:0106106 | 0.00002 | 2.94211 | 9 | 23 | 142 | cold-induced thermogenesis |
| GO:0120161 | 0.00002 | 2.94211 | 9 | 23 | 142 | regulation of cold-induced thermogenesis |
| GO:0002369 | 0.00002 | 5.74943 | 2 | 11 | 40 | T cell cytokine production |
| GO:0046456 | 0.00002 | 5.74943 | 2 | 11 | 40 | icosanoid biosynthetic process |
| GO:0046633 | 0.00002 | 5.74943 | 2 | 11 | 40 | alpha-beta T cell proliferation |
| GO:0048666 | 0.00002 | 1.56347 | 76 | 112 | 1222 | neuron development |
| GO:0045408 | 0.00002 | 7.57208 | 2 | 9 | 27 | regulation of interleukin-6 biosynthetic process |
| GO:0071624 | 0.00002 | 7.57208 | 2 | 9 | 27 | positive regulation of granulocyte chemotaxis |
| GO:0007200 | 0.00002 | 3.50714 | 6 | 18 | 96 | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0050709 | 0.00002 | 2.85499 | 9 | 24 | 152 | negative regulation of protein secretion |
| GO:0097659 | 0.00002 | 1.37135 | 179 | 231 | 2883 | nucleic acid-templated transcription |
| GO:0002792 | 0.00002 | 2.77938 | 10 | 25 | 162 | negative regulation of peptide secretion |
| GO:0007272 | 0.00002 | 2.77938 | 10 | 25 | 162 | ensheathment of neurons |
| GO:0008366 | 0.00002 | 2.77938 | 10 | 25 | 162 | axon ensheathment |
| GO:0070302 | 0.00002 | 2.41750 | 15 | 32 | 234 | regulation of stress-activated protein kinase signaling cascade |
| GO:0034763 | 0.00002 | 3.01601 | 8 | 22 | 133 | negative regulation of transmembrane transport |
| GO:0051129 | 0.00002 | 1.72399 | 47 | 76 | 755 | negative regulation of cellular component organization |
| GO:0006355 | 0.00002 | 1.37628 | 173 | 224 | 2784 | regulation of transcription, DNA-templated |
| GO:0043270 | 0.00002 | 2.16885 | 20 | 40 | 322 | positive regulation of ion transport |
| GO:0051346 | 0.00002 | 2.02758 | 25 | 47 | 402 | negative regulation of hydrolase activity |
| GO:0032655 | 0.00002 | 4.69538 | 3 | 13 | 55 | regulation of interleukin-12 production |
| GO:0050701 | 0.00002 | 4.69538 | 3 | 13 | 55 | interleukin-1 secretion |
| GO:0033631 | 0.00002 | 11.76727 | 1 | 7 | 16 | cell-cell adhesion mediated by integrin |
| GO:0072672 | 0.00002 | 11.76727 | 1 | 7 | 16 | neutrophil extravasation |
| GO:0061008 | 0.00003 | 3.10149 | 8 | 21 | 124 | hepaticobiliary system development |
| GO:0045944 | 0.00003 | 1.55756 | 76 | 112 | 1226 | positive regulation of transcription by RNA polymerase II |
| GO:0071346 | 0.00003 | 3.20148 | 7 | 20 | 115 | cellular response to interferon-gamma |
| GO:0001655 | 0.00003 | 2.11333 | 22 | 42 | 346 | urogenital system development |
| GO:0006351 | 0.00003 | 1.36840 | 179 | 230 | 2875 | transcription, DNA-templated |
| GO:0051252 | 0.00003 | 1.35863 | 190 | 242 | 3049 | regulation of RNA metabolic process |
| GO:0002428 | 0.00003 | 6.31272 | 2 | 10 | 34 | antigen processing and presentation of peptide antigen via MHC class Ib |
| GO:0050869 | 0.00003 | 6.31272 | 2 | 10 | 34 | negative regulation of B cell activation |
| GO:2000406 | 0.00003 | 6.31272 | 2 | 10 | 34 | positive regulation of T cell migration |
| GO:0034613 | 0.00003 | 1.47411 | 104 | 145 | 1676 | cellular protein localization |
| GO:2000116 | 0.00003 | 2.42509 | 14 | 31 | 226 | regulation of cysteine-type endopeptidase activity |
| GO:0098739 | 0.00003 | 3.16798 | 7 | 20 | 116 | import across plasma membrane |
| GO:0014074 | 0.00003 | 3.28209 | 7 | 19 | 107 | response to purine-containing compound |
| GO:0009615 | 0.00003 | 2.27418 | 17 | 35 | 270 | response to virus |
| GO:0052548 | 0.00003 | 2.11805 | 21 | 41 | 337 | regulation of endopeptidase activity |
| GO:0042226 | 0.00003 | 7.17322 | 2 | 9 | 28 | interleukin-6 biosynthetic process |
| GO:0086005 | 0.00003 | 7.17322 | 2 | 9 | 28 | ventricular cardiac muscle cell action potential |
| GO:1900745 | 0.00003 | 7.17322 | 2 | 9 | 28 | positive regulation of p38MAPK cascade |
| GO:0097205 | 0.00003 | 8.64937 | 1 | 8 | 22 | renal filtration |
| GO:0046638 | 0.00003 | 4.91760 | 3 | 12 | 49 | positive regulation of alpha-beta T cell differentiation |
| GO:1903305 | 0.00004 | 2.58741 | 12 | 27 | 186 | regulation of regulated secretory pathway |
| GO:0015672 | 0.00004 | 1.93441 | 28 | 51 | 455 | monovalent inorganic cation transport |
| GO:0060322 | 0.00004 | 1.74203 | 43 | 70 | 688 | head development |
| GO:0002637 | 0.00004 | 3.92579 | 5 | 15 | 73 | regulation of immunoglobulin production |
| GO:0050810 | 0.00004 | 3.92579 | 5 | 15 | 73 | regulation of steroid biosynthetic process |
| GO:0019219 | 0.00004 | 1.33850 | 209 | 262 | 3352 | regulation of nucleobase-containing compound metabolic process |
| GO:0045940 | 0.00004 | 6.05993 | 2 | 10 | 35 | positive regulation of steroid metabolic process |
| GO:0050854 | 0.00004 | 4.48154 | 4 | 13 | 57 | regulation of antigen receptor-mediated signaling pathway |
| GO:0002823 | 0.00004 | 5.37801 | 3 | 11 | 42 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0070727 | 0.00004 | 1.46382 | 105 | 145 | 1686 | cellular macromolecule localization |
| GO:0043312 | 0.00004 | 15.12092 | 1 | 6 | 12 | neutrophil degranulation |
| GO:0051899 | 0.00004 | 3.68115 | 5 | 16 | 82 | membrane depolarization |
| GO:0050855 | 0.00004 | 10.59006 | 1 | 7 | 17 | regulation of B cell receptor signaling pathway |
| GO:0046683 | 0.00004 | 3.48954 | 6 | 17 | 91 | response to organophosphorus |
| GO:0032651 | 0.00004 | 3.85907 | 5 | 15 | 74 | regulation of interleukin-1 beta production |
| GO:0045453 | 0.00004 | 3.85907 | 5 | 15 | 74 | bone resorption |
| GO:1901224 | 0.00004 | 3.85907 | 5 | 15 | 74 | positive regulation of NIK/NF-kappaB signaling |
| GO:0043370 | 0.00004 | 4.78797 | 3 | 12 | 50 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0045124 | 0.00004 | 4.78797 | 3 | 12 | 50 | regulation of bone resorption |
| GO:0043552 | 0.00004 | 6.81424 | 2 | 9 | 29 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0061572 | 0.00004 | 2.66202 | 10 | 25 | 168 | actin filament bundle organization |
| GO:0050878 | 0.00005 | 2.08238 | 21 | 41 | 342 | regulation of body fluid levels |
| GO:0032615 | 0.00005 | 4.38175 | 4 | 13 | 58 | interleukin-12 production |
| GO:0001911 | 0.00005 | 8.07237 | 1 | 8 | 23 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0048246 | 0.00005 | 5.20971 | 3 | 11 | 43 | macrophage chemotaxis |
| GO:0070232 | 0.00005 | 5.20971 | 3 | 11 | 43 | regulation of T cell apoptotic process |
| GO:0051248 | 0.00005 | 1.57510 | 67 | 99 | 1070 | negative regulation of protein metabolic process |
| GO:0008610 | 0.00005 | 1.82706 | 34 | 58 | 545 | lipid biosynthetic process |
| GO:0045935 | 0.00005 | 1.43835 | 114 | 155 | 1833 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0048638 | 0.00005 | 1.98303 | 25 | 46 | 401 | regulation of developmental growth |
| GO:0002920 | 0.00005 | 5.82659 | 2 | 10 | 36 | regulation of humoral immune response |
| GO:0032735 | 0.00005 | 5.82659 | 2 | 10 | 36 | positive regulation of interleukin-12 production |
| GO:0046907 | 0.00005 | 1.48300 | 94 | 131 | 1502 | intracellular transport |
| GO:0042552 | 0.00005 | 2.70608 | 10 | 24 | 159 | myelination |
| GO:1903531 | 0.00005 | 2.35204 | 14 | 31 | 232 | negative regulation of secretion by cell |
| GO:0044267 | 0.00005 | 1.29178 | 284 | 343 | 4569 | cellular protein metabolic process |
| GO:0006807 | 0.00005 | 1.24072 | 556 | 626 | 8923 | nitrogen compound metabolic process |
| GO:0009636 | 0.00005 | 2.06845 | 21 | 41 | 344 | response to toxic substance |
| GO:0002673 | 0.00005 | 4.00786 | 4 | 14 | 67 | regulation of acute inflammatory response |
| GO:0050710 | 0.00005 | 4.00786 | 4 | 14 | 67 | negative regulation of cytokine secretion |
| GO:0046849 | 0.00005 | 3.25573 | 6 | 18 | 102 | bone remodeling |
| GO:0046889 | 0.00005 | 3.39740 | 6 | 17 | 93 | positive regulation of lipid biosynthetic process |
| GO:1903169 | 0.00005 | 2.68605 | 10 | 24 | 160 | regulation of calcium ion transmembrane transport |
| GO:0050808 | 0.00006 | 1.90956 | 28 | 50 | 451 | synapse organization |
| GO:0098656 | 0.00006 | 2.55455 | 11 | 26 | 181 | anion transmembrane transport |
| GO:0006813 | 0.00006 | 2.32866 | 15 | 31 | 234 | potassium ion transport |
| GO:0044237 | 0.00006 | 1.23688 | 584 | 654 | 9374 | cellular metabolic process |
| GO:0006809 | 0.00006 | 3.73220 | 5 | 15 | 76 | nitric oxide biosynthetic process |
| GO:0002724 | 0.00006 | 6.48945 | 2 | 9 | 30 | regulation of T cell cytokine production |
| GO:0032673 | 0.00006 | 6.48945 | 2 | 9 | 30 | regulation of interleukin-4 production |
| GO:0032692 | 0.00006 | 6.48945 | 2 | 9 | 30 | negative regulation of interleukin-1 production |
| GO:0043271 | 0.00006 | 2.60696 | 11 | 25 | 171 | negative regulation of ion transport |
| GO:0061041 | 0.00006 | 2.81221 | 9 | 22 | 141 | regulation of wound healing |
| GO:0016049 | 0.00006 | 1.84079 | 32 | 55 | 513 | cell growth |
| GO:0034138 | 0.00006 | 9.62688 | 1 | 7 | 18 | toll-like receptor 3 signaling pathway |
| GO:0032633 | 0.00006 | 5.61053 | 2 | 10 | 37 | interleukin-4 production |
| GO:0046640 | 0.00006 | 5.61053 | 2 | 10 | 37 | regulation of alpha-beta T cell proliferation |
| GO:0061756 | 0.00006 | 5.61053 | 2 | 10 | 37 | leukocyte adhesion to vascular endothelial cell |
| GO:0032609 | 0.00006 | 2.98080 | 8 | 20 | 122 | interferon-gamma production |
| GO:0045428 | 0.00006 | 3.93346 | 4 | 14 | 68 | regulation of nitric oxide biosynthetic process |
| GO:0016331 | 0.00006 | 2.53805 | 11 | 26 | 182 | morphogenesis of embryonic epithelium |
| GO:0042493 | 0.00006 | 1.61897 | 56 | 85 | 894 | response to drug |
| GO:1901570 | 0.00007 | 4.54815 | 3 | 12 | 52 | fatty acid derivative biosynthetic process |
| GO:0072001 | 0.00007 | 2.13202 | 19 | 37 | 302 | renal system development |
| GO:0001508 | 0.00007 | 2.87690 | 8 | 21 | 132 | action potential |
| GO:0032753 | 0.00007 | 7.56750 | 1 | 8 | 24 | positive regulation of interleukin-4 production |
| GO:0032878 | 0.00007 | 7.56750 | 1 | 8 | 24 | regulation of establishment or maintenance of cell polarity |
| GO:0009892 | 0.00007 | 1.34882 | 177 | 225 | 2843 | negative regulation of metabolic process |
| GO:0007249 | 0.00007 | 2.47750 | 12 | 27 | 193 | I-kappaB kinase/NF-kappaB signaling |
| GO:0034654 | 0.00007 | 1.32590 | 206 | 257 | 3310 | nucleobase-containing compound biosynthetic process |
| GO:0045926 | 0.00007 | 2.23739 | 16 | 33 | 258 | negative regulation of growth |
| GO:0001505 | 0.00007 | 1.99833 | 23 | 43 | 372 | regulation of neurotransmitter levels |
| GO:0031032 | 0.00007 | 2.42386 | 13 | 28 | 204 | actomyosin structure organization |
| GO:1903825 | 0.00007 | 3.17972 | 6 | 18 | 104 | organic acid transmembrane transport |
| GO:1905039 | 0.00007 | 3.17972 | 6 | 18 | 104 | carboxylic acid transmembrane transport |
| GO:0010693 | 0.00007 | 60.41360 | 0 | 4 | 5 | negative regulation of alkaline phosphatase activity |
| GO:0015727 | 0.00007 | 60.41360 | 0 | 4 | 5 | lactate transport |
| GO:0035873 | 0.00007 | 60.41360 | 0 | 4 | 5 | lactate transmembrane transport |
| GO:0035879 | 0.00007 | 60.41360 | 0 | 4 | 5 | plasma membrane lactate transport |
| GO:0072007 | 0.00007 | 60.41360 | 0 | 4 | 5 | mesangial cell differentiation |
| GO:0072143 | 0.00007 | 60.41360 | 0 | 4 | 5 | mesangial cell development |
| GO:0002768 | 0.00007 | 2.05087 | 21 | 40 | 338 | immune response-regulating cell surface receptor signaling pathway |
| GO:0031344 | 0.00007 | 1.65836 | 49 | 76 | 781 | regulation of cell projection organization |
| GO:0048762 | 0.00008 | 2.36322 | 13 | 29 | 216 | mesenchymal cell differentiation |
| GO:0002828 | 0.00008 | 6.19419 | 2 | 9 | 31 | regulation of type 2 immune response |
| GO:0045932 | 0.00008 | 6.19419 | 2 | 9 | 31 | negative regulation of muscle contraction |
| GO:0090022 | 0.00008 | 6.19419 | 2 | 9 | 31 | regulation of neutrophil chemotaxis |
| GO:0051591 | 0.00008 | 4.10732 | 4 | 13 | 61 | response to cAMP |
| GO:0055078 | 0.00008 | 4.43702 | 3 | 12 | 53 | sodium ion homeostasis |
| GO:0030041 | 0.00008 | 2.55412 | 11 | 25 | 174 | actin filament polymerization |
| GO:0001562 | 0.00008 | 5.40991 | 2 | 10 | 38 | response to protozoan |
| GO:0002475 | 0.00008 | 5.40991 | 2 | 10 | 38 | antigen processing and presentation via MHC class Ib |
| GO:0014002 | 0.00008 | 5.40991 | 2 | 10 | 38 | astrocyte development |
| GO:0045622 | 0.00008 | 5.40991 | 2 | 10 | 38 | regulation of T-helper cell differentiation |
| GO:0048588 | 0.00008 | 2.21748 | 16 | 33 | 260 | developmental cell growth |
| GO:1901701 | 0.00008 | 1.52043 | 75 | 108 | 1206 | cellular response to oxygen-containing compound |
| GO:0006937 | 0.00008 | 2.67112 | 10 | 23 | 154 | regulation of muscle contraction |
| GO:0002065 | 0.00008 | 2.74268 | 9 | 22 | 144 | columnar/cuboidal epithelial cell differentiation |
| GO:0019915 | 0.00009 | 3.79263 | 4 | 14 | 70 | lipid storage |
| GO:0071704 | 0.00009 | 1.22805 | 623 | 692 | 10008 | organic substance metabolic process |
| GO:0001516 | 0.00009 | 7.12203 | 2 | 8 | 25 | prostaglandin biosynthetic process |
| GO:0046457 | 0.00009 | 7.12203 | 2 | 8 | 25 | prostanoid biosynthetic process |
| GO:0032757 | 0.00009 | 4.76250 | 3 | 11 | 46 | positive regulation of interleukin-8 production |
| GO:0072604 | 0.00009 | 4.76250 | 3 | 11 | 46 | interleukin-6 secretion |
| GO:1903727 | 0.00009 | 4.76250 | 3 | 11 | 46 | positive regulation of phospholipid metabolic process |
| GO:2000404 | 0.00009 | 4.76250 | 3 | 11 | 46 | regulation of T cell migration |
| GO:0090026 | 0.00009 | 8.82424 | 1 | 7 | 19 | positive regulation of monocyte chemotaxis |
| GO:0035234 | 0.00009 | 18.88976 | 1 | 5 | 9 | ectopic germ cell programmed cell death |
| GO:1900125 | 0.00009 | 18.88976 | 1 | 5 | 9 | regulation of hyaluronan biosynthetic process |
| GO:0007420 | 0.00010 | 1.72324 | 39 | 64 | 634 | brain development |
| GO:0086001 | 0.00010 | 4.33117 | 3 | 12 | 54 | cardiac muscle cell action potential |
| GO:0030324 | 0.00010 | 2.32558 | 14 | 29 | 219 | lung development |
| GO:0002483 | 0.00010 | 5.22312 | 2 | 10 | 39 | antigen processing and presentation of endogenous peptide antigen |
| GO:0019885 | 0.00010 | 5.22312 | 2 | 10 | 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I |
| GO:0031640 | 0.00010 | 5.22312 | 2 | 10 | 39 | killing of cells of other organism |
| GO:0043551 | 0.00010 | 5.22312 | 2 | 10 | 39 | regulation of phosphatidylinositol 3-kinase activity |
| GO:0044364 | 0.00010 | 5.22312 | 2 | 10 | 39 | disruption of cells of other organism |
| GO:0051254 | 0.00010 | 1.43892 | 102 | 139 | 1638 | positive regulation of RNA metabolic process |
| GO:0003014 | 0.00010 | 3.07212 | 7 | 18 | 107 | renal system process |
| GO:0097242 | 0.00010 | 5.92461 | 2 | 9 | 32 | amyloid-beta clearance |
| GO:0008361 | 0.00011 | 2.35636 | 13 | 28 | 209 | regulation of cell size |
| GO:0046209 | 0.00011 | 3.50188 | 5 | 15 | 80 | nitric oxide metabolic process |
| GO:1904063 | 0.00011 | 3.32709 | 6 | 16 | 89 | negative regulation of cation transmembrane transport |
| GO:0010713 | 0.00011 | 11.33965 | 1 | 6 | 14 | negative regulation of collagen metabolic process |
| GO:0030213 | 0.00011 | 11.33965 | 1 | 6 | 14 | hyaluronan biosynthetic process |
| GO:0032966 | 0.00011 | 11.33965 | 1 | 6 | 14 | negative regulation of collagen biosynthetic process |
| GO:0072537 | 0.00011 | 11.33965 | 1 | 6 | 14 | fibroblast activation |
| GO:0002712 | 0.00011 | 3.94267 | 4 | 13 | 63 | regulation of B cell mediated immunity |
| GO:0002889 | 0.00011 | 3.94267 | 4 | 13 | 63 | regulation of immunoglobulin mediated immune response |
| GO:0034121 | 0.00011 | 3.94267 | 4 | 13 | 63 | regulation of toll-like receptor signaling pathway |
| GO:0048640 | 0.00011 | 2.84086 | 8 | 20 | 127 | negative regulation of developmental growth |
| GO:0045429 | 0.00011 | 4.63000 | 3 | 11 | 47 | positive regulation of nitric oxide biosynthetic process |
| GO:0050702 | 0.00011 | 4.63000 | 3 | 11 | 47 | interleukin-1 beta secretion |
| GO:0050704 | 0.00011 | 4.63000 | 3 | 11 | 47 | regulation of interleukin-1 secretion |
| GO:0030048 | 0.00012 | 3.03784 | 7 | 18 | 108 | actin filament-based movement |
| GO:0045732 | 0.00012 | 2.34330 | 13 | 28 | 210 | positive regulation of protein catabolic process |
| GO:0050927 | 0.00013 | 6.72605 | 2 | 8 | 26 | positive regulation of positive chemotaxis |
| GO:0072012 | 0.00013 | 6.72605 | 2 | 8 | 26 | glomerulus vasculature development |
| GO:0098901 | 0.00013 | 6.72605 | 2 | 8 | 26 | regulation of cardiac muscle cell action potential |
| GO:0045833 | 0.00013 | 3.28198 | 6 | 16 | 90 | negative regulation of lipid metabolic process |
| GO:0030323 | 0.00013 | 2.28912 | 14 | 29 | 222 | respiratory tube development |
| GO:0007507 | 0.00013 | 1.71049 | 39 | 63 | 628 | heart development |
| GO:0032649 | 0.00013 | 3.00432 | 7 | 18 | 109 | regulation of interferon-gamma production |
| GO:0032963 | 0.00013 | 3.00432 | 7 | 18 | 109 | collagen metabolic process |
| GO:0042267 | 0.00013 | 3.86518 | 4 | 13 | 64 | natural killer cell mediated cytotoxicity |
| GO:0021591 | 0.00014 | 5.67749 | 2 | 9 | 33 | ventricular system development |
| GO:0090218 | 0.00014 | 5.67749 | 2 | 9 | 33 | positive regulation of lipid kinase activity |
| GO:0043281 | 0.00014 | 2.36271 | 13 | 27 | 201 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0018130 | 0.00014 | 1.30748 | 210 | 259 | 3374 | heterocycle biosynthetic process |
| GO:0031668 | 0.00014 | 2.27721 | 14 | 29 | 223 | cellular response to extracellular stimulus |
| GO:1902903 | 0.00014 | 1.98336 | 22 | 40 | 348 | regulation of supramolecular fiber organization |
| GO:0051172 | 0.00014 | 1.36653 | 141 | 183 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0038066 | 0.00014 | 4.50466 | 3 | 11 | 48 | p38MAPK cascade |
| GO:0050850 | 0.00014 | 4.50466 | 3 | 11 | 48 | positive regulation of calcium-mediated signaling |
| GO:1904407 | 0.00014 | 4.50466 | 3 | 11 | 48 | positive regulation of nitric oxide metabolic process |
| GO:0050728 | 0.00014 | 2.63409 | 9 | 22 | 149 | negative regulation of inflammatory response |
| GO:1905517 | 0.00014 | 4.13392 | 3 | 12 | 56 | macrophage migration |
| GO:0045670 | 0.00014 | 3.59928 | 5 | 14 | 73 | regulation of osteoclast differentiation |
| GO:0097190 | 0.00014 | 1.71934 | 38 | 61 | 605 | apoptotic signaling pathway |
| GO:0001890 | 0.00014 | 2.50092 | 11 | 24 | 170 | placenta development |
| GO:0007156 | 0.00015 | 2.97153 | 7 | 18 | 110 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0070588 | 0.00015 | 2.10785 | 17 | 34 | 280 | calcium ion transmembrane transport |
| GO:0002381 | 0.00016 | 3.79068 | 4 | 13 | 65 | immunoglobulin production involved in immunoglobulin mediated immune response |
| GO:0050848 | 0.00016 | 3.07270 | 6 | 17 | 101 | regulation of calcium-mediated signaling |
| GO:0006953 | 0.00016 | 4.88569 | 3 | 10 | 41 | acute-phase response |
| GO:1900744 | 0.00016 | 4.88569 | 3 | 10 | 41 | regulation of p38MAPK cascade |
| GO:0006366 | 0.00016 | 1.38054 | 128 | 167 | 2049 | transcription by RNA polymerase II |
| GO:0001822 | 0.00016 | 2.09921 | 17 | 34 | 281 | kidney development |
| GO:0072577 | 0.00017 | 4.04187 | 4 | 12 | 57 | endothelial cell apoptotic process |
| GO:0002335 | 0.00017 | 6.37175 | 2 | 8 | 27 | mature B cell differentiation |
| GO:0010893 | 0.00017 | 6.37175 | 2 | 8 | 27 | positive regulation of steroid biosynthetic process |
| GO:0031342 | 0.00017 | 6.37175 | 2 | 8 | 27 | negative regulation of cell killing |
| GO:0050901 | 0.00017 | 6.37175 | 2 | 8 | 27 | leukocyte tethering or rolling |
| GO:0050926 | 0.00017 | 6.37175 | 2 | 8 | 27 | regulation of positive chemotaxis |
| GO:0061437 | 0.00017 | 6.37175 | 2 | 8 | 27 | renal system vasculature development |
| GO:0061440 | 0.00017 | 6.37175 | 2 | 8 | 27 | kidney vasculature development |
| GO:0001916 | 0.00017 | 4.38591 | 3 | 11 | 49 | positive regulation of T cell mediated cytotoxicity |
| GO:0002474 | 0.00017 | 4.38591 | 3 | 11 | 49 | antigen processing and presentation of peptide antigen via MHC class I |
| GO:1990138 | 0.00017 | 2.36967 | 12 | 26 | 193 | neuron projection extension |
| GO:0019438 | 0.00017 | 1.30163 | 211 | 259 | 3386 | aromatic compound biosynthetic process |
| GO:1903409 | 0.00017 | 2.82978 | 8 | 19 | 121 | reactive oxygen species biosynthetic process |
| GO:0001666 | 0.00017 | 2.32234 | 13 | 27 | 204 | response to hypoxia |
| GO:0042832 | 0.00017 | 5.45014 | 2 | 9 | 34 | defense response to protozoan |
| GO:0030853 | 0.00018 | 15.11111 | 1 | 5 | 10 | negative regulation of granulocyte differentiation |
| GO:0070391 | 0.00018 | 15.11111 | 1 | 5 | 10 | response to lipoteichoic acid |
| GO:0071223 | 0.00018 | 15.11111 | 1 | 5 | 10 | cellular response to lipoteichoic acid |
| GO:1902563 | 0.00018 | 15.11111 | 1 | 5 | 10 | regulation of neutrophil activation |
| GO:0061351 | 0.00018 | 2.40763 | 11 | 25 | 183 | neural precursor cell proliferation |
| GO:0002228 | 0.00018 | 3.71898 | 4 | 13 | 66 | natural killer cell mediated immunity |
| GO:0003006 | 0.00019 | 1.60938 | 49 | 75 | 791 | developmental process involved in reproduction |
| GO:0043123 | 0.00019 | 2.90804 | 7 | 18 | 112 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0044238 | 0.00019 | 1.21704 | 588 | 653 | 9443 | primary metabolic process |
| GO:0046879 | 0.00019 | 1.93249 | 23 | 41 | 365 | hormone secretion |
| GO:0060485 | 0.00019 | 2.10496 | 17 | 33 | 272 | mesenchyme development |
| GO:0003094 | 0.00019 | 7.56293 | 1 | 7 | 21 | glomerular filtration |
| GO:0015732 | 0.00019 | 7.56293 | 1 | 7 | 21 | prostaglandin transport |
| GO:0051023 | 0.00019 | 7.56293 | 1 | 7 | 21 | regulation of immunoglobulin secretion |
| GO:0006970 | 0.00019 | 3.29827 | 5 | 15 | 84 | response to osmotic stress |
| GO:2001057 | 0.00019 | 3.29827 | 5 | 15 | 84 | reactive nitrogen species metabolic process |
| GO:0048660 | 0.00020 | 2.49837 | 10 | 23 | 163 | regulation of smooth muscle cell proliferation |
| GO:0019883 | 0.00020 | 4.73280 | 3 | 10 | 42 | antigen processing and presentation of endogenous antigen |
| GO:0014004 | 0.00020 | 30.20541 | 0 | 4 | 6 | microglia differentiation |
| GO:0030321 | 0.00020 | 30.20541 | 0 | 4 | 6 | transepithelial chloride transport |
| GO:1904238 | 0.00020 | 30.20541 | 0 | 4 | 6 | pericyte cell differentiation |
| GO:2000416 | 0.00020 | 30.20541 | 0 | 4 | 6 | regulation of eosinophil migration |
| GO:2000427 | 0.00020 | 30.20541 | 0 | 4 | 6 | positive regulation of apoptotic cell clearance |
| GO:0071622 | 0.00021 | 4.27325 | 3 | 11 | 50 | regulation of granulocyte chemotaxis |
| GO:1902930 | 0.00021 | 4.27325 | 3 | 11 | 50 | regulation of alcohol biosynthetic process |
| GO:0042391 | 0.00021 | 1.83303 | 27 | 47 | 439 | regulation of membrane potential |
| GO:0044403 | 0.00021 | 1.95819 | 21 | 39 | 343 | symbiont process |
| GO:0072073 | 0.00021 | 2.61618 | 9 | 21 | 143 | kidney epithelium development |
| GO:0071496 | 0.00021 | 2.06538 | 18 | 34 | 285 | cellular response to external stimulus |
| GO:0001570 | 0.00021 | 3.11310 | 6 | 16 | 94 | vasculogenesis |
| GO:1901568 | 0.00021 | 2.68927 | 8 | 20 | 133 | fatty acid derivative metabolic process |
| GO:0043113 | 0.00022 | 3.64995 | 4 | 13 | 67 | receptor clustering |
| GO:0071363 | 0.00022 | 1.69632 | 37 | 60 | 602 | cellular response to growth factor stimulus |
| GO:0048708 | 0.00022 | 3.25100 | 5 | 15 | 85 | astrocyte differentiation |
| GO:0098659 | 0.00022 | 3.25100 | 5 | 15 | 85 | inorganic cation import across plasma membrane |
| GO:0099587 | 0.00022 | 3.25100 | 5 | 15 | 85 | inorganic ion import across plasma membrane |
| GO:0036230 | 0.00022 | 5.24028 | 2 | 9 | 35 | granulocyte activation |
| GO:0043304 | 0.00022 | 5.24028 | 2 | 9 | 35 | regulation of mast cell degranulation |
| GO:0060292 | 0.00022 | 5.24028 | 2 | 9 | 35 | long-term synaptic depression |
| GO:0060441 | 0.00022 | 5.24028 | 2 | 9 | 35 | epithelial tube branching involved in lung morphogenesis |
| GO:1902895 | 0.00022 | 5.24028 | 2 | 9 | 35 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0048844 | 0.00022 | 3.42465 | 5 | 14 | 76 | artery morphogenesis |
| GO:0055008 | 0.00022 | 3.42465 | 5 | 14 | 76 | cardiac muscle tissue morphogenesis |
| GO:0042742 | 0.00022 | 1.84054 | 27 | 46 | 428 | defense response to bacterium |
| GO:0070848 | 0.00022 | 1.68751 | 38 | 61 | 615 | response to growth factor |
| GO:0002507 | 0.00022 | 6.05289 | 2 | 8 | 28 | tolerance induction |
| GO:0060384 | 0.00022 | 6.05289 | 2 | 8 | 28 | innervation |
| GO:0072539 | 0.00022 | 6.05289 | 2 | 8 | 28 | T-helper 17 cell differentiation |
| GO:0043902 | 0.00023 | 2.41755 | 11 | 24 | 175 | positive regulation of multi-organism process |
| GO:0030101 | 0.00023 | 2.96634 | 6 | 17 | 104 | natural killer cell activation |
| GO:0006357 | 0.00023 | 1.37466 | 124 | 162 | 1993 | regulation of transcription by RNA polymerase II |
| GO:0043491 | 0.00023 | 2.36244 | 12 | 25 | 186 | protein kinase B signaling |
| GO:0043534 | 0.00024 | 2.84719 | 7 | 18 | 114 | blood vessel endothelial cell migration |
| GO:0051928 | 0.00024 | 2.66556 | 8 | 20 | 134 | positive regulation of calcium ion transport |
| GO:0043122 | 0.00024 | 2.46295 | 10 | 23 | 165 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0051017 | 0.00024 | 2.46295 | 10 | 23 | 165 | actin filament bundle assembly |
| GO:1904158 | 0.00024 | Inf | 0 | 3 | 3 | axonemal central apparatus assembly |
| GO:0120035 | 0.00024 | 1.60352 | 48 | 73 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0086002 | 0.00025 | 4.58917 | 3 | 10 | 43 | cardiac muscle cell action potential involved in contraction |
| GO:1901362 | 0.00025 | 1.28811 | 219 | 266 | 3510 | organic cyclic compound biosynthetic process |
| GO:0015908 | 0.00025 | 3.20506 | 5 | 15 | 86 | fatty acid transport |
| GO:0034766 | 0.00026 | 2.93249 | 7 | 17 | 105 | negative regulation of ion transmembrane transport |
| GO:1904950 | 0.00026 | 2.25802 | 13 | 27 | 209 | negative regulation of establishment of protein localization |
| GO:0044255 | 0.00026 | 1.54354 | 58 | 85 | 932 | cellular lipid metabolic process |
| GO:0007423 | 0.00026 | 1.68358 | 38 | 60 | 606 | sensory organ development |
| GO:0002374 | 0.00027 | 7.05841 | 1 | 7 | 22 | cytokine secretion involved in immune response |
| GO:0046641 | 0.00027 | 7.05841 | 1 | 7 | 22 | positive regulation of alpha-beta T cell proliferation |
| GO:0010035 | 0.00027 | 1.76495 | 31 | 51 | 493 | response to inorganic substance |
| GO:0002283 | 0.00027 | 9.07088 | 1 | 6 | 16 | neutrophil activation involved in immune response |
| GO:0002544 | 0.00027 | 9.07088 | 1 | 6 | 16 | chronic inflammatory response |
| GO:0002830 | 0.00027 | 9.07088 | 1 | 6 | 16 | positive regulation of type 2 immune response |
| GO:0046629 | 0.00027 | 9.07088 | 1 | 6 | 16 | gamma-delta T cell activation |
| GO:0007596 | 0.00027 | 2.49568 | 10 | 22 | 156 | blood coagulation |
| GO:0030279 | 0.00027 | 3.03499 | 6 | 16 | 96 | negative regulation of ossification |
| GO:0033209 | 0.00028 | 3.78873 | 4 | 12 | 60 | tumor necrosis factor-mediated signaling pathway |
| GO:0070098 | 0.00028 | 3.78873 | 4 | 12 | 60 | chemokine-mediated signaling pathway |
| GO:0033006 | 0.00028 | 5.04596 | 2 | 9 | 36 | regulation of mast cell activation involved in immune response |
| GO:0051482 | 0.00028 | 5.04596 | 2 | 9 | 36 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
| GO:0071320 | 0.00028 | 5.04596 | 2 | 9 | 36 | cellular response to cAMP |
| GO:0044419 | 0.00028 | 1.84649 | 25 | 44 | 408 | interspecies interaction between organisms |
| GO:0110053 | 0.00028 | 2.10829 | 16 | 31 | 255 | regulation of actin filament organization |
| GO:0048661 | 0.00029 | 2.89941 | 7 | 17 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:1904894 | 0.00029 | 2.89941 | 7 | 17 | 106 | positive regulation of STAT cascade |
| GO:0031295 | 0.00029 | 5.76439 | 2 | 8 | 29 | T cell costimulation |
| GO:0042119 | 0.00029 | 5.76439 | 2 | 8 | 29 | neutrophil activation |
| GO:0006766 | 0.00029 | 3.51927 | 4 | 13 | 69 | vitamin metabolic process |
| GO:0032637 | 0.00029 | 3.51927 | 4 | 13 | 69 | interleukin-8 production |
| GO:1903670 | 0.00029 | 3.51927 | 4 | 13 | 69 | regulation of sprouting angiogenesis |
| GO:0051588 | 0.00029 | 2.37013 | 11 | 24 | 178 | regulation of neurotransmitter transport |
| GO:0030278 | 0.00030 | 2.16458 | 15 | 29 | 233 | regulation of ossification |
| GO:0035924 | 0.00030 | 4.06443 | 3 | 11 | 52 | cellular response to vascular endothelial growth factor stimulus |
| GO:0048247 | 0.00030 | 4.06443 | 3 | 11 | 52 | lymphocyte chemotaxis |
| GO:0032269 | 0.00030 | 1.51698 | 62 | 90 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0061098 | 0.00030 | 4.45399 | 3 | 10 | 44 | positive regulation of protein tyrosine kinase activity |
| GO:0009914 | 0.00030 | 1.88522 | 23 | 41 | 373 | hormone transport |
| GO:0010563 | 0.00030 | 1.71441 | 34 | 55 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00030 | 1.71441 | 34 | 55 | 546 | negative regulation of phosphate metabolic process |
| GO:0010595 | 0.00031 | 2.99738 | 6 | 16 | 97 | positive regulation of endothelial cell migration |
| GO:0048659 | 0.00031 | 2.41166 | 10 | 23 | 168 | smooth muscle cell proliferation |
| GO:0002923 | 0.00031 | 12.59201 | 1 | 5 | 11 | regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0060537 | 0.00032 | 1.77095 | 29 | 49 | 472 | muscle tissue development |
| GO:0008154 | 0.00033 | 2.26051 | 13 | 26 | 201 | actin polymerization or depolymerization |
| GO:0033077 | 0.00033 | 3.11697 | 5 | 15 | 88 | T cell differentiation in thymus |
| GO:1903428 | 0.00033 | 3.71124 | 4 | 12 | 61 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0002244 | 0.00033 | 2.45876 | 10 | 22 | 158 | hematopoietic progenitor cell differentiation |
| GO:0007599 | 0.00033 | 2.45876 | 10 | 22 | 158 | hemostasis |
| GO:0010038 | 0.00034 | 2.05714 | 17 | 32 | 269 | response to metal ion |
| GO:1903725 | 0.00034 | 3.45737 | 4 | 13 | 70 | regulation of phospholipid metabolic process |
| GO:0055067 | 0.00034 | 2.51260 | 9 | 21 | 148 | monovalent inorganic cation homeostasis |
| GO:0002675 | 0.00035 | 4.86552 | 2 | 9 | 37 | positive regulation of acute inflammatory response |
| GO:0048812 | 0.00035 | 1.62800 | 42 | 65 | 677 | neuron projection morphogenesis |
| GO:0009913 | 0.00035 | 2.20905 | 13 | 27 | 213 | epidermal cell differentiation |
| GO:0055010 | 0.00035 | 3.96747 | 3 | 11 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0071715 | 0.00035 | 3.96747 | 3 | 11 | 53 | icosanoid transport |
| GO:1901571 | 0.00035 | 3.96747 | 3 | 11 | 53 | fatty acid derivative transport |
| GO:0050817 | 0.00036 | 2.44070 | 10 | 22 | 159 | coagulation |
| GO:2000112 | 0.00036 | 1.29001 | 200 | 245 | 3219 | regulation of cellular macromolecule biosynthetic process |
| GO:0035743 | 0.00036 | 6.61696 | 1 | 7 | 23 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0120039 | 0.00036 | 1.61884 | 43 | 66 | 691 | plasma membrane bounded cell projection morphogenesis |
| GO:0030890 | 0.00036 | 4.32653 | 3 | 10 | 45 | positive regulation of B cell proliferation |
| GO:1905954 | 0.00037 | 3.07470 | 6 | 15 | 89 | positive regulation of lipid localization |
| GO:0033005 | 0.00038 | 5.50212 | 2 | 8 | 30 | positive regulation of mast cell activation |
| GO:2000778 | 0.00038 | 5.50212 | 2 | 8 | 30 | positive regulation of interleukin-6 secretion |
| GO:0021675 | 0.00039 | 3.21650 | 5 | 14 | 80 | nerve development |
| GO:0048667 | 0.00039 | 1.64780 | 39 | 61 | 628 | cell morphogenesis involved in neuron differentiation |
| GO:0032413 | 0.00039 | 3.39760 | 4 | 13 | 71 | negative regulation of ion transmembrane transporter activity |
| GO:0032310 | 0.00039 | 8.24588 | 1 | 6 | 17 | prostaglandin secretion |
| GO:0034331 | 0.00039 | 8.24588 | 1 | 6 | 17 | cell junction maintenance |
| GO:0045064 | 0.00039 | 8.24588 | 1 | 6 | 17 | T-helper 2 cell differentiation |
| GO:0045410 | 0.00039 | 8.24588 | 1 | 6 | 17 | positive regulation of interleukin-6 biosynthetic process |
| GO:0050755 | 0.00039 | 8.24588 | 1 | 6 | 17 | chemokine metabolic process |
| GO:0048738 | 0.00040 | 2.06178 | 16 | 31 | 260 | cardiac muscle tissue development |
| GO:0009790 | 0.00041 | 1.45239 | 77 | 106 | 1231 | embryo development |
| GO:0051224 | 0.00041 | 2.22210 | 13 | 26 | 204 | negative regulation of protein transport |
| GO:0014009 | 0.00042 | 3.87503 | 3 | 11 | 54 | glial cell proliferation |
| GO:0045687 | 0.00042 | 3.87503 | 3 | 11 | 54 | positive regulation of glial cell differentiation |
| GO:0050922 | 0.00042 | 3.87503 | 3 | 11 | 54 | negative regulation of chemotaxis |
| GO:2000351 | 0.00042 | 3.87503 | 3 | 11 | 54 | regulation of endothelial cell apoptotic process |
| GO:0032526 | 0.00042 | 3.03357 | 6 | 15 | 90 | response to retinoic acid |
| GO:0043535 | 0.00042 | 3.03357 | 6 | 15 | 90 | regulation of blood vessel endothelial cell migration |
| GO:0045444 | 0.00042 | 2.11231 | 15 | 29 | 238 | fat cell differentiation |
| GO:0006636 | 0.00043 | 4.69753 | 2 | 9 | 38 | unsaturated fatty acid biosynthetic process |
| GO:0046006 | 0.00043 | 4.69753 | 2 | 9 | 38 | regulation of activated T cell proliferation |
| GO:1904645 | 0.00043 | 4.69753 | 2 | 9 | 38 | response to amyloid-beta |
| GO:0048858 | 0.00044 | 1.60561 | 43 | 66 | 696 | cell projection morphogenesis |
| GO:0032677 | 0.00045 | 3.56537 | 4 | 12 | 63 | regulation of interleukin-8 production |
| GO:0046579 | 0.00045 | 3.56537 | 4 | 12 | 63 | positive regulation of Ras protein signal transduction |
| GO:0044070 | 0.00045 | 2.67896 | 7 | 18 | 120 | regulation of anion transport |
| GO:0006690 | 0.00045 | 2.77419 | 7 | 17 | 110 | icosanoid metabolic process |
| GO:0006145 | 0.00045 | 20.13602 | 0 | 4 | 7 | purine nucleobase catabolic process |
| GO:0034154 | 0.00045 | 20.13602 | 0 | 4 | 7 | toll-like receptor 7 signaling pathway |
| GO:0050861 | 0.00045 | 20.13602 | 0 | 4 | 7 | positive regulation of B cell receptor signaling pathway |
| GO:0060558 | 0.00045 | 20.13602 | 0 | 4 | 7 | regulation of calcidiol 1-monooxygenase activity |
| GO:2000425 | 0.00045 | 20.13602 | 0 | 4 | 7 | regulation of apoptotic cell clearance |
| GO:0002028 | 0.00047 | 2.99351 | 6 | 15 | 91 | regulation of sodium ion transport |
| GO:0010758 | 0.00048 | 5.26265 | 2 | 8 | 31 | regulation of macrophage chemotaxis |
| GO:0031294 | 0.00048 | 5.26265 | 2 | 8 | 31 | lymphocyte costimulation |
| GO:0032967 | 0.00048 | 5.26265 | 2 | 8 | 31 | positive regulation of collagen biosynthetic process |
| GO:0033081 | 0.00048 | 5.26265 | 2 | 8 | 31 | regulation of T cell differentiation in thymus |
| GO:0043537 | 0.00048 | 5.26265 | 2 | 8 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0007205 | 0.00048 | 6.22744 | 1 | 7 | 24 | protein kinase C-activating G protein-coupled receptor signaling pathway |
| GO:0019724 | 0.00049 | 2.03483 | 16 | 31 | 263 | B cell mediated immunity |
| GO:0042531 | 0.00049 | 3.78679 | 3 | 11 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0045058 | 0.00049 | 3.78679 | 3 | 11 | 55 | T cell selection |
| GO:0010817 | 0.00050 | 1.67598 | 35 | 55 | 557 | regulation of hormone levels |
| GO:0046717 | 0.00050 | 2.65283 | 8 | 18 | 121 | acid secretion |
| GO:0051495 | 0.00051 | 2.15072 | 14 | 27 | 218 | positive regulation of cytoskeleton organization |
| GO:0032754 | 0.00051 | 10.79266 | 1 | 5 | 12 | positive regulation of interleukin-5 production |
| GO:0033632 | 0.00051 | 10.79266 | 1 | 5 | 12 | regulation of cell-cell adhesion mediated by integrin |
| GO:0045086 | 0.00051 | 10.79266 | 1 | 5 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:0045217 | 0.00051 | 10.79266 | 1 | 5 | 12 | cell-cell junction maintenance |
| GO:0002763 | 0.00052 | 3.49665 | 4 | 12 | 64 | positive regulation of myeloid leukocyte differentiation |
| GO:0031667 | 0.00052 | 1.84357 | 23 | 40 | 371 | response to nutrient levels |
| GO:0002639 | 0.00053 | 4.09229 | 3 | 10 | 47 | positive regulation of immunoglobulin production |
| GO:0046885 | 0.00053 | 4.54074 | 2 | 9 | 39 | regulation of hormone biosynthetic process |
| GO:0036293 | 0.00053 | 2.10934 | 14 | 28 | 230 | response to decreased oxygen levels |
| GO:0061061 | 0.00053 | 1.59260 | 44 | 66 | 701 | muscle structure development |
| GO:0071887 | 0.00054 | 2.55302 | 8 | 19 | 132 | leukocyte apoptotic process |
| GO:0061024 | 0.00054 | 1.55964 | 49 | 72 | 780 | membrane organization |
| GO:1902106 | 0.00055 | 2.82246 | 6 | 16 | 102 | negative regulation of leukocyte differentiation |
| GO:0032674 | 0.00056 | 7.55837 | 1 | 6 | 18 | regulation of interleukin-5 production |
| GO:0072148 | 0.00056 | 7.55837 | 1 | 6 | 18 | epithelial cell fate commitment |
| GO:0044283 | 0.00056 | 1.61457 | 40 | 62 | 650 | small molecule biosynthetic process |
| GO:0019233 | 0.00057 | 2.46949 | 9 | 20 | 143 | sensory perception of pain |
| GO:0009719 | 0.00057 | 1.41022 | 88 | 118 | 1409 | response to endogenous stimulus |
| GO:0032412 | 0.00058 | 2.03884 | 16 | 30 | 254 | regulation of ion transmembrane transporter activity |
| GO:0046486 | 0.00059 | 1.89866 | 20 | 36 | 325 | glycerolipid metabolic process |
| GO:0002066 | 0.00059 | 3.23006 | 5 | 13 | 74 | columnar/cuboidal epithelial cell development |
| GO:0030072 | 0.00060 | 1.98105 | 17 | 32 | 278 | peptide hormone secretion |
| GO:0043903 | 0.00061 | 2.19735 | 12 | 25 | 198 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0032689 | 0.00061 | 5.04315 | 2 | 8 | 32 | negative regulation of interferon-gamma production |
| GO:0032743 | 0.00061 | 5.04315 | 2 | 8 | 32 | positive regulation of interleukin-2 production |
| GO:0045577 | 0.00061 | 5.04315 | 2 | 8 | 32 | regulation of B cell differentiation |
| GO:0072538 | 0.00061 | 5.04315 | 2 | 8 | 32 | T-helper 17 type immune response |
| GO:1904646 | 0.00061 | 5.04315 | 2 | 8 | 32 | cellular response to amyloid-beta |
| GO:0035148 | 0.00061 | 2.28471 | 11 | 23 | 176 | tube formation |
| GO:1903426 | 0.00062 | 2.78989 | 6 | 16 | 103 | regulation of reactive oxygen species biosynthetic process |
| GO:2000177 | 0.00062 | 2.68713 | 7 | 17 | 113 | regulation of neural precursor cell proliferation |
| GO:0032990 | 0.00062 | 1.57694 | 45 | 67 | 718 | cell part morphogenesis |
| GO:0002714 | 0.00063 | 3.98441 | 3 | 10 | 48 | positive regulation of B cell mediated immunity |
| GO:0002762 | 0.00063 | 3.98441 | 3 | 10 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0002891 | 0.00063 | 3.98441 | 3 | 10 | 48 | positive regulation of immunoglobulin mediated immune response |
| GO:0010107 | 0.00063 | 3.98441 | 3 | 10 | 48 | potassium ion import |
| GO:0042088 | 0.00063 | 3.98441 | 3 | 10 | 48 | T-helper 1 type immune response |
| GO:0043550 | 0.00063 | 3.98441 | 3 | 10 | 48 | regulation of lipid kinase activity |
| GO:0050873 | 0.00063 | 3.98441 | 3 | 10 | 48 | brown fat cell differentiation |
| GO:0051590 | 0.00063 | 3.98441 | 3 | 10 | 48 | positive regulation of neurotransmitter transport |
| GO:0050832 | 0.00064 | 5.88120 | 2 | 7 | 25 | defense response to fungus |
| GO:0086019 | 0.00064 | 5.88120 | 2 | 7 | 25 | cell-cell signaling involved in cardiac conduction |
| GO:0010721 | 0.00064 | 1.80776 | 24 | 41 | 387 | negative regulation of cell development |
| GO:0014706 | 0.00064 | 1.74292 | 28 | 46 | 449 | striated muscle tissue development |
| GO:0019935 | 0.00064 | 2.14904 | 13 | 26 | 210 | cyclic-nucleotide-mediated signaling |
| GO:0006692 | 0.00065 | 4.39406 | 2 | 9 | 40 | prostanoid metabolic process |
| GO:0006693 | 0.00065 | 4.39406 | 2 | 9 | 40 | prostaglandin metabolic process |
| GO:0030225 | 0.00065 | 4.39406 | 2 | 9 | 40 | macrophage differentiation |
| GO:0050706 | 0.00065 | 4.39406 | 2 | 9 | 40 | regulation of interleukin-1 beta secretion |
| GO:0007219 | 0.00066 | 2.26977 | 11 | 23 | 177 | Notch signaling pathway |
| GO:0043062 | 0.00066 | 1.90470 | 20 | 35 | 315 | extracellular structure organization |
| GO:1905952 | 0.00068 | 2.42975 | 9 | 20 | 145 | regulation of lipid localization |
| GO:0061097 | 0.00068 | 3.17781 | 5 | 13 | 75 | regulation of protein tyrosine kinase activity |
| GO:0048260 | 0.00068 | 3.62181 | 4 | 11 | 57 | positive regulation of receptor-mediated endocytosis |
| GO:0032386 | 0.00069 | 1.74798 | 27 | 45 | 438 | regulation of intracellular transport |
| GO:0042136 | 0.00069 | 2.75806 | 6 | 16 | 104 | neurotransmitter biosynthetic process |
| GO:0032388 | 0.00070 | 2.17203 | 12 | 25 | 200 | positive regulation of intracellular transport |
| GO:0033002 | 0.00070 | 2.06800 | 15 | 28 | 234 | muscle cell proliferation |
| GO:0044260 | 0.00072 | 1.20409 | 442 | 497 | 7099 | cellular macromolecule metabolic process |
| GO:0021700 | 0.00074 | 1.89101 | 20 | 35 | 317 | developmental maturation |
| GO:0032660 | 0.00076 | 4.84120 | 2 | 8 | 33 | regulation of interleukin-17 production |
| GO:0086091 | 0.00076 | 4.84120 | 2 | 8 | 33 | regulation of heart rate by cardiac conduction |
| GO:1904467 | 0.00076 | 4.84120 | 2 | 8 | 33 | regulation of tumor necrosis factor secretion |
| GO:0043266 | 0.00076 | 2.72695 | 7 | 16 | 105 | regulation of potassium ion transport |
| GO:0034767 | 0.00077 | 2.24047 | 11 | 23 | 179 | positive regulation of ion transmembrane transport |
| GO:0070228 | 0.00077 | 3.12723 | 5 | 13 | 76 | regulation of lymphocyte apoptotic process |
| GO:0002726 | 0.00077 | 6.97664 | 1 | 6 | 19 | positive regulation of T cell cytokine production |
| GO:0010766 | 0.00077 | 6.97664 | 1 | 6 | 19 | negative regulation of sodium ion transport |
| GO:0030852 | 0.00077 | 6.97664 | 1 | 6 | 19 | regulation of granulocyte differentiation |
| GO:0030889 | 0.00077 | 6.97664 | 1 | 6 | 19 | negative regulation of B cell proliferation |
| GO:0032634 | 0.00077 | 6.97664 | 1 | 6 | 19 | interleukin-5 production |
| GO:0045076 | 0.00077 | 6.97664 | 1 | 6 | 19 | regulation of interleukin-2 biosynthetic process |
| GO:0060088 | 0.00077 | 6.97664 | 1 | 6 | 19 | auditory receptor cell stereocilium organization |
| GO:1900424 | 0.00077 | 6.97664 | 1 | 6 | 19 | regulation of defense response to bacterium |
| GO:2000114 | 0.00077 | 6.97664 | 1 | 6 | 19 | regulation of establishment of cell polarity |
| GO:2000251 | 0.00077 | 6.97664 | 1 | 6 | 19 | positive regulation of actin cytoskeleton reorganization |
| GO:0002832 | 0.00078 | 4.25655 | 3 | 9 | 41 | negative regulation of response to biotic stimulus |
| GO:0038083 | 0.00078 | 4.25655 | 3 | 9 | 41 | peptidyl-tyrosine autophosphorylation |
| GO:0060122 | 0.00078 | 4.25655 | 3 | 9 | 41 | inner ear receptor cell stereocilium organization |
| GO:0042492 | 0.00078 | 9.44314 | 1 | 5 | 13 | gamma-delta T cell differentiation |
| GO:0045628 | 0.00078 | 9.44314 | 1 | 5 | 13 | regulation of T-helper 2 cell differentiation |
| GO:0050711 | 0.00078 | 9.44314 | 1 | 5 | 13 | negative regulation of interleukin-1 secretion |
| GO:0090594 | 0.00078 | 9.44314 | 1 | 5 | 13 | inflammatory response to wounding |
| GO:2000018 | 0.00078 | 9.44314 | 1 | 5 | 13 | regulation of male gonad development |
| GO:2000650 | 0.00078 | 9.44314 | 1 | 5 | 13 | negative regulation of sodium ion transmembrane transporter activity |
| GO:0016064 | 0.00079 | 1.99386 | 16 | 30 | 259 | immunoglobulin mediated immune response |
| GO:0043954 | 0.00079 | 3.54459 | 4 | 11 | 58 | cellular component maintenance |
| GO:0070231 | 0.00079 | 3.54459 | 4 | 11 | 58 | T cell apoptotic process |
| GO:0098900 | 0.00079 | 3.54459 | 4 | 11 | 58 | regulation of action potential |
| GO:0008643 | 0.00081 | 2.39127 | 9 | 20 | 147 | carbohydrate transport |
| GO:0030856 | 0.00081 | 2.39127 | 9 | 20 | 147 | regulation of epithelial cell differentiation |
| GO:0010769 | 0.00082 | 1.84284 | 21 | 37 | 343 | regulation of cell morphogenesis involved in differentiation |
| GO:0051767 | 0.00082 | 5.57141 | 2 | 7 | 26 | nitric-oxide synthase biosynthetic process |
| GO:0051769 | 0.00082 | 5.57141 | 2 | 7 | 26 | regulation of nitric-oxide synthase biosynthetic process |
| GO:0070168 | 0.00082 | 5.57141 | 2 | 7 | 26 | negative regulation of biomineral tissue development |
| GO:0090025 | 0.00082 | 5.57141 | 2 | 7 | 26 | regulation of monocyte chemotaxis |
| GO:1901380 | 0.00082 | 5.57141 | 2 | 7 | 26 | negative regulation of potassium ion transmembrane transport |
| GO:1903707 | 0.00082 | 2.32812 | 10 | 21 | 158 | negative regulation of hemopoiesis |
| GO:0071804 | 0.00083 | 2.18431 | 12 | 24 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.00083 | 2.18431 | 12 | 24 | 191 | potassium ion transmembrane transport |
| GO:0010638 | 0.00083 | 1.62029 | 37 | 57 | 595 | positive regulation of organelle organization |
| GO:0008406 | 0.00085 | 2.10293 | 13 | 26 | 214 | gonad development |
| GO:0043313 | 0.00085 | 15.10132 | 0 | 4 | 8 | regulation of neutrophil degranulation |
| GO:0098883 | 0.00085 | 15.10132 | 0 | 4 | 8 | synapse pruning |
| GO:0032409 | 0.00086 | 1.95802 | 17 | 31 | 272 | regulation of transporter activity |
| GO:0061564 | 0.00086 | 1.67492 | 32 | 50 | 506 | axon development |
| GO:0003018 | 0.00087 | 2.13513 | 13 | 25 | 203 | vascular process in circulatory system |
| GO:0030193 | 0.00088 | 3.07822 | 5 | 13 | 77 | regulation of blood coagulation |
| GO:0003206 | 0.00088 | 2.37248 | 9 | 20 | 148 | cardiac chamber morphogenesis |
| GO:0003231 | 0.00088 | 2.37248 | 9 | 20 | 148 | cardiac ventricle development |
| GO:0009894 | 0.00088 | 1.51868 | 51 | 74 | 821 | regulation of catabolic process |
| GO:0031663 | 0.00088 | 3.78484 | 3 | 10 | 50 | lipopolysaccharide-mediated signaling pathway |
| GO:0051055 | 0.00088 | 3.78484 | 3 | 10 | 50 | negative regulation of lipid biosynthetic process |
| GO:0001558 | 0.00089 | 1.73488 | 27 | 44 | 431 | regulation of cell growth |
| GO:0061387 | 0.00089 | 2.50611 | 8 | 18 | 127 | regulation of extent of cell growth |
| GO:0034109 | 0.00091 | 3.24629 | 4 | 12 | 68 | homotypic cell-cell adhesion |
| GO:0002835 | 0.00092 | 45.27878 | 0 | 3 | 4 | negative regulation of response to tumor cell |
| GO:0002838 | 0.00092 | 45.27878 | 0 | 3 | 4 | negative regulation of immune response to tumor cell |
| GO:0002924 | 0.00092 | 45.27878 | 0 | 3 | 4 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0043315 | 0.00092 | 45.27878 | 0 | 3 | 4 | positive regulation of neutrophil degranulation |
| GO:0045917 | 0.00092 | 45.27878 | 0 | 3 | 4 | positive regulation of complement activation |
| GO:0071896 | 0.00092 | 45.27878 | 0 | 3 | 4 | protein localization to adherens junction |
| GO:0072008 | 0.00092 | 45.27878 | 0 | 3 | 4 | glomerular mesangial cell differentiation |
| GO:0072144 | 0.00092 | 45.27878 | 0 | 3 | 4 | glomerular mesangial cell development |
| GO:0072180 | 0.00092 | 45.27878 | 0 | 3 | 4 | mesonephric duct morphogenesis |
| GO:0098904 | 0.00092 | 45.27878 | 0 | 3 | 4 | regulation of AV node cell action potential |
| GO:0106015 | 0.00092 | 45.27878 | 0 | 3 | 4 | negative regulation of inflammatory response to wounding |
| GO:1902565 | 0.00092 | 45.27878 | 0 | 3 | 4 | positive regulation of neutrophil activation |
| GO:1902566 | 0.00092 | 45.27878 | 0 | 3 | 4 | regulation of eosinophil activation |
| GO:2000259 | 0.00092 | 45.27878 | 0 | 3 | 4 | positive regulation of protein activation cascade |
| GO:2000520 | 0.00092 | 45.27878 | 0 | 3 | 4 | regulation of immunological synapse formation |
| GO:0015807 | 0.00092 | 3.47058 | 4 | 11 | 59 | L-amino acid transport |
| GO:0045806 | 0.00092 | 3.47058 | 4 | 11 | 59 | negative regulation of endocytosis |
| GO:0070252 | 0.00092 | 2.90713 | 5 | 14 | 87 | actin-mediated cell contraction |
| GO:2000117 | 0.00092 | 2.90713 | 5 | 14 | 87 | negative regulation of cysteine-type endopeptidase activity |
| GO:0006836 | 0.00092 | 1.90342 | 18 | 33 | 297 | neurotransmitter transport |
| GO:0001773 | 0.00094 | 4.65478 | 2 | 8 | 34 | myeloid dendritic cell activation |
| GO:0010714 | 0.00094 | 4.65478 | 2 | 8 | 34 | positive regulation of collagen metabolic process |
| GO:0097178 | 0.00094 | 4.12737 | 3 | 9 | 42 | ruffle assembly |
| GO:0022898 | 0.00096 | 1.96780 | 16 | 30 | 262 | regulation of transmembrane transporter activity |
| GO:0043009 | 0.00097 | 1.51239 | 51 | 74 | 824 | chordate embryonic development |
| GO:0090257 | 0.00098 | 2.01852 | 15 | 28 | 239 | regulation of muscle system process |
| GO:1903522 | 0.00098 | 2.01852 | 15 | 28 | 239 | regulation of blood circulation |
| GO:0007163 | 0.00098 | 2.08060 | 13 | 26 | 216 | establishment or maintenance of cell polarity |
| GO:1900046 | 0.00099 | 3.03073 | 5 | 13 | 78 | regulation of hemostasis |
| GO:0043170 | 0.00101 | 1.18948 | 528 | 584 | 8488 | macromolecule metabolic process |
| GO:0048863 | 0.00101 | 2.04278 | 14 | 27 | 228 | stem cell differentiation |
| GO:0015698 | 0.00102 | 2.40331 | 9 | 19 | 139 | inorganic anion transport |
| GO:0070542 | 0.00104 | 3.69236 | 3 | 10 | 51 | response to fatty acid |
| GO:0006865 | 0.00104 | 2.33576 | 9 | 20 | 150 | amino acid transport |
| GO:2000106 | 0.00104 | 2.63766 | 7 | 16 | 108 | regulation of leukocyte apoptotic process |
| GO:0071495 | 0.00104 | 1.41476 | 76 | 103 | 1223 | cellular response to endogenous stimulus |
| GO:0002755 | 0.00105 | 6.47801 | 1 | 6 | 20 | MyD88-dependent toll-like receptor signaling pathway |
| GO:0006691 | 0.00105 | 6.47801 | 1 | 6 | 20 | leukotriene metabolic process |
| GO:0045986 | 0.00105 | 6.47801 | 1 | 6 | 20 | negative regulation of smooth muscle contraction |
| GO:0048143 | 0.00105 | 6.47801 | 1 | 6 | 20 | astrocyte activation |
| GO:0048245 | 0.00105 | 6.47801 | 1 | 6 | 20 | eosinophil chemotaxis |
| GO:0060252 | 0.00105 | 6.47801 | 1 | 6 | 20 | positive regulation of glial cell proliferation |
| GO:1904994 | 0.00105 | 6.47801 | 1 | 6 | 20 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0070227 | 0.00105 | 2.74016 | 6 | 15 | 98 | lymphocyte apoptotic process |
| GO:0010954 | 0.00105 | 5.29259 | 2 | 7 | 27 | positive regulation of protein processing |
| GO:0030212 | 0.00105 | 5.29259 | 2 | 7 | 27 | hyaluronan metabolic process |
| GO:0045730 | 0.00105 | 5.29259 | 2 | 7 | 27 | respiratory burst |
| GO:0045780 | 0.00105 | 5.29259 | 2 | 7 | 27 | positive regulation of bone resorption |
| GO:0046852 | 0.00105 | 5.29259 | 2 | 7 | 27 | positive regulation of bone remodeling |
| GO:0060008 | 0.00105 | 5.29259 | 2 | 7 | 27 | Sertoli cell differentiation |
| GO:0090183 | 0.00107 | 3.39960 | 4 | 11 | 60 | regulation of kidney development |
| GO:0043523 | 0.00108 | 1.95080 | 16 | 30 | 264 | regulation of neuron apoptotic process |
| GO:0050864 | 0.00108 | 1.95080 | 16 | 30 | 264 | regulation of B cell activation |
| GO:0097191 | 0.00108 | 2.03257 | 14 | 27 | 229 | extrinsic apoptotic signaling pathway |
| GO:0007548 | 0.00110 | 1.90278 | 18 | 32 | 288 | sex differentiation |
| GO:0003205 | 0.00111 | 2.13282 | 12 | 24 | 195 | cardiac chamber development |
| GO:1902905 | 0.00111 | 2.13282 | 12 | 24 | 195 | positive regulation of supramolecular fiber organization |
| GO:0045137 | 0.00112 | 2.05873 | 14 | 26 | 218 | development of primary sexual characteristics |
| GO:0003208 | 0.00112 | 2.98467 | 5 | 13 | 79 | cardiac ventricle morphogenesis |
| GO:0032890 | 0.00112 | 2.98467 | 5 | 13 | 79 | regulation of organic acid transport |
| GO:1990573 | 0.00113 | 4.00580 | 3 | 9 | 43 | potassium ion import across plasma membrane |
| GO:0033554 | 0.00114 | 1.34281 | 110 | 141 | 1763 | cellular response to stress |
| GO:0071356 | 0.00114 | 2.26165 | 10 | 21 | 162 | cellular response to tumor necrosis factor |
| GO:0015804 | 0.00115 | 4.48218 | 2 | 8 | 35 | neutral amino acid transport |
| GO:0034122 | 0.00115 | 4.48218 | 2 | 8 | 35 | negative regulation of toll-like receptor signaling pathway |
| GO:1990774 | 0.00115 | 4.48218 | 2 | 8 | 35 | tumor necrosis factor secretion |
| GO:0072009 | 0.00115 | 2.60918 | 7 | 16 | 109 | nephron epithelium development |
| GO:0015893 | 0.00116 | 2.08782 | 13 | 25 | 207 | drug transport |
| GO:0030949 | 0.00116 | 8.39352 | 1 | 5 | 14 | positive regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0035745 | 0.00116 | 8.39352 | 1 | 5 | 14 | T-helper 2 cell cytokine production |
| GO:0045618 | 0.00116 | 8.39352 | 1 | 5 | 14 | positive regulation of keratinocyte differentiation |
| GO:0071850 | 0.00116 | 8.39352 | 1 | 5 | 14 | mitotic cell cycle arrest |
| GO:0098911 | 0.00116 | 8.39352 | 1 | 5 | 14 | regulation of ventricular cardiac muscle cell action potential |
| GO:1902306 | 0.00116 | 8.39352 | 1 | 5 | 14 | negative regulation of sodium ion transmembrane transport |
| GO:0006936 | 0.00116 | 1.89529 | 18 | 32 | 289 | muscle contraction |
| GO:0060415 | 0.00116 | 2.82935 | 6 | 14 | 89 | muscle tissue morphogenesis |
| GO:0046394 | 0.00117 | 1.78727 | 23 | 38 | 362 | carboxylic acid biosynthetic process |
| GO:0045639 | 0.00117 | 2.70742 | 6 | 15 | 99 | positive regulation of myeloid cell differentiation |
| GO:0045664 | 0.00117 | 1.51855 | 48 | 70 | 776 | regulation of neuron differentiation |
| GO:0010466 | 0.00118 | 1.98995 | 15 | 28 | 242 | negative regulation of peptidase activity |
| GO:0051057 | 0.00119 | 3.13406 | 4 | 12 | 70 | positive regulation of small GTPase mediated signal transduction |
| GO:0035637 | 0.00121 | 2.36370 | 9 | 19 | 141 | multicellular organismal signaling |
| GO:0045017 | 0.00121 | 2.36370 | 9 | 19 | 141 | glycerolipid biosynthetic process |
| GO:0046165 | 0.00121 | 2.36370 | 9 | 19 | 141 | alcohol biosynthetic process |
| GO:0001764 | 0.00121 | 2.15689 | 12 | 23 | 185 | neuron migration |
| GO:0051668 | 0.00121 | 2.15689 | 12 | 23 | 185 | localization within membrane |
| GO:0002429 | 0.00121 | 1.83176 | 20 | 35 | 326 | immune response-activating cell surface receptor signaling pathway |
| GO:0031529 | 0.00121 | 3.60428 | 3 | 10 | 52 | ruffle organization |
| GO:0061614 | 0.00121 | 3.60428 | 3 | 10 | 52 | pri-miRNA transcription by RNA polymerase II |
| GO:0006066 | 0.00122 | 1.84897 | 20 | 34 | 314 | alcohol metabolic process |
| GO:0016053 | 0.00123 | 1.78168 | 23 | 38 | 363 | organic acid biosynthetic process |
| GO:0045840 | 0.00123 | 3.33145 | 4 | 11 | 61 | positive regulation of mitotic nuclear division |
| GO:0008584 | 0.00123 | 2.50370 | 7 | 17 | 120 | male gonad development |
| GO:0051208 | 0.00123 | 2.50370 | 7 | 17 | 120 | sequestering of calcium ion |
| GO:1904064 | 0.00123 | 2.24562 | 10 | 21 | 163 | positive regulation of cation transmembrane transport |
| GO:0044281 | 0.00125 | 1.34030 | 109 | 140 | 1753 | small molecule metabolic process |
| GO:0032410 | 0.00127 | 2.93999 | 5 | 13 | 80 | negative regulation of transporter activity |
| GO:0043154 | 0.00127 | 2.93999 | 5 | 13 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0050805 | 0.00127 | 2.93999 | 5 | 13 | 80 | negative regulation of synaptic transmission |
| GO:0060113 | 0.00127 | 2.93999 | 5 | 13 | 80 | inner ear receptor cell differentiation |
| GO:1904427 | 0.00127 | 2.93999 | 5 | 13 | 80 | positive regulation of calcium ion transmembrane transport |
| GO:0007584 | 0.00130 | 2.67544 | 6 | 15 | 100 | response to nutrient |
| GO:0110020 | 0.00130 | 2.67544 | 6 | 15 | 100 | regulation of actomyosin structure organization |
| GO:0014031 | 0.00130 | 2.79199 | 6 | 14 | 90 | mesenchymal cell development |
| GO:0050680 | 0.00132 | 2.34437 | 9 | 19 | 142 | negative regulation of epithelial cell proliferation |
| GO:0006929 | 0.00133 | 5.04033 | 2 | 7 | 28 | substrate-dependent cell migration |
| GO:0060444 | 0.00133 | 5.04033 | 2 | 7 | 28 | branching involved in mammary gland duct morphogenesis |
| GO:0060445 | 0.00133 | 5.04033 | 2 | 7 | 28 | branching involved in salivary gland morphogenesis |
| GO:0050919 | 0.00134 | 3.89117 | 3 | 9 | 44 | negative chemotaxis |
| GO:0046546 | 0.00135 | 2.47951 | 8 | 17 | 121 | development of primary male sexual characteristics |
| GO:0009743 | 0.00137 | 2.09576 | 12 | 24 | 198 | response to carbohydrate |
| GO:0048469 | 0.00137 | 2.09576 | 12 | 24 | 198 | cell maturation |
| GO:0072657 | 0.00138 | 1.61741 | 34 | 52 | 543 | protein localization to membrane |
| GO:0031346 | 0.00138 | 1.67104 | 29 | 46 | 466 | positive regulation of cell projection organization |
| GO:0042094 | 0.00139 | 6.04587 | 1 | 6 | 21 | interleukin-2 biosynthetic process |
| GO:1901017 | 0.00139 | 6.04587 | 1 | 6 | 21 | negative regulation of potassium ion transmembrane transporter activity |
| GO:0051181 | 0.00140 | 4.32190 | 2 | 8 | 36 | cofactor transport |
| GO:0070528 | 0.00140 | 4.32190 | 2 | 8 | 36 | protein kinase C signaling |
| GO:0003229 | 0.00141 | 3.26598 | 4 | 11 | 62 | ventricular cardiac muscle tissue development |
| GO:0030858 | 0.00141 | 3.26598 | 4 | 11 | 62 | positive regulation of epithelial cell differentiation |
| GO:0086003 | 0.00141 | 3.26598 | 4 | 11 | 62 | cardiac muscle cell contraction |
| GO:0002204 | 0.00141 | 3.52030 | 3 | 10 | 53 | somatic recombination of immunoglobulin genes involved in immune response |
| GO:0002208 | 0.00141 | 3.52030 | 3 | 10 | 53 | somatic diversification of immunoglobulins involved in immune response |
| GO:0045190 | 0.00141 | 3.52030 | 3 | 10 | 53 | isotype switching |
| GO:0050818 | 0.00142 | 2.89662 | 5 | 13 | 81 | regulation of coagulation |
| GO:0006022 | 0.00144 | 2.64421 | 6 | 15 | 101 | aminoglycan metabolic process |
| GO:0001838 | 0.00144 | 2.26562 | 10 | 20 | 154 | embryonic epithelial tube formation |
| GO:0048864 | 0.00145 | 2.75561 | 6 | 14 | 91 | stem cell development |
| GO:0008354 | 0.00146 | 12.08050 | 1 | 4 | 9 | germ cell migration |
| GO:0032836 | 0.00146 | 12.08050 | 1 | 4 | 9 | glomerular basement membrane development |
| GO:0043320 | 0.00146 | 12.08050 | 1 | 4 | 9 | natural killer cell degranulation |
| GO:0046113 | 0.00146 | 12.08050 | 1 | 4 | 9 | nucleobase catabolic process |
| GO:0060556 | 0.00146 | 12.08050 | 1 | 4 | 9 | regulation of vitamin D biosynthetic process |
| GO:0090286 | 0.00146 | 12.08050 | 1 | 4 | 9 | cytoskeletal anchoring at nuclear membrane |
| GO:2000489 | 0.00146 | 12.08050 | 1 | 4 | 9 | regulation of hepatic stellate cell activation |
| GO:0006639 | 0.00148 | 2.45578 | 8 | 17 | 122 | acylglycerol metabolic process |
| GO:0006959 | 0.00152 | 1.77231 | 22 | 37 | 355 | humoral immune response |
| GO:0030516 | 0.00154 | 2.52729 | 7 | 16 | 112 | regulation of axon extension |
| GO:0009628 | 0.00156 | 1.43349 | 64 | 88 | 1030 | response to abiotic stimulus |
| GO:0090207 | 0.00158 | 3.78290 | 3 | 9 | 45 | regulation of triglyceride metabolic process |
| GO:1902893 | 0.00158 | 3.78290 | 3 | 9 | 45 | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0046427 | 0.00159 | 2.61370 | 6 | 15 | 102 | positive regulation of JAK-STAT cascade |
| GO:0010921 | 0.00162 | 2.43250 | 8 | 17 | 123 | regulation of phosphatase activity |
| GO:0032350 | 0.00164 | 3.44013 | 3 | 10 | 54 | regulation of hormone metabolic process |
| GO:0007409 | 0.00164 | 1.65497 | 29 | 46 | 470 | axonogenesis |
| GO:0001771 | 0.00165 | 7.55382 | 1 | 5 | 15 | immunological synapse formation |
| GO:0006978 | 0.00165 | 7.55382 | 1 | 5 | 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0030656 | 0.00165 | 7.55382 | 1 | 5 | 15 | regulation of vitamin metabolic process |
| GO:0033089 | 0.00165 | 7.55382 | 1 | 5 | 15 | positive regulation of T cell differentiation in thymus |
| GO:0042033 | 0.00165 | 7.55382 | 1 | 5 | 15 | chemokine biosynthetic process |
| GO:0042953 | 0.00165 | 7.55382 | 1 | 5 | 15 | lipoprotein transport |
| GO:0044872 | 0.00165 | 7.55382 | 1 | 5 | 15 | lipoprotein localization |
| GO:0045073 | 0.00165 | 7.55382 | 1 | 5 | 15 | regulation of chemokine biosynthetic process |
| GO:0050872 | 0.00165 | 7.55382 | 1 | 5 | 15 | white fat cell differentiation |
| GO:0051044 | 0.00165 | 7.55382 | 1 | 5 | 15 | positive regulation of membrane protein ectodomain proteolysis |
| GO:0051712 | 0.00165 | 7.55382 | 1 | 5 | 15 | positive regulation of killing of cells of other organism |
| GO:1900027 | 0.00166 | 4.81101 | 2 | 7 | 29 | regulation of ruffle assembly |
| GO:1903319 | 0.00166 | 4.81101 | 2 | 7 | 29 | positive regulation of protein maturation |
| GO:0035303 | 0.00168 | 2.18370 | 10 | 21 | 167 | regulation of dephosphorylation |
| GO:0009792 | 0.00168 | 1.47767 | 52 | 74 | 841 | embryo development ending in birth or egg hatching |
| GO:0045746 | 0.00169 | 4.17268 | 2 | 8 | 37 | negative regulation of Notch signaling pathway |
| GO:0048846 | 0.00169 | 4.17268 | 2 | 8 | 37 | axon extension involved in axon guidance |
| GO:0086065 | 0.00169 | 4.17268 | 2 | 8 | 37 | cell communication involved in cardiac conduction |
| GO:1902284 | 0.00169 | 4.17268 | 2 | 8 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:0045165 | 0.00172 | 1.86411 | 18 | 31 | 284 | cell fate commitment |
| GO:0071695 | 0.00173 | 2.09182 | 12 | 23 | 190 | anatomical structure maturation |
| GO:0010605 | 0.00175 | 1.27334 | 161 | 196 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0006638 | 0.00177 | 2.40966 | 8 | 17 | 124 | neutral lipid metabolic process |
| GO:0030832 | 0.00177 | 2.12781 | 11 | 22 | 179 | regulation of actin filament length |
| GO:0034612 | 0.00177 | 2.12781 | 11 | 22 | 179 | response to tumor necrosis factor |
| GO:0002027 | 0.00179 | 2.68560 | 6 | 14 | 93 | regulation of heart rate |
| GO:0032691 | 0.00181 | 5.66774 | 1 | 6 | 22 | negative regulation of interleukin-1 beta production |
| GO:0033008 | 0.00181 | 5.66774 | 1 | 6 | 22 | positive regulation of mast cell activation involved in immune response |
| GO:0043306 | 0.00181 | 5.66774 | 1 | 6 | 22 | positive regulation of mast cell degranulation |
| GO:0045606 | 0.00181 | 5.66774 | 1 | 6 | 22 | positive regulation of epidermal cell differentiation |
| GO:0050857 | 0.00181 | 5.66774 | 1 | 6 | 22 | positive regulation of antigen receptor-mediated signaling pathway |
| GO:0062012 | 0.00185 | 1.74996 | 22 | 37 | 359 | regulation of small molecule metabolic process |
| GO:0043029 | 0.00186 | 3.68049 | 3 | 9 | 46 | T cell homeostasis |
| GO:0009896 | 0.00187 | 1.68468 | 26 | 42 | 422 | positive regulation of catabolic process |
| GO:0031400 | 0.00188 | 1.58364 | 35 | 53 | 564 | negative regulation of protein modification process |
| GO:0050732 | 0.00190 | 3.36353 | 3 | 10 | 55 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0051258 | 0.00193 | 1.86998 | 17 | 30 | 274 | protein polymerization |
| GO:0097553 | 0.00197 | 2.31400 | 8 | 18 | 136 | calcium ion transmembrane import into cytosol |
| GO:0006941 | 0.00197 | 2.19954 | 10 | 20 | 158 | striated muscle contraction |
| GO:0042133 | 0.00198 | 2.25227 | 9 | 19 | 147 | neurotransmitter metabolic process |
| GO:1901379 | 0.00200 | 2.77384 | 5 | 13 | 84 | regulation of potassium ion transmembrane transport |
| GO:0043267 | 0.00202 | 4.03340 | 2 | 8 | 38 | negative regulation of potassium ion transport |
| GO:0000187 | 0.00204 | 2.45037 | 7 | 16 | 115 | activation of MAPK activity |
| GO:0051209 | 0.00204 | 2.45037 | 7 | 16 | 115 | release of sequestered calcium ion into cytosol |
| GO:0002825 | 0.00205 | 4.60162 | 2 | 7 | 30 | regulation of T-helper 1 type immune response |
| GO:0007188 | 0.00205 | 2.02533 | 13 | 24 | 204 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0060425 | 0.00209 | 3.08411 | 4 | 11 | 65 | lung morphogenesis |
| GO:1903793 | 0.00209 | 3.08411 | 4 | 11 | 65 | positive regulation of anion transport |
| GO:0030833 | 0.00213 | 2.18362 | 10 | 20 | 159 | regulation of actin filament polymerization |
| GO:0048675 | 0.00214 | 2.29445 | 9 | 18 | 137 | axon extension |
| GO:0150063 | 0.00217 | 1.69276 | 25 | 40 | 400 | visual system development |
| GO:0032309 | 0.00217 | 3.58347 | 3 | 9 | 47 | icosanoid secretion |
| GO:0031641 | 0.00218 | 3.29026 | 3 | 10 | 56 | regulation of myelination |
| GO:0001915 | 0.00219 | 22.63835 | 0 | 3 | 5 | negative regulation of T cell mediated cytotoxicity |
| GO:0001922 | 0.00219 | 22.63835 | 0 | 3 | 5 | B-1 B cell homeostasis |
| GO:0006116 | 0.00219 | 22.63835 | 0 | 3 | 5 | NADH oxidation |
| GO:0009407 | 0.00219 | 22.63835 | 0 | 3 | 5 | toxin catabolic process |
| GO:0010694 | 0.00219 | 22.63835 | 0 | 3 | 5 | positive regulation of alkaline phosphatase activity |
| GO:0014005 | 0.00219 | 22.63835 | 0 | 3 | 5 | microglia development |
| GO:0032329 | 0.00219 | 22.63835 | 0 | 3 | 5 | serine transport |
| GO:0032632 | 0.00219 | 22.63835 | 0 | 3 | 5 | interleukin-3 production |
| GO:0060298 | 0.00219 | 22.63835 | 0 | 3 | 5 | positive regulation of sarcomere organization |
| GO:0071593 | 0.00219 | 22.63835 | 0 | 3 | 5 | lymphocyte aggregation |
| GO:0086029 | 0.00219 | 22.63835 | 0 | 3 | 5 | Purkinje myocyte to ventricular cardiac muscle cell signaling |
| GO:0086068 | 0.00219 | 22.63835 | 0 | 3 | 5 | Purkinje myocyte to ventricular cardiac muscle cell communication |
| GO:0098910 | 0.00219 | 22.63835 | 0 | 3 | 5 | regulation of atrial cardiac muscle cell action potential |
| GO:0106014 | 0.00219 | 22.63835 | 0 | 3 | 5 | regulation of inflammatory response to wounding |
| GO:1900127 | 0.00219 | 22.63835 | 0 | 3 | 5 | positive regulation of hyaluronan biosynthetic process |
| GO:1900425 | 0.00219 | 22.63835 | 0 | 3 | 5 | negative regulation of defense response to bacterium |
| GO:1901509 | 0.00219 | 22.63835 | 0 | 3 | 5 | regulation of endothelial tube morphogenesis |
| GO:1903969 | 0.00219 | 22.63835 | 0 | 3 | 5 | regulation of response to macrophage colony-stimulating factor |
| GO:1903972 | 0.00219 | 22.63835 | 0 | 3 | 5 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:0060563 | 0.00220 | 2.88466 | 5 | 12 | 75 | neuroepithelial cell differentiation |
| GO:0014032 | 0.00223 | 2.73519 | 5 | 13 | 85 | neural crest cell development |
| GO:0030282 | 0.00223 | 2.42575 | 7 | 16 | 116 | bone mineralization |
| GO:0001886 | 0.00227 | 6.86679 | 1 | 5 | 16 | endothelial cell morphogenesis |
| GO:0002281 | 0.00227 | 6.86679 | 1 | 5 | 16 | macrophage activation involved in immune response |
| GO:0002295 | 0.00227 | 6.86679 | 1 | 5 | 16 | T-helper cell lineage commitment |
| GO:0002467 | 0.00227 | 6.86679 | 1 | 5 | 16 | germinal center formation |
| GO:0007512 | 0.00227 | 6.86679 | 1 | 5 | 16 | adult heart development |
| GO:0042772 | 0.00227 | 6.86679 | 1 | 5 | 16 | DNA damage response, signal transduction resulting in transcription |
| GO:0051709 | 0.00227 | 6.86679 | 1 | 5 | 16 | regulation of killing of cells of other organism |
| GO:0051852 | 0.00227 | 6.86679 | 1 | 5 | 16 | disruption by host of symbiont cells |
| GO:0051873 | 0.00227 | 6.86679 | 1 | 5 | 16 | killing by host of symbiont cells |
| GO:0072109 | 0.00227 | 6.86679 | 1 | 5 | 16 | glomerular mesangium development |
| GO:1902414 | 0.00227 | 6.86679 | 1 | 5 | 16 | protein localization to cell junction |
| GO:1904996 | 0.00227 | 6.86679 | 1 | 5 | 16 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0031214 | 0.00229 | 2.16792 | 10 | 20 | 160 | biomineral tissue development |
| GO:0002315 | 0.00232 | 10.06662 | 1 | 4 | 10 | marginal zone B cell differentiation |
| GO:0002634 | 0.00232 | 10.06662 | 1 | 4 | 10 | regulation of germinal center formation |
| GO:0002934 | 0.00232 | 10.06662 | 1 | 4 | 10 | desmosome organization |
| GO:0021612 | 0.00232 | 10.06662 | 1 | 4 | 10 | facial nerve structural organization |
| GO:0034145 | 0.00232 | 10.06662 | 1 | 4 | 10 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:0051601 | 0.00232 | 10.06662 | 1 | 4 | 10 | exocyst localization |
| GO:2000389 | 0.00232 | 10.06662 | 1 | 4 | 10 | regulation of neutrophil extravasation |
| GO:2000391 | 0.00232 | 10.06662 | 1 | 4 | 10 | positive regulation of neutrophil extravasation |
| GO:2000551 | 0.00232 | 10.06662 | 1 | 4 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:0002093 | 0.00232 | 5.33410 | 1 | 6 | 23 | auditory receptor cell morphogenesis |
| GO:0050765 | 0.00232 | 5.33410 | 1 | 6 | 23 | negative regulation of phagocytosis |
| GO:0060840 | 0.00235 | 2.49835 | 7 | 15 | 106 | artery development |
| GO:0050792 | 0.00235 | 2.07456 | 11 | 22 | 183 | regulation of viral process |
| GO:0007257 | 0.00241 | 3.90311 | 2 | 8 | 39 | activation of JUN kinase activity |
| GO:0044331 | 0.00241 | 3.90311 | 2 | 8 | 39 | cell-cell adhesion mediated by cadherin |
| GO:0060251 | 0.00241 | 3.90311 | 2 | 8 | 39 | regulation of glial cell proliferation |
| GO:0090049 | 0.00241 | 3.90311 | 2 | 8 | 39 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0140029 | 0.00243 | 2.58699 | 6 | 14 | 96 | exocytic process |
| GO:0051283 | 0.00244 | 2.40162 | 7 | 16 | 117 | negative regulation of sequestering of calcium ion |
| GO:0051147 | 0.00247 | 2.15244 | 10 | 20 | 161 | regulation of muscle cell differentiation |
| GO:0072175 | 0.00247 | 2.15244 | 10 | 20 | 161 | epithelial tube formation |
| GO:0008593 | 0.00248 | 2.69760 | 5 | 13 | 86 | regulation of Notch signaling pathway |
| GO:0042490 | 0.00248 | 2.69760 | 5 | 13 | 86 | mechanoreceptor differentiation |
| GO:0048880 | 0.00248 | 1.67854 | 25 | 40 | 403 | sensory system development |
| GO:0086010 | 0.00250 | 4.40968 | 2 | 7 | 31 | membrane depolarization during action potential |
| GO:0072659 | 0.00254 | 1.83201 | 17 | 30 | 279 | protein localization to plasma membrane |
| GO:0071396 | 0.00256 | 1.53791 | 38 | 56 | 612 | cellular response to lipid |
| GO:0048145 | 0.00257 | 2.47108 | 7 | 15 | 107 | regulation of fibroblast proliferation |
| GO:0060759 | 0.00266 | 2.37797 | 7 | 16 | 118 | regulation of response to cytokine stimulus |
| GO:0003012 | 0.00267 | 1.68253 | 24 | 39 | 392 | muscle system process |
| GO:0045638 | 0.00268 | 2.55570 | 6 | 14 | 97 | negative regulation of myeloid cell differentiation |
| GO:0048644 | 0.00268 | 2.55570 | 6 | 14 | 97 | muscle organ morphogenesis |
| GO:0070167 | 0.00268 | 2.55570 | 6 | 14 | 97 | regulation of biomineral tissue development |
| GO:0006940 | 0.00268 | 2.97369 | 4 | 11 | 67 | regulation of smooth muscle contraction |
| GO:0007269 | 0.00269 | 2.04892 | 12 | 22 | 185 | neurotransmitter secretion |
| GO:0032729 | 0.00276 | 2.79564 | 5 | 12 | 77 | positive regulation of interferon-gamma production |
| GO:0051785 | 0.00276 | 2.79564 | 5 | 12 | 77 | positive regulation of nuclear division |
| GO:0061180 | 0.00276 | 2.79564 | 5 | 12 | 77 | mammary gland epithelium development |
| GO:0051402 | 0.00279 | 1.79933 | 18 | 31 | 293 | neuron apoptotic process |
| GO:1901214 | 0.00283 | 1.70167 | 23 | 37 | 368 | regulation of neuron death |
| GO:0032620 | 0.00285 | 3.78097 | 2 | 8 | 40 | interleukin-17 production |
| GO:0034105 | 0.00285 | 3.78097 | 2 | 8 | 40 | positive regulation of tissue remodeling |
| GO:0045911 | 0.00285 | 3.78097 | 2 | 8 | 40 | positive regulation of DNA recombination |
| GO:0060603 | 0.00285 | 3.78097 | 2 | 8 | 40 | mammary gland duct morphogenesis |
| GO:0016447 | 0.00286 | 3.15287 | 4 | 10 | 58 | somatic recombination of immunoglobulin gene segments |
| GO:0061337 | 0.00286 | 3.15287 | 4 | 10 | 58 | cardiac conduction |
| GO:0099643 | 0.00287 | 2.03633 | 12 | 22 | 186 | signal release from synapse |
| GO:0034764 | 0.00288 | 1.90822 | 15 | 26 | 233 | positive regulation of transmembrane transport |
| GO:0001503 | 0.00288 | 1.68677 | 24 | 38 | 381 | ossification |
| GO:0051282 | 0.00290 | 2.35477 | 7 | 16 | 119 | regulation of sequestering of calcium ion |
| GO:0046661 | 0.00291 | 2.16710 | 9 | 19 | 152 | male sex differentiation |
| GO:0051955 | 0.00293 | 3.40399 | 3 | 9 | 49 | regulation of amino acid transport |
| GO:0033622 | 0.00293 | 5.03753 | 1 | 6 | 24 | integrin activation |
| GO:0034104 | 0.00293 | 5.03753 | 1 | 6 | 24 | negative regulation of tissue remodeling |
| GO:0065005 | 0.00293 | 5.03753 | 1 | 6 | 24 | protein-lipid complex assembly |
| GO:0072080 | 0.00295 | 2.52516 | 6 | 14 | 98 | nephron tubule development |
| GO:0055081 | 0.00303 | 2.92138 | 4 | 11 | 68 | anion homeostasis |
| GO:0001779 | 0.00304 | 4.23310 | 2 | 7 | 32 | natural killer cell differentiation |
| GO:0040036 | 0.00304 | 4.23310 | 2 | 7 | 32 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0051149 | 0.00305 | 2.62542 | 5 | 13 | 88 | positive regulation of muscle cell differentiation |
| GO:1903035 | 0.00305 | 2.62542 | 5 | 13 | 88 | negative regulation of response to wounding |
| GO:0042692 | 0.00305 | 1.66811 | 25 | 39 | 395 | muscle cell differentiation |
| GO:0099003 | 0.00305 | 1.87331 | 15 | 27 | 246 | vesicle-mediated transport in synapse |
| GO:0002922 | 0.00306 | 6.29427 | 1 | 5 | 17 | positive regulation of humoral immune response |
| GO:0030033 | 0.00306 | 6.29427 | 1 | 5 | 17 | microvillus assembly |
| GO:0043373 | 0.00306 | 6.29427 | 1 | 5 | 17 | CD4-positive, alpha-beta T cell lineage commitment |
| GO:0045793 | 0.00306 | 6.29427 | 1 | 5 | 17 | positive regulation of cell size |
| GO:0071071 | 0.00306 | 6.29427 | 1 | 5 | 17 | regulation of phospholipid biosynthetic process |
| GO:0099171 | 0.00306 | 6.29427 | 1 | 5 | 17 | presynaptic modulation of chemical synaptic transmission |
| GO:2000257 | 0.00306 | 6.29427 | 1 | 5 | 17 | regulation of protein activation cascade |
| GO:0097696 | 0.00307 | 2.02389 | 12 | 22 | 187 | STAT cascade |
| GO:0048144 | 0.00309 | 2.41828 | 7 | 15 | 109 | fibroblast proliferation |
| GO:0030522 | 0.00314 | 1.98403 | 12 | 23 | 199 | intracellular receptor signaling pathway |
| GO:0009890 | 0.00317 | 1.32856 | 94 | 120 | 1509 | negative regulation of biosynthetic process |
| GO:0045667 | 0.00317 | 2.20143 | 9 | 18 | 142 | regulation of osteoblast differentiation |
| GO:0030198 | 0.00318 | 1.82147 | 17 | 29 | 271 | extracellular matrix organization |
| GO:0002262 | 0.00319 | 2.05604 | 11 | 21 | 176 | myeloid cell homeostasis |
| GO:0008064 | 0.00319 | 2.05604 | 11 | 21 | 176 | regulation of actin polymerization or depolymerization |
| GO:0048839 | 0.00319 | 1.94889 | 13 | 24 | 211 | inner ear development |
| GO:0060711 | 0.00325 | 3.08839 | 4 | 10 | 59 | labyrinthine layer development |
| GO:1901016 | 0.00325 | 3.08839 | 4 | 10 | 59 | regulation of potassium ion transmembrane transporter activity |
| GO:0001937 | 0.00335 | 3.66622 | 3 | 8 | 41 | negative regulation of endothelial cell proliferation |
| GO:0007431 | 0.00335 | 3.66622 | 3 | 8 | 41 | salivary gland development |
| GO:1905521 | 0.00335 | 3.66622 | 3 | 8 | 41 | regulation of macrophage migration |
| GO:1904035 | 0.00337 | 2.59075 | 6 | 13 | 89 | regulation of epithelial cell apoptotic process |
| GO:0001843 | 0.00337 | 2.39271 | 7 | 15 | 110 | neural tube closure |
| GO:0010596 | 0.00338 | 3.32081 | 3 | 9 | 50 | negative regulation of endothelial cell migration |
| GO:0042491 | 0.00338 | 3.32081 | 3 | 9 | 50 | inner ear auditory receptor cell differentiation |
| GO:0048146 | 0.00340 | 2.87088 | 4 | 11 | 69 | positive regulation of fibroblast proliferation |
| GO:0051279 | 0.00343 | 2.71194 | 5 | 12 | 79 | regulation of release of sequestered calcium ion into cytosol |
| GO:0032411 | 0.00344 | 2.30971 | 8 | 16 | 121 | positive regulation of transporter activity |
| GO:0002676 | 0.00347 | 8.62814 | 1 | 4 | 11 | regulation of chronic inflammatory response |
| GO:0031630 | 0.00347 | 8.62814 | 1 | 4 | 11 | regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0035733 | 0.00347 | 8.62814 | 1 | 4 | 11 | hepatic stellate cell activation |
| GO:0036005 | 0.00347 | 8.62814 | 1 | 4 | 11 | response to macrophage colony-stimulating factor |
| GO:0036006 | 0.00347 | 8.62814 | 1 | 4 | 11 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0042368 | 0.00347 | 8.62814 | 1 | 4 | 11 | vitamin D biosynthetic process |
| GO:0045416 | 0.00347 | 8.62814 | 1 | 4 | 11 | positive regulation of interleukin-8 biosynthetic process |
| GO:0051764 | 0.00347 | 8.62814 | 1 | 4 | 11 | actin crosslink formation |
| GO:0070943 | 0.00347 | 8.62814 | 1 | 4 | 11 | neutrophil mediated killing of symbiont cell |
| GO:0086016 | 0.00347 | 8.62814 | 1 | 4 | 11 | AV node cell action potential |
| GO:0086027 | 0.00347 | 8.62814 | 1 | 4 | 11 | AV node cell to bundle of His cell signaling |
| GO:1902260 | 0.00347 | 8.62814 | 1 | 4 | 11 | negative regulation of delayed rectifier potassium channel activity |
| GO:0099177 | 0.00358 | 1.49392 | 41 | 59 | 662 | regulation of trans-synaptic signaling |
| GO:0043010 | 0.00360 | 1.70127 | 22 | 35 | 348 | camera-type eye development |
| GO:0062013 | 0.00362 | 2.11900 | 10 | 19 | 155 | positive regulation of small molecule metabolic process |
| GO:0010951 | 0.00364 | 2.02966 | 11 | 21 | 178 | negative regulation of endopeptidase activity |
| GO:0043524 | 0.00364 | 2.02966 | 11 | 21 | 178 | negative regulation of neuron apoptotic process |
| GO:0048841 | 0.00365 | 4.07010 | 2 | 7 | 33 | regulation of axon extension involved in axon guidance |
| GO:0001956 | 0.00366 | 4.77217 | 2 | 6 | 25 | positive regulation of neurotransmitter secretion |
| GO:0002478 | 0.00366 | 4.77217 | 2 | 6 | 25 | antigen processing and presentation of exogenous peptide antigen |
| GO:0010894 | 0.00366 | 4.77217 | 2 | 6 | 25 | negative regulation of steroid biosynthetic process |
| GO:0031629 | 0.00366 | 4.77217 | 2 | 6 | 25 | synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0032703 | 0.00366 | 4.77217 | 2 | 6 | 25 | negative regulation of interleukin-2 production |
| GO:0034123 | 0.00366 | 4.77217 | 2 | 6 | 25 | positive regulation of toll-like receptor signaling pathway |
| GO:0045939 | 0.00366 | 4.77217 | 2 | 6 | 25 | negative regulation of steroid metabolic process |
| GO:0055094 | 0.00366 | 4.77217 | 2 | 6 | 25 | response to lipoprotein particle |
| GO:1903671 | 0.00366 | 4.77217 | 2 | 6 | 25 | negative regulation of sprouting angiogenesis |
| GO:1905939 | 0.00366 | 4.77217 | 2 | 6 | 25 | regulation of gonad development |
| GO:0051961 | 0.00366 | 1.68552 | 22 | 36 | 361 | negative regulation of nervous system development |
| GO:0015749 | 0.00368 | 2.36768 | 7 | 15 | 111 | monosaccharide transmembrane transport |
| GO:0060606 | 0.00368 | 2.36768 | 7 | 15 | 111 | tube closure |
| GO:0045824 | 0.00369 | 3.02648 | 4 | 10 | 60 | negative regulation of innate immune response |
| GO:0050982 | 0.00369 | 3.02648 | 4 | 10 | 60 | detection of mechanical stimulus |
| GO:0046928 | 0.00373 | 2.22178 | 8 | 17 | 133 | regulation of neurotransmitter secretion |
| GO:0045787 | 0.00377 | 1.69577 | 22 | 35 | 349 | positive regulation of cell cycle |
| GO:0010923 | 0.00381 | 2.67193 | 5 | 12 | 80 | negative regulation of phosphatase activity |
| GO:0042326 | 0.00384 | 1.60146 | 28 | 43 | 452 | negative regulation of phosphorylation |
| GO:0001970 | 0.00387 | Inf | 0 | 2 | 2 | positive regulation of activation of membrane attack complex |
| GO:0002032 | 0.00387 | Inf | 0 | 2 | 2 | desensitization of G protein-coupled receptor signaling pathway by arrestin |
| GO:0002380 | 0.00387 | Inf | 0 | 2 | 2 | immunoglobulin secretion involved in immune response |
| GO:0002436 | 0.00387 | Inf | 0 | 2 | 2 | immune complex clearance by monocytes and macrophages |
| GO:0002519 | 0.00387 | Inf | 0 | 2 | 2 | natural killer cell tolerance induction |
| GO:0002545 | 0.00387 | Inf | 0 | 2 | 2 | chronic inflammatory response to non-antigenic stimulus |
| GO:0002880 | 0.00387 | Inf | 0 | 2 | 2 | regulation of chronic inflammatory response to non-antigenic stimulus |
| GO:0003366 | 0.00387 | Inf | 0 | 2 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
| GO:0006127 | 0.00387 | Inf | 0 | 2 | 2 | glycerophosphate shuttle |
| GO:0009814 | 0.00387 | Inf | 0 | 2 | 2 | defense response, incompatible interaction |
| GO:0010716 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of extracellular matrix disassembly |
| GO:0015882 | 0.00387 | Inf | 0 | 2 | 2 | L-ascorbic acid transmembrane transport |
| GO:0015939 | 0.00387 | Inf | 0 | 2 | 2 | pantothenate metabolic process |
| GO:0019547 | 0.00387 | Inf | 0 | 2 | 2 | arginine catabolic process to ornithine |
| GO:0030185 | 0.00387 | Inf | 0 | 2 | 2 | nitric oxide transport |
| GO:0033624 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of integrin activation |
| GO:0034125 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
| GO:0035377 | 0.00387 | Inf | 0 | 2 | 2 | transepithelial water transport |
| GO:0043316 | 0.00387 | Inf | 0 | 2 | 2 | cytotoxic T cell degranulation |
| GO:0045366 | 0.00387 | Inf | 0 | 2 | 2 | regulation of interleukin-13 biosynthetic process |
| GO:0045368 | 0.00387 | Inf | 0 | 2 | 2 | positive regulation of interleukin-13 biosynthetic process |
| GO:0050712 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of interleukin-1 alpha secretion |
| GO:0060101 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of phagocytosis, engulfment |
| GO:0061017 | 0.00387 | Inf | 0 | 2 | 2 | hepatoblast differentiation |
| GO:0070904 | 0.00387 | Inf | 0 | 2 | 2 | transepithelial L-ascorbic acid transport |
| GO:0071460 | 0.00387 | Inf | 0 | 2 | 2 | cellular response to cell-matrix adhesion |
| GO:0071594 | 0.00387 | Inf | 0 | 2 | 2 | thymocyte aggregation |
| GO:0072564 | 0.00387 | Inf | 0 | 2 | 2 | blood microparticle formation |
| GO:0090264 | 0.00387 | Inf | 0 | 2 | 2 | regulation of immune complex clearance by monocytes and macrophages |
| GO:0090265 | 0.00387 | Inf | 0 | 2 | 2 | positive regulation of immune complex clearance by monocytes and macrophages |
| GO:0150064 | 0.00387 | Inf | 0 | 2 | 2 | vertebrate eye-specific patterning |
| GO:1902159 | 0.00387 | Inf | 0 | 2 | 2 | regulation of cyclic nucleotide-gated ion channel activity |
| GO:1902567 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of eosinophil activation |
| GO:1904470 | 0.00387 | Inf | 0 | 2 | 2 | regulation of endothelin secretion |
| GO:1905397 | 0.00387 | Inf | 0 | 2 | 2 | activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905402 | 0.00387 | Inf | 0 | 2 | 2 | regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905704 | 0.00387 | Inf | 0 | 2 | 2 | positive regulation of inhibitory synapse assembly |
| GO:1990775 | 0.00387 | Inf | 0 | 2 | 2 | endothelin secretion |
| GO:2000332 | 0.00387 | Inf | 0 | 2 | 2 | regulation of blood microparticle formation |
| GO:2000334 | 0.00387 | Inf | 0 | 2 | 2 | positive regulation of blood microparticle formation |
| GO:2000417 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of eosinophil migration |
| GO:2000471 | 0.00387 | Inf | 0 | 2 | 2 | regulation of hematopoietic stem cell migration |
| GO:2000473 | 0.00387 | Inf | 0 | 2 | 2 | positive regulation of hematopoietic stem cell migration |
| GO:2000521 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of immunological synapse formation |
| GO:2001189 | 0.00387 | Inf | 0 | 2 | 2 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0001974 | 0.00388 | 3.24159 | 3 | 9 | 51 | blood vessel remodeling |
| GO:0033619 | 0.00388 | 3.24159 | 3 | 9 | 51 | membrane protein proteolysis |
| GO:2000649 | 0.00388 | 3.24159 | 3 | 9 | 51 | regulation of sodium ion transmembrane transporter activity |
| GO:0006694 | 0.00389 | 2.10344 | 10 | 19 | 156 | steroid biosynthetic process |
| GO:0051302 | 0.00389 | 2.10344 | 10 | 19 | 156 | regulation of cell division |
| GO:0019933 | 0.00389 | 2.01673 | 11 | 21 | 179 | cAMP-mediated signaling |
| GO:0032768 | 0.00391 | 3.55823 | 3 | 8 | 42 | regulation of monooxygenase activity |
| GO:0045923 | 0.00391 | 3.55823 | 3 | 8 | 42 | positive regulation of fatty acid metabolic process |
| GO:0034219 | 0.00401 | 2.34316 | 7 | 15 | 112 | carbohydrate transmembrane transport |
| GO:0032700 | 0.00402 | 5.80983 | 1 | 5 | 18 | negative regulation of interleukin-17 production |
| GO:0035089 | 0.00402 | 5.80983 | 1 | 5 | 18 | establishment of apical/basal cell polarity |
| GO:0038093 | 0.00402 | 5.80983 | 1 | 5 | 18 | Fc receptor signaling pathway |
| GO:0000122 | 0.00406 | 1.42390 | 53 | 73 | 857 | negative regulation of transcription by RNA polymerase II |
| GO:0032271 | 0.00406 | 1.90772 | 13 | 24 | 215 | regulation of protein polymerization |
| GO:0071216 | 0.00409 | 1.73148 | 19 | 32 | 313 | cellular response to biotic stimulus |
| GO:0043436 | 0.00416 | 1.40242 | 59 | 79 | 941 | oxoacid metabolic process |
| GO:1902305 | 0.00417 | 2.96700 | 4 | 10 | 61 | regulation of sodium ion transmembrane transport |
| GO:0060402 | 0.00417 | 2.08810 | 10 | 19 | 157 | calcium ion transport into cytosol |
| GO:0002461 | 0.00418 | 15.09154 | 0 | 3 | 6 | tolerance induction dependent upon immune response |
| GO:0008228 | 0.00418 | 15.09154 | 0 | 3 | 6 | opsonization |
| GO:0009912 | 0.00418 | 15.09154 | 0 | 3 | 6 | auditory receptor cell fate commitment |
| GO:0034242 | 0.00418 | 15.09154 | 0 | 3 | 6 | negative regulation of syncytium formation by plasma membrane fusion |
| GO:0038033 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
| GO:0042695 | 0.00418 | 15.09154 | 0 | 3 | 6 | thelarche |
| GO:0043307 | 0.00418 | 15.09154 | 0 | 3 | 6 | eosinophil activation |
| GO:0045588 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of gamma-delta T cell differentiation |
| GO:0046645 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of gamma-delta T cell activation |
| GO:0060120 | 0.00418 | 15.09154 | 0 | 3 | 6 | inner ear receptor cell fate commitment |
| GO:0060744 | 0.00418 | 15.09154 | 0 | 3 | 6 | mammary gland branching involved in thelarche |
| GO:0070339 | 0.00418 | 15.09154 | 0 | 3 | 6 | response to bacterial lipopeptide |
| GO:0071220 | 0.00418 | 15.09154 | 0 | 3 | 6 | cellular response to bacterial lipoprotein |
| GO:0071221 | 0.00418 | 15.09154 | 0 | 3 | 6 | cellular response to bacterial lipopeptide |
| GO:0072177 | 0.00418 | 15.09154 | 0 | 3 | 6 | mesonephric duct development |
| GO:1905563 | 0.00418 | 15.09154 | 0 | 3 | 6 | negative regulation of vascular endothelial cell proliferation |
| GO:2000321 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of T-helper 17 cell differentiation |
| GO:2000491 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of hepatic stellate cell activation |
| GO:2000664 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of interleukin-5 secretion |
| GO:2001181 | 0.00418 | 15.09154 | 0 | 3 | 6 | positive regulation of interleukin-10 secretion |
| GO:0042509 | 0.00427 | 2.77493 | 4 | 11 | 71 | regulation of tyrosine phosphorylation of STAT protein |
| GO:0051648 | 0.00435 | 1.77691 | 17 | 29 | 277 | vesicle localization |
| GO:0000186 | 0.00435 | 3.91918 | 2 | 7 | 34 | activation of MAPKK activity |
| GO:0031338 | 0.00435 | 3.91918 | 2 | 7 | 34 | regulation of vesicle fusion |
| GO:0035116 | 0.00435 | 3.91918 | 2 | 7 | 34 | embryonic hindlimb morphogenesis |
| GO:0060048 | 0.00439 | 2.24524 | 8 | 16 | 124 | cardiac muscle contraction |
| GO:0042176 | 0.00442 | 1.65099 | 24 | 37 | 378 | regulation of protein catabolic process |
| GO:2001222 | 0.00444 | 3.16606 | 3 | 9 | 52 | regulation of neuron migration |
| GO:0019752 | 0.00447 | 1.40730 | 56 | 76 | 902 | carboxylic acid metabolic process |
| GO:0071219 | 0.00449 | 1.75360 | 18 | 30 | 290 | cellular response to molecule of bacterial origin |
| GO:0014033 | 0.00451 | 2.49203 | 6 | 13 | 92 | neural crest cell differentiation |
| GO:0010829 | 0.00451 | 4.53336 | 2 | 6 | 26 | negative regulation of glucose transmembrane transport |
| GO:0032528 | 0.00451 | 4.53336 | 2 | 6 | 26 | microvillus organization |
| GO:0042104 | 0.00451 | 4.53336 | 2 | 6 | 26 | positive regulation of activated T cell proliferation |
| GO:0072574 | 0.00451 | 4.53336 | 2 | 6 | 26 | hepatocyte proliferation |
| GO:0072575 | 0.00451 | 4.53336 | 2 | 6 | 26 | epithelial cell proliferation involved in liver morphogenesis |
| GO:0099500 | 0.00451 | 4.53336 | 2 | 6 | 26 | vesicle fusion to plasma membrane |
| GO:0043112 | 0.00455 | 1.91809 | 13 | 23 | 205 | receptor metabolic process |
| GO:0060401 | 0.00462 | 2.02246 | 11 | 20 | 170 | cytosolic calcium ion transport |
| GO:1904892 | 0.00462 | 2.02246 | 11 | 20 | 170 | regulation of STAT cascade |
| GO:0070997 | 0.00466 | 1.62178 | 25 | 39 | 405 | neuron death |
| GO:0030038 | 0.00467 | 2.38274 | 6 | 14 | 103 | contractile actin filament bundle assembly |
| GO:0043149 | 0.00467 | 2.38274 | 6 | 14 | 103 | stress fiber assembly |
| GO:0015748 | 0.00468 | 2.59535 | 5 | 12 | 82 | organophosphate ester transport |
| GO:0090630 | 0.00468 | 2.59535 | 5 | 12 | 82 | activation of GTPase activity |
| GO:0002437 | 0.00470 | 2.90981 | 4 | 10 | 62 | inflammatory response to antigenic stimulus |
| GO:0035051 | 0.00472 | 1.97887 | 11 | 21 | 182 | cardiocyte differentiation |
| GO:0120032 | 0.00472 | 1.97887 | 11 | 21 | 182 | regulation of plasma membrane bounded cell projection assembly |
| GO:0032414 | 0.00475 | 2.29561 | 7 | 15 | 114 | positive regulation of ion transmembrane transporter activity |
| GO:0030239 | 0.00476 | 2.72931 | 4 | 11 | 72 | myofibril assembly |
| GO:0043583 | 0.00478 | 1.82795 | 15 | 26 | 242 | ear development |
| GO:0030308 | 0.00479 | 1.94090 | 12 | 22 | 194 | negative regulation of cell growth |
| GO:0031669 | 0.00479 | 1.94090 | 12 | 22 | 194 | cellular response to nutrient levels |
| GO:0008544 | 0.00480 | 1.69512 | 20 | 33 | 329 | epidermis development |
| GO:0002921 | 0.00494 | 7.54927 | 1 | 4 | 12 | negative regulation of humoral immune response |
| GO:0006957 | 0.00494 | 7.54927 | 1 | 4 | 12 | complement activation, alternative pathway |
| GO:0021561 | 0.00494 | 7.54927 | 1 | 4 | 12 | facial nerve development |
| GO:0021610 | 0.00494 | 7.54927 | 1 | 4 | 12 | facial nerve morphogenesis |
| GO:0032308 | 0.00494 | 7.54927 | 1 | 4 | 12 | positive regulation of prostaglandin secretion |
| GO:0032353 | 0.00494 | 7.54927 | 1 | 4 | 12 | negative regulation of hormone biosynthetic process |
| GO:0033004 | 0.00494 | 7.54927 | 1 | 4 | 12 | negative regulation of mast cell activation |
| GO:0060430 | 0.00494 | 7.54927 | 1 | 4 | 12 | lung saccule development |
| GO:0070444 | 0.00494 | 7.54927 | 1 | 4 | 12 | oligodendrocyte progenitor proliferation |
| GO:0070445 | 0.00494 | 7.54927 | 1 | 4 | 12 | regulation of oligodendrocyte progenitor proliferation |
| GO:0071639 | 0.00494 | 7.54927 | 1 | 4 | 12 | positive regulation of monocyte chemotactic protein-1 production |
| GO:0072540 | 0.00494 | 7.54927 | 1 | 4 | 12 | T-helper 17 cell lineage commitment |
| GO:0072608 | 0.00494 | 7.54927 | 1 | 4 | 12 | interleukin-10 secretion |
| GO:1903789 | 0.00494 | 7.54927 | 1 | 4 | 12 | regulation of amino acid transmembrane transport |
| GO:0001701 | 0.00499 | 1.52719 | 33 | 49 | 538 | in utero embryonic development |
| GO:0006023 | 0.00506 | 3.09396 | 3 | 9 | 53 | aminoglycan biosynthetic process |
| GO:0045214 | 0.00506 | 3.09396 | 3 | 9 | 53 | sarcomere organization |
| GO:0045933 | 0.00506 | 3.09396 | 3 | 9 | 53 | positive regulation of muscle contraction |
| GO:0061383 | 0.00506 | 3.09396 | 3 | 9 | 53 | trabecula morphogenesis |
| GO:1900024 | 0.00506 | 3.09396 | 3 | 9 | 53 | regulation of substrate adhesion-dependent cell spreading |
| GO:0051783 | 0.00509 | 1.92959 | 12 | 22 | 195 | regulation of nuclear division |
| GO:0060348 | 0.00509 | 1.84252 | 14 | 25 | 231 | bone development |
| GO:0001657 | 0.00510 | 2.35616 | 6 | 14 | 104 | ureteric bud development |
| GO:0061326 | 0.00510 | 2.35616 | 6 | 14 | 104 | renal tubule development |
| GO:0072163 | 0.00510 | 2.35616 | 6 | 14 | 104 | mesonephric epithelium development |
| GO:0072164 | 0.00510 | 2.35616 | 6 | 14 | 104 | mesonephric tubule development |
| GO:0050852 | 0.00513 | 2.20421 | 8 | 16 | 126 | T cell receptor signaling pathway |
| GO:0019432 | 0.00515 | 3.77903 | 2 | 7 | 35 | triglyceride biosynthetic process |
| GO:0019835 | 0.00515 | 3.77903 | 2 | 7 | 35 | cytolysis |
| GO:0032733 | 0.00515 | 3.77903 | 2 | 7 | 35 | positive regulation of interleukin-10 production |
| GO:0038084 | 0.00515 | 3.77903 | 2 | 7 | 35 | vascular endothelial growth factor signaling pathway |
| GO:0055083 | 0.00515 | 3.77903 | 2 | 7 | 35 | monovalent inorganic anion homeostasis |
| GO:0060142 | 0.00515 | 3.77903 | 2 | 7 | 35 | regulation of syncytium formation by plasma membrane fusion |
| GO:0007610 | 0.00516 | 1.44642 | 45 | 63 | 728 | behavior |
| GO:0006942 | 0.00517 | 2.55868 | 5 | 12 | 83 | regulation of striated muscle contraction |
| GO:0018105 | 0.00517 | 1.70081 | 20 | 32 | 318 | peptidyl-serine phosphorylation |
| GO:0002363 | 0.00518 | 5.39459 | 1 | 5 | 19 | alpha-beta T cell lineage commitment |
| GO:0002495 | 0.00518 | 5.39459 | 1 | 5 | 19 | antigen processing and presentation of peptide antigen via MHC class II |
| GO:0002710 | 0.00518 | 5.39459 | 1 | 5 | 19 | negative regulation of T cell mediated immunity |
| GO:0010623 | 0.00518 | 5.39459 | 1 | 5 | 19 | programmed cell death involved in cell development |
| GO:0030502 | 0.00518 | 5.39459 | 1 | 5 | 19 | negative regulation of bone mineralization |
| GO:0045953 | 0.00518 | 5.39459 | 1 | 5 | 19 | negative regulation of natural killer cell mediated cytotoxicity |
| GO:0051818 | 0.00518 | 5.39459 | 1 | 5 | 19 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0051883 | 0.00518 | 5.39459 | 1 | 5 | 19 | killing of cells in other organism involved in symbiotic interaction |
| GO:0071605 | 0.00518 | 5.39459 | 1 | 5 | 19 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.00518 | 5.39459 | 1 | 5 | 19 | regulation of monocyte chemotactic protein-1 production |
| GO:0043588 | 0.00520 | 1.73336 | 18 | 30 | 293 | skin development |
| GO:0001569 | 0.00526 | 3.36024 | 3 | 8 | 44 | branching involved in blood vessel morphogenesis |
| GO:0015914 | 0.00528 | 2.85478 | 4 | 10 | 63 | phospholipid transport |
| GO:0035904 | 0.00528 | 2.85478 | 4 | 10 | 63 | aorta development |
| GO:0050804 | 0.00534 | 1.46754 | 41 | 58 | 661 | modulation of chemical synaptic transmission |
| GO:0060491 | 0.00536 | 1.95441 | 11 | 21 | 184 | regulation of cell projection assembly |
| GO:0002347 | 0.00550 | 4.31728 | 2 | 6 | 27 | response to tumor cell |
| GO:0045061 | 0.00550 | 4.31728 | 2 | 6 | 27 | thymic T cell selection |
| GO:0045332 | 0.00550 | 4.31728 | 2 | 6 | 27 | phospholipid translocation |
| GO:0045830 | 0.00550 | 4.31728 | 2 | 6 | 27 | positive regulation of isotype switching |
| GO:0048843 | 0.00550 | 4.31728 | 2 | 6 | 27 | negative regulation of axon extension involved in axon guidance |
| GO:0060713 | 0.00550 | 4.31728 | 2 | 6 | 27 | labyrinthine layer morphogenesis |
| GO:0071402 | 0.00550 | 4.31728 | 2 | 6 | 27 | cellular response to lipoprotein particle stimulus |
| GO:0038127 | 0.00555 | 2.33016 | 7 | 14 | 105 | ERBB signaling pathway |
| GO:0035296 | 0.00561 | 1.98252 | 11 | 20 | 173 | regulation of tube diameter |
| GO:0050880 | 0.00561 | 1.98252 | 11 | 20 | 173 | regulation of blood vessel size |
| GO:0097746 | 0.00561 | 1.98252 | 11 | 20 | 173 | regulation of blood vessel diameter |
| GO:0048524 | 0.00569 | 2.52303 | 5 | 12 | 84 | positive regulation of viral process |
| GO:0001654 | 0.00570 | 1.61039 | 25 | 38 | 397 | eye development |
| GO:0043030 | 0.00575 | 3.02507 | 3 | 9 | 54 | regulation of macrophage activation |
| GO:0051650 | 0.00582 | 1.77501 | 16 | 27 | 258 | establishment of vesicle localization |
| GO:0045927 | 0.00583 | 1.70070 | 19 | 31 | 308 | positive regulation of growth |
| GO:0006082 | 0.00585 | 1.37788 | 60 | 80 | 968 | organic acid metabolic process |
| GO:0010952 | 0.00586 | 2.01462 | 10 | 19 | 162 | positive regulation of peptidase activity |
| GO:0002532 | 0.00588 | 2.64243 | 5 | 11 | 74 | production of molecular mediator involved in inflammatory response |
| GO:0003333 | 0.00588 | 2.64243 | 5 | 11 | 74 | amino acid transmembrane transport |
| GO:0007173 | 0.00593 | 2.40052 | 6 | 13 | 95 | epidermal growth factor receptor signaling pathway |
| GO:0035150 | 0.00598 | 1.96956 | 11 | 20 | 174 | regulation of tube size |
| GO:0014020 | 0.00605 | 2.22779 | 7 | 15 | 117 | primary neural tube formation |
| GO:0042987 | 0.00606 | 3.26927 | 3 | 8 | 45 | amyloid precursor protein catabolic process |
| GO:0050974 | 0.00606 | 3.26927 | 3 | 8 | 45 | detection of mechanical stimulus involved in sensory perception |
| GO:0060135 | 0.00606 | 3.26927 | 3 | 8 | 45 | maternal process involved in female pregnancy |
| GO:0045601 | 0.00606 | 3.64855 | 2 | 7 | 36 | regulation of endothelial cell differentiation |
| GO:1902991 | 0.00606 | 3.64855 | 2 | 7 | 36 | regulation of amyloid precursor protein catabolic process |
| GO:0065003 | 0.00610 | 1.28106 | 108 | 133 | 1729 | protein-containing complex assembly |
| GO:0007088 | 0.00626 | 2.00054 | 10 | 19 | 163 | regulation of mitotic nuclear division |
| GO:1903829 | 0.00628 | 1.70707 | 18 | 30 | 297 | positive regulation of cellular protein localization |
| GO:0017156 | 0.00637 | 1.95676 | 11 | 20 | 175 | calcium ion regulated exocytosis |
| GO:0030073 | 0.00639 | 1.83035 | 14 | 24 | 223 | insulin secretion |
| GO:0002042 | 0.00650 | 2.95917 | 3 | 9 | 55 | cell migration involved in sprouting angiogenesis |
| GO:0002833 | 0.00650 | 2.95917 | 3 | 9 | 55 | positive regulation of response to biotic stimulus |
| GO:0035019 | 0.00650 | 2.95917 | 3 | 9 | 55 | somatic stem cell population maintenance |
| GO:0035306 | 0.00650 | 2.95917 | 3 | 9 | 55 | positive regulation of dephosphorylation |
| GO:0035315 | 0.00650 | 2.95917 | 3 | 9 | 55 | hair cell differentiation |
| GO:0007260 | 0.00651 | 2.60102 | 5 | 11 | 75 | tyrosine phosphorylation of STAT protein |
| GO:0002313 | 0.00656 | 5.03472 | 1 | 5 | 20 | mature B cell differentiation involved in immune response |
| GO:0002504 | 0.00656 | 5.03472 | 1 | 5 | 20 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0002716 | 0.00656 | 5.03472 | 1 | 5 | 20 | negative regulation of natural killer cell mediated immunity |
| GO:0034377 | 0.00656 | 5.03472 | 1 | 5 | 20 | plasma lipoprotein particle assembly |
| GO:0042178 | 0.00656 | 5.03472 | 1 | 5 | 20 | xenobiotic catabolic process |
| GO:0043011 | 0.00656 | 5.03472 | 1 | 5 | 20 | myeloid dendritic cell differentiation |
| GO:0051195 | 0.00656 | 5.03472 | 1 | 5 | 20 | negative regulation of cofactor metabolic process |
| GO:0055064 | 0.00656 | 5.03472 | 1 | 5 | 20 | chloride ion homeostasis |
| GO:0061162 | 0.00656 | 5.03472 | 1 | 5 | 20 | establishment of monopolar cell polarity |
| GO:0001823 | 0.00656 | 2.27984 | 7 | 14 | 107 | mesonephros development |
| GO:0016445 | 0.00661 | 2.75071 | 4 | 10 | 65 | somatic diversification of immunoglobulins |
| GO:0001945 | 0.00664 | 4.12085 | 2 | 6 | 28 | lymph vessel development |
| GO:0034204 | 0.00664 | 4.12085 | 2 | 6 | 28 | lipid translocation |
| GO:0035162 | 0.00664 | 4.12085 | 2 | 6 | 28 | embryonic hemopoiesis |
| GO:0044788 | 0.00664 | 4.12085 | 2 | 6 | 28 | modulation by host of viral process |
| GO:0045671 | 0.00664 | 4.12085 | 2 | 6 | 28 | negative regulation of osteoclast differentiation |
| GO:0072576 | 0.00664 | 4.12085 | 2 | 6 | 28 | liver morphogenesis |
| GO:1902668 | 0.00664 | 4.12085 | 2 | 6 | 28 | negative regulation of axon guidance |
| GO:1902932 | 0.00664 | 4.12085 | 2 | 6 | 28 | positive regulation of alcohol biosynthetic process |
| GO:0007346 | 0.00666 | 1.52944 | 31 | 45 | 493 | regulation of mitotic cell cycle |
| GO:2001233 | 0.00668 | 1.58219 | 26 | 39 | 414 | regulation of apoptotic signaling pathway |
| GO:1903827 | 0.00674 | 1.51337 | 32 | 47 | 520 | regulation of cellular protein localization |
| GO:0009612 | 0.00678 | 1.94413 | 11 | 20 | 176 | response to mechanical stimulus |
| GO:0001660 | 0.00679 | 6.71015 | 1 | 4 | 13 | fever generation |
| GO:0001845 | 0.00679 | 6.71015 | 1 | 4 | 13 | phagolysosome assembly |
| GO:0002430 | 0.00679 | 6.71015 | 1 | 4 | 13 | complement receptor mediated signaling pathway |
| GO:0003157 | 0.00679 | 6.71015 | 1 | 4 | 13 | endocardium development |
| GO:0021604 | 0.00679 | 6.71015 | 1 | 4 | 13 | cranial nerve structural organization |
| GO:0032351 | 0.00679 | 6.71015 | 1 | 4 | 13 | negative regulation of hormone metabolic process |
| GO:0032494 | 0.00679 | 6.71015 | 1 | 4 | 13 | response to peptidoglycan |
| GO:0033280 | 0.00679 | 6.71015 | 1 | 4 | 13 | response to vitamin D |
| GO:0060670 | 0.00679 | 6.71015 | 1 | 4 | 13 | branching involved in labyrinthine layer morphogenesis |
| GO:0070942 | 0.00679 | 6.71015 | 1 | 4 | 13 | neutrophil mediated cytotoxicity |
| GO:0086067 | 0.00679 | 6.71015 | 1 | 4 | 13 | AV node cell to bundle of His cell communication |
| GO:0090193 | 0.00679 | 6.71015 | 1 | 4 | 13 | positive regulation of glomerulus development |
| GO:1903587 | 0.00679 | 6.71015 | 1 | 4 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:1903817 | 0.00679 | 6.71015 | 1 | 4 | 13 | negative regulation of voltage-gated potassium channel activity |
| GO:1904181 | 0.00679 | 6.71015 | 1 | 4 | 13 | positive regulation of membrane depolarization |
| GO:2001223 | 0.00679 | 6.71015 | 1 | 4 | 13 | negative regulation of neuron migration |
| GO:0035264 | 0.00681 | 1.84645 | 13 | 23 | 212 | multicellular organism growth |
| GO:0050768 | 0.00685 | 1.64989 | 21 | 33 | 337 | negative regulation of neurogenesis |
| GO:0010827 | 0.00688 | 2.45461 | 5 | 12 | 86 | regulation of glucose transmembrane transport |
| GO:0090068 | 0.00690 | 1.77000 | 16 | 26 | 249 | positive regulation of cell cycle process |
| GO:0007189 | 0.00694 | 2.12648 | 8 | 16 | 130 | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0030517 | 0.00694 | 3.18309 | 3 | 8 | 46 | negative regulation of axon extension |
| GO:0010950 | 0.00697 | 2.02102 | 10 | 18 | 153 | positive regulation of endopeptidase activity |
| GO:0003160 | 0.00697 | 11.31813 | 0 | 3 | 7 | endocardium morphogenesis |
| GO:0007256 | 0.00697 | 11.31813 | 0 | 3 | 7 | activation of JNKK activity |
| GO:0009635 | 0.00697 | 11.31813 | 0 | 3 | 7 | response to herbicide |
| GO:0019852 | 0.00697 | 11.31813 | 0 | 3 | 7 | L-ascorbic acid metabolic process |
| GO:0032493 | 0.00697 | 11.31813 | 0 | 3 | 7 | response to bacterial lipoprotein |
| GO:0033634 | 0.00697 | 11.31813 | 0 | 3 | 7 | positive regulation of cell-cell adhesion mediated by integrin |
| GO:0035701 | 0.00697 | 11.31813 | 0 | 3 | 7 | hematopoietic stem cell migration |
| GO:0045409 | 0.00697 | 11.31813 | 0 | 3 | 7 | negative regulation of interleukin-6 biosynthetic process |
| GO:0060385 | 0.00697 | 11.31813 | 0 | 3 | 7 | axonogenesis involved in innervation |
| GO:0060664 | 0.00697 | 11.31813 | 0 | 3 | 7 | epithelial cell proliferation involved in salivary gland morphogenesis |
| GO:0072603 | 0.00697 | 11.31813 | 0 | 3 | 7 | interleukin-5 secretion |
| GO:0086042 | 0.00697 | 11.31813 | 0 | 3 | 7 | cardiac muscle cell-cardiac muscle cell adhesion |
| GO:0150094 | 0.00697 | 11.31813 | 0 | 3 | 7 | amyloid-beta clearance by cellular catabolic process |
| GO:2000048 | 0.00697 | 11.31813 | 0 | 3 | 7 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:2000553 | 0.00697 | 11.31813 | 0 | 3 | 7 | positive regulation of T-helper 2 cell cytokine production |
| GO:2000662 | 0.00697 | 11.31813 | 0 | 3 | 7 | regulation of interleukin-5 secretion |
| GO:2000665 | 0.00697 | 11.31813 | 0 | 3 | 7 | regulation of interleukin-13 secretion |
| GO:1905114 | 0.00698 | 1.51011 | 32 | 47 | 521 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0007435 | 0.00708 | 3.52677 | 2 | 7 | 37 | salivary gland morphogenesis |
| GO:0035850 | 0.00708 | 3.52677 | 2 | 7 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0045684 | 0.00708 | 3.52677 | 2 | 7 | 37 | positive regulation of epidermis development |
| GO:0046470 | 0.00708 | 3.52677 | 2 | 7 | 37 | phosphatidylcholine metabolic process |
| GO:0050892 | 0.00708 | 3.52677 | 2 | 7 | 37 | intestinal absorption |
| GO:0051647 | 0.00708 | 3.52677 | 2 | 7 | 37 | nucleus localization |
| GO:0097028 | 0.00708 | 3.52677 | 2 | 7 | 37 | dendritic cell differentiation |
| GO:0043901 | 0.00712 | 1.97295 | 10 | 19 | 165 | negative regulation of multi-organism process |
| GO:0030168 | 0.00719 | 2.56088 | 5 | 11 | 76 | platelet activation |
| GO:0008016 | 0.00721 | 1.93166 | 11 | 20 | 177 | regulation of heart contraction |
| GO:0001101 | 0.00723 | 1.61732 | 23 | 35 | 364 | response to acid chemical |
| GO:0051098 | 0.00723 | 1.58347 | 25 | 38 | 403 | regulation of binding |
| GO:0032732 | 0.00733 | 2.89608 | 3 | 9 | 56 | positive regulation of interleukin-1 production |
| GO:0034394 | 0.00737 | 2.70147 | 4 | 10 | 66 | protein localization to cell surface |
| GO:1901576 | 0.00750 | 1.17128 | 313 | 351 | 5031 | organic substance biosynthetic process |
| GO:0010717 | 0.00754 | 2.42177 | 5 | 12 | 87 | regulation of epithelial to mesenchymal transition |
| GO:0072091 | 0.00754 | 2.42177 | 5 | 12 | 87 | regulation of stem cell proliferation |
| GO:0048639 | 0.00760 | 1.82695 | 13 | 23 | 214 | positive regulation of developmental growth |
| GO:1901216 | 0.00762 | 2.16384 | 7 | 15 | 120 | positive regulation of neuron death |
| GO:0009058 | 0.00763 | 1.16970 | 319 | 357 | 5125 | biosynthetic process |
| GO:0048259 | 0.00771 | 2.23164 | 7 | 14 | 109 | regulation of receptor-mediated endocytosis |
| GO:0015850 | 0.00779 | 1.77299 | 15 | 25 | 239 | organic hydroxy compound transport |
| GO:0016311 | 0.00784 | 1.60740 | 23 | 35 | 366 | dephosphorylation |
| GO:0046883 | 0.00791 | 1.67530 | 19 | 30 | 302 | regulation of hormone secretion |
| GO:0071300 | 0.00792 | 3.10133 | 3 | 8 | 47 | cellular response to retinoic acid |
| GO:0030224 | 0.00794 | 3.94151 | 2 | 6 | 29 | monocyte differentiation |
| GO:0060117 | 0.00794 | 3.94151 | 2 | 6 | 29 | auditory receptor cell development |
| GO:1903131 | 0.00794 | 3.94151 | 2 | 6 | 29 | mononuclear cell differentiation |
| GO:0051896 | 0.00795 | 1.99133 | 10 | 18 | 155 | regulation of protein kinase B signaling |
| GO:0002377 | 0.00803 | 1.74626 | 16 | 26 | 252 | immunoglobulin production |
| GO:0035265 | 0.00803 | 1.81735 | 13 | 23 | 215 | organ growth |
| GO:0002863 | 0.00817 | 4.71984 | 1 | 5 | 21 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0010866 | 0.00817 | 4.71984 | 1 | 5 | 21 | regulation of triglyceride biosynthetic process |
| GO:0032682 | 0.00817 | 4.71984 | 1 | 5 | 21 | negative regulation of chemokine production |
| GO:0035357 | 0.00817 | 4.71984 | 1 | 5 | 21 | peroxisome proliferator activated receptor signaling pathway |
| GO:0043369 | 0.00817 | 4.71984 | 1 | 5 | 21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
| GO:0046339 | 0.00817 | 4.71984 | 1 | 5 | 21 | diacylglycerol metabolic process |
| GO:0051770 | 0.00817 | 4.71984 | 1 | 5 | 21 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0061339 | 0.00817 | 4.71984 | 1 | 5 | 21 | establishment or maintenance of monopolar cell polarity |
| GO:0070230 | 0.00817 | 4.71984 | 1 | 5 | 21 | positive regulation of lymphocyte apoptotic process |
| GO:1901623 | 0.00817 | 4.71984 | 1 | 5 | 21 | regulation of lymphocyte chemotaxis |
| GO:0000768 | 0.00819 | 2.65395 | 4 | 10 | 67 | syncytium formation by plasma membrane fusion |
| GO:0002562 | 0.00819 | 2.65395 | 4 | 10 | 67 | somatic diversification of immune receptors via germline recombination within a single locus |
| GO:0016444 | 0.00819 | 2.65395 | 4 | 10 | 67 | somatic cell DNA recombination |
| GO:0050771 | 0.00819 | 2.65395 | 4 | 10 | 67 | negative regulation of axonogenesis |
| GO:0140253 | 0.00819 | 2.65395 | 4 | 10 | 67 | cell-cell fusion |
| GO:2000179 | 0.00819 | 2.65395 | 4 | 10 | 67 | positive regulation of neural precursor cell proliferation |
| GO:0016339 | 0.00822 | 3.41285 | 2 | 7 | 38 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0016601 | 0.00822 | 3.41285 | 2 | 7 | 38 | Rac protein signal transduction |
| GO:0043368 | 0.00822 | 3.41285 | 2 | 7 | 38 | positive T cell selection |
| GO:0046460 | 0.00822 | 3.41285 | 2 | 7 | 38 | neutral lipid biosynthetic process |
| GO:0046463 | 0.00822 | 3.41285 | 2 | 7 | 38 | acylglycerol biosynthetic process |
| GO:1900026 | 0.00822 | 3.41285 | 2 | 7 | 38 | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0045071 | 0.00823 | 2.83561 | 4 | 9 | 57 | negative regulation of viral genome replication |
| GO:0051492 | 0.00825 | 2.38980 | 5 | 12 | 88 | regulation of stress fiber assembly |
| GO:0006641 | 0.00837 | 2.28845 | 6 | 13 | 99 | triglyceride metabolic process |
| GO:0006821 | 0.00837 | 2.28845 | 6 | 13 | 99 | chloride transport |
| GO:0062014 | 0.00837 | 2.28845 | 6 | 13 | 99 | negative regulation of small molecule metabolic process |
| GO:0031331 | 0.00850 | 1.60973 | 22 | 34 | 355 | positive regulation of cellular catabolic process |
| GO:1902532 | 0.00854 | 1.49081 | 33 | 47 | 527 | negative regulation of intracellular signal transduction |
| GO:0061515 | 0.00873 | 2.48421 | 5 | 11 | 78 | myeloid cell development |
| GO:0001933 | 0.00877 | 1.56171 | 25 | 38 | 408 | negative regulation of protein phosphorylation |
| GO:0045666 | 0.00880 | 1.52509 | 29 | 42 | 461 | positive regulation of neuron differentiation |
| GO:0018209 | 0.00883 | 1.61751 | 21 | 33 | 343 | peptidyl-serine modification |
| GO:0044249 | 0.00890 | 1.16782 | 307 | 344 | 4938 | cellular biosynthetic process |
| GO:0048598 | 0.00894 | 1.44017 | 40 | 55 | 637 | embryonic morphogenesis |
| GO:0032731 | 0.00900 | 3.02366 | 3 | 8 | 48 | positive regulation of interleukin-1 beta production |
| GO:0061005 | 0.00900 | 3.02366 | 3 | 8 | 48 | cell differentiation involved in kidney development |
| GO:0071466 | 0.00903 | 1.96250 | 10 | 18 | 157 | cellular response to xenobiotic stimulus |
| GO:0018119 | 0.00905 | 6.03886 | 1 | 4 | 14 | peptidyl-cysteine S-nitrosylation |
| GO:0032306 | 0.00905 | 6.03886 | 1 | 4 | 14 | regulation of prostaglandin secretion |
| GO:0042362 | 0.00905 | 6.03886 | 1 | 4 | 14 | fat-soluble vitamin biosynthetic process |
| GO:0044546 | 0.00905 | 6.03886 | 1 | 4 | 14 | NLRP3 inflammasome complex assembly |
| GO:0045060 | 0.00905 | 6.03886 | 1 | 4 | 14 | negative thymic T cell selection |
| GO:0048711 | 0.00905 | 6.03886 | 1 | 4 | 14 | positive regulation of astrocyte differentiation |
| GO:0051782 | 0.00905 | 6.03886 | 1 | 4 | 14 | negative regulation of cell division |
| GO:0072224 | 0.00905 | 6.03886 | 1 | 4 | 14 | metanephric glomerulus development |
| GO:0086069 | 0.00905 | 6.03886 | 1 | 4 | 14 | bundle of His cell to Purkinje myocyte communication |
| GO:0097066 | 0.00905 | 6.03886 | 1 | 4 | 14 | response to thyroid hormone |
| GO:1901550 | 0.00905 | 6.03886 | 1 | 4 | 14 | regulation of endothelial cell development |
| GO:1903140 | 0.00905 | 6.03886 | 1 | 4 | 14 | regulation of establishment of endothelial barrier |
| GO:1905063 | 0.00905 | 6.03886 | 1 | 4 | 14 | regulation of vascular smooth muscle cell differentiation |
| GO:2000047 | 0.00905 | 6.03886 | 1 | 4 | 14 | regulation of cell-cell adhesion mediated by cadherin |
| GO:0031345 | 0.00905 | 1.82330 | 13 | 22 | 205 | negative regulation of cell projection organization |
| GO:0050770 | 0.00905 | 1.82330 | 13 | 22 | 205 | regulation of axonogenesis |
| GO:0051099 | 0.00905 | 1.82330 | 13 | 22 | 205 | positive regulation of binding |
| GO:1990778 | 0.00920 | 1.61223 | 21 | 33 | 344 | protein localization to cell periphery |
| GO:0060443 | 0.00922 | 2.77761 | 4 | 9 | 58 | mammary gland morphogenesis |
| GO:1903510 | 0.00922 | 2.77761 | 4 | 9 | 58 | mucopolysaccharide metabolic process |
| GO:0099536 | 0.00926 | 1.37070 | 54 | 72 | 874 | synaptic signaling |
| GO:0031297 | 0.00941 | 3.77710 | 2 | 6 | 30 | replication fork processing |
| GO:0035767 | 0.00941 | 3.77710 | 2 | 6 | 30 | endothelial cell chemotaxis |
| GO:0070306 | 0.00941 | 3.77710 | 2 | 6 | 30 | lens fiber cell differentiation |
| GO:1902003 | 0.00941 | 3.77710 | 2 | 6 | 30 | regulation of amyloid-beta formation |
| GO:1901021 | 0.00950 | 3.30605 | 2 | 7 | 39 | positive regulation of calcium ion transmembrane transporter activity |
| GO:0038034 | 0.00959 | 2.44757 | 5 | 11 | 79 | signal transduction in absence of ligand |
| GO:0097192 | 0.00959 | 2.44757 | 5 | 11 | 79 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0007259 | 0.00970 | 1.87160 | 11 | 20 | 182 | JAK-STAT cascade |
| GO:1905330 | 0.00974 | 2.16302 | 7 | 14 | 112 | regulation of morphogenesis of an epithelium |
| GO:0031329 | 0.00975 | 1.41420 | 43 | 59 | 695 | regulation of cellular catabolic process |
| GO:0042770 | 0.00982 | 2.32831 | 6 | 12 | 90 | signal transduction in response to DNA damage |
| GO:1903524 | 0.00982 | 2.32831 | 6 | 12 | 90 | positive regulation of blood circulation |
| GO:0072331 | 0.00986 | 2.03666 | 8 | 16 | 135 | signal transduction by p53 class mediator |
| GO:1903364 | 0.00986 | 2.03666 | 8 | 16 | 135 | positive regulation of cellular protein catabolic process |
| GO:0002834 | 0.01004 | 4.44199 | 1 | 5 | 22 | regulation of response to tumor cell |
| GO:0002837 | 0.01004 | 4.44199 | 1 | 5 | 22 | regulation of immune response to tumor cell |
| GO:0009110 | 0.01004 | 4.44199 | 1 | 5 | 22 | vitamin biosynthetic process |
| GO:0010884 | 0.01004 | 4.44199 | 1 | 5 | 22 | positive regulation of lipid storage |
| GO:0031649 | 0.01004 | 4.44199 | 1 | 5 | 22 | heat generation |
| GO:0032303 | 0.01004 | 4.44199 | 1 | 5 | 22 | regulation of icosanoid secretion |
| GO:0045063 | 0.01004 | 4.44199 | 1 | 5 | 22 | T-helper 1 cell differentiation |
| GO:0048532 | 0.01004 | 4.44199 | 1 | 5 | 22 | anatomical structure arrangement |
| GO:0051043 | 0.01004 | 4.44199 | 1 | 5 | 22 | regulation of membrane protein ectodomain proteolysis |
| GO:0060009 | 0.01004 | 4.44199 | 1 | 5 | 22 | Sertoli cell development |
| GO:0071800 | 0.01004 | 4.44199 | 1 | 5 | 22 | podosome assembly |
| GO:0072111 | 0.01004 | 4.44199 | 1 | 5 | 22 | cell proliferation involved in kidney development |
| GO:0090382 | 0.01004 | 4.44199 | 1 | 5 | 22 | phagosome maturation |
| GO:0098581 | 0.01004 | 4.44199 | 1 | 5 | 22 | detection of external biotic stimulus |
| GO:2001026 | 0.01004 | 4.44199 | 1 | 5 | 22 | regulation of endothelial cell chemotaxis |
| GO:0006949 | 0.01005 | 2.56375 | 4 | 10 | 69 | syncytium formation |
| GO:0010633 | 0.01005 | 2.56375 | 4 | 10 | 69 | negative regulation of epithelial cell migration |
| GO:0032370 | 0.01005 | 2.56375 | 4 | 10 | 69 | positive regulation of lipid transport |
| GO:0055117 | 0.01005 | 2.56375 | 4 | 10 | 69 | regulation of cardiac muscle contraction |
| GO:0070482 | 0.01009 | 1.67346 | 18 | 28 | 282 | response to oxygen levels |
| GO:0071222 | 0.01009 | 1.67346 | 18 | 28 | 282 | cellular response to lipopolysaccharide |
| GO:0050851 | 0.01021 | 1.65528 | 18 | 29 | 295 | antigen receptor-mediated signaling pathway |
| GO:0140014 | 0.01023 | 1.70806 | 16 | 26 | 257 | mitotic nuclear division |
| GO:0001755 | 0.01029 | 2.72194 | 4 | 9 | 59 | neural crest cell migration |
| GO:0008347 | 0.01029 | 2.72194 | 4 | 9 | 59 | glial cell migration |
| GO:0032613 | 0.01029 | 2.72194 | 4 | 9 | 59 | interleukin-10 production |
| GO:0060119 | 0.01029 | 2.72194 | 4 | 9 | 59 | inner ear receptor cell development |
| GO:1903078 | 0.01029 | 2.72194 | 4 | 9 | 59 | positive regulation of protein localization to plasma membrane |
| GO:0030900 | 0.01031 | 1.56330 | 24 | 36 | 386 | forebrain development |
| GO:0099537 | 0.01050 | 1.36480 | 54 | 71 | 865 | trans-synaptic signaling |
| GO:0051054 | 0.01050 | 1.72415 | 15 | 25 | 245 | positive regulation of DNA metabolic process |
| GO:0030500 | 0.01051 | 2.41198 | 5 | 11 | 80 | regulation of bone mineralization |
| GO:0070613 | 0.01051 | 2.41198 | 5 | 11 | 80 | regulation of protein processing |
| GO:0072078 | 0.01051 | 2.41198 | 5 | 11 | 80 | nephron tubule morphogenesis |
| GO:2001056 | 0.01055 | 2.01959 | 8 | 16 | 136 | positive regulation of cysteine-type endopeptidase activity |
| GO:0016032 | 0.01055 | 1.66682 | 18 | 28 | 283 | viral process |
| GO:0000185 | 0.01064 | 9.05409 | 0 | 3 | 8 | activation of MAPKKK activity |
| GO:0031665 | 0.01064 | 9.05409 | 0 | 3 | 8 | negative regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0031946 | 0.01064 | 9.05409 | 0 | 3 | 8 | regulation of glucocorticoid biosynthetic process |
| GO:0032534 | 0.01064 | 9.05409 | 0 | 3 | 8 | regulation of microvillus assembly |
| GO:0032627 | 0.01064 | 9.05409 | 0 | 3 | 8 | interleukin-23 production |
| GO:0032667 | 0.01064 | 9.05409 | 0 | 3 | 8 | regulation of interleukin-23 production |
| GO:0035360 | 0.01064 | 9.05409 | 0 | 3 | 8 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0035425 | 0.01064 | 9.05409 | 0 | 3 | 8 | autocrine signaling |
| GO:0035696 | 0.01064 | 9.05409 | 0 | 3 | 8 | monocyte extravasation |
| GO:0038089 | 0.01064 | 9.05409 | 0 | 3 | 8 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway |
| GO:0042045 | 0.01064 | 9.05409 | 0 | 3 | 8 | epithelial fluid transport |
| GO:0043615 | 0.01064 | 9.05409 | 0 | 3 | 8 | astrocyte cell migration |
| GO:0045743 | 0.01064 | 9.05409 | 0 | 3 | 8 | positive regulation of fibroblast growth factor receptor signaling pathway |
| GO:0051126 | 0.01064 | 9.05409 | 0 | 3 | 8 | negative regulation of actin nucleation |
| GO:0055009 | 0.01064 | 9.05409 | 0 | 3 | 8 | atrial cardiac muscle tissue morphogenesis |
| GO:0072126 | 0.01064 | 9.05409 | 0 | 3 | 8 | positive regulation of glomerular mesangial cell proliferation |
| GO:0072239 | 0.01064 | 9.05409 | 0 | 3 | 8 | metanephric glomerulus vasculature development |
| GO:0072611 | 0.01064 | 9.05409 | 0 | 3 | 8 | interleukin-13 secretion |
| GO:0090385 | 0.01064 | 9.05409 | 0 | 3 | 8 | phagosome-lysosome fusion |
| GO:0097368 | 0.01064 | 9.05409 | 0 | 3 | 8 | establishment of Sertoli cell barrier |
| GO:1905651 | 0.01064 | 9.05409 | 0 | 3 | 8 | regulation of artery morphogenesis |
| GO:0010522 | 0.01067 | 2.21100 | 6 | 13 | 102 | regulation of calcium ion transport into cytosol |
| GO:0051897 | 0.01067 | 2.21100 | 6 | 13 | 102 | positive regulation of protein kinase B signaling |
| GO:1905477 | 0.01067 | 2.21100 | 6 | 13 | 102 | positive regulation of protein localization to membrane |
| GO:0045685 | 0.01069 | 2.29873 | 6 | 12 | 91 | regulation of glial cell differentiation |
| GO:0007187 | 0.01076 | 1.74196 | 15 | 24 | 233 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0045930 | 0.01076 | 1.74196 | 15 | 24 | 233 | negative regulation of mitotic cell cycle |
| GO:0006644 | 0.01082 | 1.59146 | 22 | 33 | 348 | phospholipid metabolic process |
| GO:0002686 | 0.01091 | 3.20572 | 2 | 7 | 40 | negative regulation of leukocyte migration |
| GO:0014037 | 0.01091 | 3.20572 | 2 | 7 | 40 | Schwann cell differentiation |
| GO:0038179 | 0.01091 | 3.20572 | 2 | 7 | 40 | neurotrophin signaling pathway |
| GO:0044764 | 0.01091 | 3.20572 | 2 | 7 | 40 | multi-organism cellular process |
| GO:0086004 | 0.01091 | 3.20572 | 2 | 7 | 40 | regulation of cardiac muscle cell contraction |
| GO:0098801 | 0.01091 | 3.20572 | 2 | 7 | 40 | regulation of renal system process |
| GO:0110111 | 0.01091 | 3.20572 | 2 | 7 | 40 | negative regulation of animal organ morphogenesis |
| GO:0010975 | 0.01103 | 1.43722 | 38 | 52 | 603 | regulation of neuron projection development |
| GO:0006767 | 0.01106 | 3.62585 | 2 | 6 | 31 | water-soluble vitamin metabolic process |
| GO:0019884 | 0.01106 | 3.62585 | 2 | 6 | 31 | antigen processing and presentation of exogenous antigen |
| GO:0042036 | 0.01106 | 3.62585 | 2 | 6 | 31 | negative regulation of cytokine biosynthetic process |
| GO:0045662 | 0.01106 | 3.62585 | 2 | 6 | 31 | negative regulation of myoblast differentiation |
| GO:0048011 | 0.01106 | 3.62585 | 2 | 6 | 31 | neurotrophin TRK receptor signaling pathway |
| GO:0050718 | 0.01106 | 3.62585 | 2 | 6 | 31 | positive regulation of interleukin-1 beta secretion |
| GO:0070741 | 0.01106 | 3.62585 | 2 | 6 | 31 | response to interleukin-6 |
| GO:2000352 | 0.01106 | 3.62585 | 2 | 6 | 31 | negative regulation of endothelial cell apoptotic process |
| GO:0002432 | 0.01114 | 30.16493 | 0 | 2 | 3 | granuloma formation |
| GO:0002485 | 0.01114 | 30.16493 | 0 | 2 | 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent |
| GO:0002652 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of tolerance induction dependent upon immune response |
| GO:0002856 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of natural killer cell mediated immune response to tumor cell |
| GO:0002859 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0005997 | 0.01114 | 30.16493 | 0 | 2 | 3 | xylulose metabolic process |
| GO:0009850 | 0.01114 | 30.16493 | 0 | 2 | 3 | auxin metabolic process |
| GO:0009852 | 0.01114 | 30.16493 | 0 | 2 | 3 | auxin catabolic process |
| GO:0010124 | 0.01114 | 30.16493 | 0 | 2 | 3 | phenylacetate catabolic process |
| GO:0010963 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of L-arginine import |
| GO:0010979 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of vitamin D 24-hydroxylase activity |
| GO:0010980 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of vitamin D 24-hydroxylase activity |
| GO:0015825 | 0.01114 | 30.16493 | 0 | 2 | 3 | L-serine transport |
| GO:0019371 | 0.01114 | 30.16493 | 0 | 2 | 3 | cyclooxygenase pathway |
| GO:0031580 | 0.01114 | 30.16493 | 0 | 2 | 3 | membrane raft distribution |
| GO:0032690 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of interleukin-1 alpha production |
| GO:0034140 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of toll-like receptor 3 signaling pathway |
| GO:0035887 | 0.01114 | 30.16493 | 0 | 2 | 3 | aortic smooth muscle cell differentiation |
| GO:0036151 | 0.01114 | 30.16493 | 0 | 2 | 3 | phosphatidylcholine acyl-chain remodeling |
| GO:0042231 | 0.01114 | 30.16493 | 0 | 2 | 3 | interleukin-13 biosynthetic process |
| GO:0042942 | 0.01114 | 30.16493 | 0 | 2 | 3 | D-serine transport |
| GO:0043309 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of eosinophil degranulation |
| GO:0045079 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of chemokine biosynthetic process |
| GO:0045082 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of interleukin-10 biosynthetic process |
| GO:0045404 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of interleukin-4 biosynthetic process |
| GO:0045658 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0060448 | 0.01114 | 30.16493 | 0 | 2 | 3 | dichotomous subdivision of terminal units involved in lung branching |
| GO:0060557 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of vitamin D biosynthetic process |
| GO:0060559 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of calcidiol 1-monooxygenase activity |
| GO:0060671 | 0.01114 | 30.16493 | 0 | 2 | 3 | epithelial cell differentiation involved in embryonic placenta development |
| GO:0060672 | 0.01114 | 30.16493 | 0 | 2 | 3 | epithelial cell morphogenesis involved in placental branching |
| GO:0061144 | 0.01114 | 30.16493 | 0 | 2 | 3 | alveolar secondary septum development |
| GO:0070428 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0070488 | 0.01114 | 30.16493 | 0 | 2 | 3 | neutrophil aggregation |
| GO:0070489 | 0.01114 | 30.16493 | 0 | 2 | 3 | T cell aggregation |
| GO:0070960 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of neutrophil mediated cytotoxicity |
| GO:0070961 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of neutrophil mediated killing of symbiont cell |
| GO:0071691 | 0.01114 | 30.16493 | 0 | 2 | 3 | cardiac muscle thin filament assembly |
| GO:0072708 | 0.01114 | 30.16493 | 0 | 2 | 3 | response to sorbitol |
| GO:0097195 | 0.01114 | 30.16493 | 0 | 2 | 3 | pilomotor reflex |
| GO:0150062 | 0.01114 | 30.16493 | 0 | 2 | 3 | complement-mediated synapse pruning |
| GO:1902994 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of phospholipid efflux |
| GO:1902995 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of phospholipid efflux |
| GO:1903971 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of response to macrophage colony-stimulating factor |
| GO:1903974 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:1904444 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of establishment of Sertoli cell barrier |
| GO:1905154 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of membrane invagination |
| GO:1905702 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of inhibitory synapse assembly |
| GO:2000019 | 0.01114 | 30.16493 | 0 | 2 | 3 | negative regulation of male gonad development |
| GO:2000182 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of progesterone biosynthetic process |
| GO:2000439 | 0.01114 | 30.16493 | 0 | 2 | 3 | positive regulation of monocyte extravasation |
| GO:2001188 | 0.01114 | 30.16493 | 0 | 2 | 3 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:2000027 | 0.01121 | 1.78397 | 13 | 22 | 209 | regulation of animal organ morphogenesis |
| GO:0045861 | 0.01126 | 1.58635 | 22 | 33 | 349 | negative regulation of proteolysis |
| GO:0060419 | 0.01130 | 2.11957 | 7 | 14 | 114 | heart growth |
| GO:0022414 | 0.01144 | 1.27483 | 92 | 113 | 1471 | reproductive process |
| GO:0031327 | 0.01144 | 1.27483 | 92 | 113 | 1471 | negative regulation of cellular biosynthetic process |
| GO:0060324 | 0.01146 | 2.66844 | 4 | 9 | 60 | face development |
| GO:0090329 | 0.01148 | 2.87941 | 3 | 8 | 50 | regulation of DNA-dependent DNA replication |
| GO:0031646 | 0.01150 | 2.37742 | 5 | 11 | 81 | positive regulation of neurological system process |
| GO:0043255 | 0.01153 | 2.18634 | 6 | 13 | 103 | regulation of carbohydrate biosynthetic process |
| GO:0031644 | 0.01157 | 1.86977 | 11 | 19 | 173 | regulation of neurological system process |
| GO:0000003 | 0.01165 | 1.27383 | 92 | 113 | 1472 | reproduction |
| GO:0007379 | 0.01174 | 5.48962 | 1 | 4 | 15 | segment specification |
| GO:0010715 | 0.01174 | 5.48962 | 1 | 4 | 15 | regulation of extracellular matrix disassembly |
| GO:0010935 | 0.01174 | 5.48962 | 1 | 4 | 15 | regulation of macrophage cytokine production |
| GO:0017014 | 0.01174 | 5.48962 | 1 | 4 | 15 | protein nitrosylation |
| GO:0032530 | 0.01174 | 5.48962 | 1 | 4 | 15 | regulation of microvillus organization |
| GO:0033623 | 0.01174 | 5.48962 | 1 | 4 | 15 | regulation of integrin activation |
| GO:0043383 | 0.01174 | 5.48962 | 1 | 4 | 15 | negative T cell selection |
| GO:0045342 | 0.01174 | 5.48962 | 1 | 4 | 15 | MHC class II biosynthetic process |
| GO:0045414 | 0.01174 | 5.48962 | 1 | 4 | 15 | regulation of interleukin-8 biosynthetic process |
| GO:0050930 | 0.01174 | 5.48962 | 1 | 4 | 15 | induction of positive chemotaxis |
| GO:0055089 | 0.01174 | 5.48962 | 1 | 4 | 15 | fatty acid homeostasis |
| GO:0061430 | 0.01174 | 5.48962 | 1 | 4 | 15 | bone trabecula morphogenesis |
| GO:0070234 | 0.01174 | 5.48962 | 1 | 4 | 15 | positive regulation of T cell apoptotic process |
| GO:0070293 | 0.01174 | 5.48962 | 1 | 4 | 15 | renal absorption |
| GO:0071404 | 0.01174 | 5.48962 | 1 | 4 | 15 | cellular response to low-density lipoprotein particle stimulus |
| GO:0072567 | 0.01174 | 5.48962 | 1 | 4 | 15 | chemokine (C-X-C motif) ligand 2 production |
| GO:0086014 | 0.01174 | 5.48962 | 1 | 4 | 15 | atrial cardiac muscle cell action potential |
| GO:0086026 | 0.01174 | 5.48962 | 1 | 4 | 15 | atrial cardiac muscle cell to AV node cell signaling |
| GO:0086066 | 0.01174 | 5.48962 | 1 | 4 | 15 | atrial cardiac muscle cell to AV node cell communication |
| GO:1900029 | 0.01174 | 5.48962 | 1 | 4 | 15 | positive regulation of ruffle assembly |
| GO:1902430 | 0.01174 | 5.48962 | 1 | 4 | 15 | negative regulation of amyloid-beta formation |
| GO:0031623 | 0.01175 | 2.04631 | 8 | 15 | 126 | receptor internalization |
| GO:0007268 | 0.01191 | 1.35881 | 53 | 70 | 856 | chemical synaptic transmission |
| GO:0098916 | 0.01191 | 1.35881 | 53 | 70 | 856 | anterograde trans-synaptic signaling |
| GO:0016079 | 0.01205 | 1.98630 | 9 | 16 | 138 | synaptic vesicle exocytosis |
| GO:0030010 | 0.01205 | 1.98630 | 9 | 16 | 138 | establishment of cell polarity |
| GO:0032368 | 0.01215 | 2.09848 | 7 | 14 | 115 | regulation of lipid transport |
| GO:2001023 | 0.01215 | 2.09848 | 7 | 14 | 115 | regulation of response to drug |
| GO:0002827 | 0.01219 | 4.19502 | 1 | 5 | 23 | positive regulation of T-helper 1 type immune response |
| GO:0010874 | 0.01219 | 4.19502 | 1 | 5 | 23 | regulation of cholesterol efflux |
| GO:0060047 | 0.01243 | 1.76493 | 13 | 22 | 211 | heart contraction |
| GO:0086009 | 0.01246 | 3.11129 | 3 | 7 | 41 | membrane repolarization |
| GO:2000008 | 0.01246 | 3.11129 | 3 | 7 | 41 | regulation of protein localization to cell surface |
| GO:0072088 | 0.01255 | 2.34382 | 5 | 11 | 82 | nephron epithelium morphogenesis |
| GO:1903317 | 0.01255 | 2.34382 | 5 | 11 | 82 | regulation of protein maturation |
| GO:0035305 | 0.01261 | 2.24176 | 6 | 12 | 93 | negative regulation of dephosphorylation |
| GO:0010812 | 0.01272 | 2.61701 | 4 | 9 | 61 | negative regulation of cell-substrate adhesion |
| GO:0030216 | 0.01285 | 1.97006 | 9 | 16 | 139 | keratinocyte differentiation |
| GO:0045912 | 0.01289 | 2.81232 | 3 | 8 | 51 | negative regulation of carbohydrate metabolic process |
| GO:0007097 | 0.01292 | 3.48624 | 2 | 6 | 32 | nuclear migration |
| GO:0035025 | 0.01292 | 3.48624 | 2 | 6 | 32 | positive regulation of Rho protein signal transduction |
| GO:0045616 | 0.01292 | 3.48624 | 2 | 6 | 32 | regulation of keratinocyte differentiation |
| GO:0045672 | 0.01292 | 3.48624 | 2 | 6 | 32 | positive regulation of osteoclast differentiation |
| GO:0060561 | 0.01292 | 3.48624 | 2 | 6 | 32 | apoptotic process involved in morphogenesis |
| GO:0060669 | 0.01292 | 3.48624 | 2 | 6 | 32 | embryonic placenta morphogenesis |
| GO:0060706 | 0.01292 | 3.48624 | 2 | 6 | 32 | cell differentiation involved in embryonic placenta development |
| GO:0060041 | 0.01302 | 1.88077 | 10 | 18 | 163 | retina development in camera-type eye |
| GO:0007049 | 0.01303 | 1.25468 | 102 | 124 | 1639 | cell cycle |
| GO:0010927 | 0.01305 | 2.07781 | 7 | 14 | 116 | cellular component assembly involved in morphogenesis |
| GO:0097755 | 0.01341 | 2.43936 | 4 | 10 | 72 | positive regulation of blood vessel diameter |
| GO:0006906 | 0.01366 | 2.21432 | 6 | 12 | 94 | vesicle fusion |
| GO:0030203 | 0.01368 | 2.31116 | 5 | 11 | 83 | glycosaminoglycan metabolic process |
| GO:0072028 | 0.01368 | 2.31116 | 5 | 11 | 83 | nephron morphogenesis |
| GO:0080135 | 0.01381 | 1.39820 | 41 | 56 | 666 | regulation of cellular response to stress |
| GO:0045668 | 0.01408 | 2.56751 | 4 | 9 | 62 | negative regulation of osteoblast differentiation |
| GO:0010765 | 0.01417 | 3.02225 | 3 | 7 | 42 | positive regulation of sodium ion transport |
| GO:0010883 | 0.01417 | 3.02225 | 3 | 7 | 42 | regulation of lipid storage |
| GO:0045740 | 0.01417 | 3.02225 | 3 | 7 | 42 | positive regulation of DNA replication |
| GO:0046636 | 0.01417 | 3.02225 | 3 | 7 | 42 | negative regulation of alpha-beta T cell activation |
| GO:0006911 | 0.01430 | 1.79350 | 12 | 20 | 189 | phagocytosis, engulfment |
| GO:0016485 | 0.01438 | 1.69288 | 15 | 24 | 239 | protein processing |
| GO:0001960 | 0.01443 | 2.74828 | 3 | 8 | 52 | negative regulation of cytokine-mediated signaling pathway |
| GO:0002418 | 0.01462 | 3.97405 | 1 | 5 | 24 | immune response to tumor cell |
| GO:0032352 | 0.01462 | 3.97405 | 1 | 5 | 24 | positive regulation of hormone metabolic process |
| GO:0043921 | 0.01462 | 3.97405 | 1 | 5 | 24 | modulation by host of viral transcription |
| GO:0046685 | 0.01462 | 3.97405 | 1 | 5 | 24 | response to arsenic-containing substance |
| GO:0052312 | 0.01462 | 3.97405 | 1 | 5 | 24 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0052472 | 0.01462 | 3.97405 | 1 | 5 | 24 | modulation by host of symbiont transcription |
| GO:0097150 | 0.01462 | 3.97405 | 1 | 5 | 24 | neuronal stem cell population maintenance |
| GO:0097186 | 0.01462 | 3.97405 | 1 | 5 | 24 | amelogenesis |
| GO:0019827 | 0.01462 | 1.85501 | 10 | 18 | 165 | stem cell population maintenance |
| GO:0046425 | 0.01462 | 1.85501 | 10 | 18 | 165 | regulation of JAK-STAT cascade |
| GO:0051145 | 0.01470 | 2.40053 | 5 | 10 | 73 | smooth muscle cell differentiation |
| GO:1903036 | 0.01470 | 2.40053 | 5 | 10 | 73 | positive regulation of response to wounding |
| GO:0042593 | 0.01475 | 1.65028 | 16 | 26 | 265 | glucose homeostasis |
| GO:0060420 | 0.01488 | 2.27940 | 5 | 11 | 84 | regulation of heart growth |
| GO:0002739 | 0.01489 | 5.03192 | 1 | 4 | 16 | regulation of cytokine secretion involved in immune response |
| GO:0003159 | 0.01489 | 5.03192 | 1 | 4 | 16 | morphogenesis of an endothelium |
| GO:0006968 | 0.01489 | 5.03192 | 1 | 4 | 16 | cellular defense response |
| GO:0016322 | 0.01489 | 5.03192 | 1 | 4 | 16 | neuron remodeling |
| GO:0030449 | 0.01489 | 5.03192 | 1 | 4 | 16 | regulation of complement activation |
| GO:0032252 | 0.01489 | 5.03192 | 1 | 4 | 16 | secretory granule localization |
| GO:0034134 | 0.01489 | 5.03192 | 1 | 4 | 16 | toll-like receptor 2 signaling pathway |
| GO:0042228 | 0.01489 | 5.03192 | 1 | 4 | 16 | interleukin-8 biosynthetic process |
| GO:0042359 | 0.01489 | 5.03192 | 1 | 4 | 16 | vitamin D metabolic process |
| GO:0043923 | 0.01489 | 5.03192 | 1 | 4 | 16 | positive regulation by host of viral transcription |
| GO:0045655 | 0.01489 | 5.03192 | 1 | 4 | 16 | regulation of monocyte differentiation |
| GO:0045779 | 0.01489 | 5.03192 | 1 | 4 | 16 | negative regulation of bone resorption |
| GO:0061154 | 0.01489 | 5.03192 | 1 | 4 | 16 | endothelial tube morphogenesis |
| GO:0090051 | 0.01489 | 5.03192 | 1 | 4 | 16 | negative regulation of cell migration involved in sprouting angiogenesis |
| GO:1903779 | 0.01489 | 5.03192 | 1 | 4 | 16 | regulation of cardiac conduction |
| GO:0006775 | 0.01498 | 3.35696 | 2 | 6 | 33 | fat-soluble vitamin metabolic process |
| GO:0010543 | 0.01498 | 3.35696 | 2 | 6 | 33 | regulation of platelet activation |
| GO:0051952 | 0.01501 | 2.03767 | 7 | 14 | 118 | regulation of amine transport |
| GO:0046483 | 0.01513 | 1.15290 | 308 | 341 | 4940 | heterocycle metabolic process |
| GO:0001767 | 0.01523 | 7.54473 | 1 | 3 | 9 | establishment of lymphocyte polarity |
| GO:0001768 | 0.01523 | 7.54473 | 1 | 3 | 9 | establishment of T cell polarity |
| GO:0001794 | 0.01523 | 7.54473 | 1 | 3 | 9 | type IIa hypersensitivity |
| GO:0001796 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of type IIa hypersensitivity |
| GO:0001798 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of type IIa hypersensitivity |
| GO:0002246 | 0.01523 | 7.54473 | 1 | 3 | 9 | wound healing involved in inflammatory response |
| GO:0002445 | 0.01523 | 7.54473 | 1 | 3 | 9 | type II hypersensitivity |
| GO:0002713 | 0.01523 | 7.54473 | 1 | 3 | 9 | negative regulation of B cell mediated immunity |
| GO:0002741 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of cytokine secretion involved in immune response |
| GO:0002890 | 0.01523 | 7.54473 | 1 | 3 | 9 | negative regulation of immunoglobulin mediated immune response |
| GO:0002892 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of type II hypersensitivity |
| GO:0002894 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of type II hypersensitivity |
| GO:0003223 | 0.01523 | 7.54473 | 1 | 3 | 9 | ventricular compact myocardium morphogenesis |
| GO:0003228 | 0.01523 | 7.54473 | 1 | 3 | 9 | atrial cardiac muscle tissue development |
| GO:0016338 | 0.01523 | 7.54473 | 1 | 3 | 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0030223 | 0.01523 | 7.54473 | 1 | 3 | 9 | neutrophil differentiation |
| GO:0031622 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of fever generation |
| GO:0034139 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of toll-like receptor 3 signaling pathway |
| GO:0036363 | 0.01523 | 7.54473 | 1 | 3 | 9 | transforming growth factor beta activation |
| GO:0045084 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of interleukin-12 biosynthetic process |
| GO:0045586 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of gamma-delta T cell differentiation |
| GO:0045657 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of monocyte differentiation |
| GO:0045988 | 0.01523 | 7.54473 | 1 | 3 | 9 | negative regulation of striated muscle contraction |
| GO:0046643 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of gamma-delta T cell activation |
| GO:0050713 | 0.01523 | 7.54473 | 1 | 3 | 9 | negative regulation of interleukin-1 beta secretion |
| GO:0070944 | 0.01523 | 7.54473 | 1 | 3 | 9 | neutrophil mediated killing of bacterium |
| GO:0071372 | 0.01523 | 7.54473 | 1 | 3 | 9 | cellular response to follicle-stimulating hormone stimulus |
| GO:0086015 | 0.01523 | 7.54473 | 1 | 3 | 9 | SA node cell action potential |
| GO:0086018 | 0.01523 | 7.54473 | 1 | 3 | 9 | SA node cell to atrial cardiac muscle cell signaling |
| GO:0086070 | 0.01523 | 7.54473 | 1 | 3 | 9 | SA node cell to atrial cardiac muscle cell communication |
| GO:0090520 | 0.01523 | 7.54473 | 1 | 3 | 9 | sphingolipid mediated signaling pathway |
| GO:0097067 | 0.01523 | 7.54473 | 1 | 3 | 9 | cellular response to thyroid hormone stimulus |
| GO:0099612 | 0.01523 | 7.54473 | 1 | 3 | 9 | protein localization to axon |
| GO:1902023 | 0.01523 | 7.54473 | 1 | 3 | 9 | L-arginine transport |
| GO:1903054 | 0.01523 | 7.54473 | 1 | 3 | 9 | negative regulation of extracellular matrix organization |
| GO:1903236 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of leukocyte tethering or rolling |
| GO:1903589 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:2000121 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of removal of superoxide radicals |
| GO:2001138 | 0.01523 | 7.54473 | 1 | 3 | 9 | regulation of phospholipid transport |
| GO:2001140 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of phospholipid transport |
| GO:2001187 | 0.01523 | 7.54473 | 1 | 3 | 9 | positive regulation of CD8-positive, alpha-beta T cell activation |
| GO:0033500 | 0.01541 | 1.64332 | 17 | 26 | 266 | carbohydrate homeostasis |
| GO:0090276 | 0.01552 | 1.70107 | 14 | 23 | 228 | regulation of peptide hormone secretion |
| GO:0034101 | 0.01552 | 1.92289 | 9 | 16 | 142 | erythrocyte homeostasis |
| GO:0030330 | 0.01555 | 2.51985 | 4 | 9 | 63 | DNA damage response, signal transduction by p53 class mediator |
| GO:0043388 | 0.01555 | 2.51985 | 4 | 9 | 63 | positive regulation of DNA binding |
| GO:0071248 | 0.01556 | 1.87939 | 10 | 17 | 154 | cellular response to metal ion |
| GO:0007517 | 0.01557 | 1.49586 | 26 | 38 | 424 | muscle organ development |
| GO:0006024 | 0.01604 | 2.93817 | 3 | 7 | 43 | glycosaminoglycan biosynthetic process |
| GO:0006919 | 0.01607 | 2.36291 | 5 | 10 | 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0097327 | 0.01607 | 2.36291 | 5 | 10 | 74 | response to antineoplastic agent |
| GO:0042269 | 0.01609 | 2.68708 | 3 | 8 | 53 | regulation of natural killer cell mediated cytotoxicity |
| GO:0048662 | 0.01609 | 2.68708 | 3 | 8 | 53 | negative regulation of smooth muscle cell proliferation |
| GO:1904705 | 0.01609 | 2.68708 | 3 | 8 | 53 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.01609 | 2.68708 | 3 | 8 | 53 | vascular smooth muscle cell proliferation |
| GO:0051341 | 0.01617 | 2.24849 | 5 | 11 | 85 | regulation of oxidoreductase activity |
| GO:0003007 | 0.01618 | 1.61900 | 17 | 27 | 280 | heart morphogenesis |
| GO:1901617 | 0.01627 | 1.69274 | 14 | 23 | 229 | organic hydroxy compound biosynthetic process |
| GO:0055007 | 0.01650 | 1.90766 | 9 | 16 | 143 | cardiac muscle cell differentiation |
| GO:0001959 | 0.01671 | 2.07079 | 7 | 13 | 108 | regulation of cytokine-mediated signaling pathway |
| GO:1904659 | 0.01671 | 2.07079 | 7 | 13 | 108 | glucose transmembrane transport |
| GO:0034599 | 0.01681 | 1.62959 | 17 | 26 | 268 | cellular response to oxidative stress |
| GO:0006979 | 0.01714 | 1.50219 | 25 | 36 | 400 | response to oxidative stress |
| GO:1901615 | 0.01715 | 1.45424 | 30 | 42 | 481 | organic hydroxy compound metabolic process |
| GO:0002021 | 0.01725 | 3.23692 | 2 | 6 | 34 | response to dietary excess |
| GO:0003209 | 0.01725 | 3.23692 | 2 | 6 | 34 | cardiac atrium morphogenesis |
| GO:0006739 | 0.01725 | 3.23692 | 2 | 6 | 34 | NADP metabolic process |
| GO:0010737 | 0.01725 | 3.23692 | 2 | 6 | 34 | protein kinase A signaling |
| GO:0050716 | 0.01725 | 3.23692 | 2 | 6 | 34 | positive regulation of interleukin-1 secretion |
| GO:0003351 | 0.01736 | 3.77517 | 2 | 5 | 25 | epithelial cilium movement |
| GO:0009595 | 0.01736 | 3.77517 | 2 | 5 | 25 | detection of biotic stimulus |
| GO:0010669 | 0.01736 | 3.77517 | 2 | 5 | 25 | epithelial structure maintenance |
| GO:0034114 | 0.01736 | 3.77517 | 2 | 5 | 25 | regulation of heterotypic cell-cell adhesion |
| GO:0046688 | 0.01736 | 3.77517 | 2 | 5 | 25 | response to copper ion |
| GO:0090140 | 0.01736 | 3.77517 | 2 | 5 | 25 | regulation of mitochondrial fission |
| GO:0090280 | 0.01736 | 3.77517 | 2 | 5 | 25 | positive regulation of calcium ion import |
| GO:0001841 | 0.01744 | 1.94083 | 8 | 15 | 132 | neural tube formation |
| GO:0061333 | 0.01753 | 2.21841 | 5 | 11 | 86 | renal tubule morphogenesis |
| GO:0002200 | 0.01754 | 2.32645 | 5 | 10 | 75 | somatic diversification of immune receptors |
| GO:0030258 | 0.01758 | 1.70134 | 14 | 22 | 218 | lipid modification |
| GO:0002715 | 0.01789 | 2.62854 | 3 | 8 | 54 | regulation of natural killer cell mediated immunity |
| GO:0035272 | 0.01789 | 2.62854 | 3 | 8 | 54 | exocrine system development |
| GO:0045604 | 0.01789 | 2.62854 | 3 | 8 | 54 | regulation of epidermal cell differentiation |
| GO:0055025 | 0.01789 | 2.62854 | 3 | 8 | 54 | positive regulation of cardiac muscle tissue development |
| GO:0008645 | 0.01793 | 2.04912 | 7 | 13 | 109 | hexose transmembrane transport |
| GO:0009749 | 0.01799 | 1.77678 | 11 | 19 | 181 | response to glucose |
| GO:1901215 | 0.01807 | 1.65402 | 15 | 24 | 244 | negative regulation of neuron death |
| GO:1902115 | 0.01807 | 1.72024 | 13 | 21 | 206 | regulation of organelle assembly |
| GO:0098727 | 0.01828 | 1.80554 | 11 | 18 | 169 | maintenance of cell number |
| GO:0050954 | 0.01833 | 1.58501 | 18 | 28 | 296 | sensory perception of mechanical stimulus |
| GO:0048565 | 0.01836 | 1.98026 | 8 | 14 | 121 | digestive tract development |
| GO:0048285 | 0.01837 | 1.46106 | 28 | 40 | 456 | organelle fission |
| GO:0010976 | 0.01841 | 1.52274 | 23 | 33 | 362 | positive regulation of neuron projection development |
| GO:0002883 | 0.01853 | 4.64464 | 1 | 4 | 17 | regulation of hypersensitivity |
| GO:0007288 | 0.01853 | 4.64464 | 1 | 4 | 17 | sperm axoneme assembly |
| GO:0010867 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of triglyceride biosynthetic process |
| GO:0010934 | 0.01853 | 4.64464 | 1 | 4 | 17 | macrophage cytokine production |
| GO:0032305 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of icosanoid secretion |
| GO:0032740 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of interleukin-17 production |
| GO:0044406 | 0.01853 | 4.64464 | 1 | 4 | 17 | adhesion of symbiont to host |
| GO:0045579 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of B cell differentiation |
| GO:0048739 | 0.01853 | 4.64464 | 1 | 4 | 17 | cardiac muscle fiber development |
| GO:0070886 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0086012 | 0.01853 | 4.64464 | 1 | 4 | 17 | membrane depolarization during cardiac muscle cell action potential |
| GO:0090185 | 0.01853 | 4.64464 | 1 | 4 | 17 | negative regulation of kidney development |
| GO:0090192 | 0.01853 | 4.64464 | 1 | 4 | 17 | regulation of glomerulus development |
| GO:0106058 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of calcineurin-mediated signaling |
| GO:0140131 | 0.01853 | 4.64464 | 1 | 4 | 17 | positive regulation of lymphocyte chemotaxis |
| GO:1902992 | 0.01853 | 4.64464 | 1 | 4 | 17 | negative regulation of amyloid precursor protein catabolic process |
| GO:2001185 | 0.01853 | 4.64464 | 1 | 4 | 17 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0001837 | 0.01857 | 1.92429 | 8 | 15 | 133 | epithelial to mesenchymal transition |
| GO:0061025 | 0.01857 | 1.92429 | 8 | 15 | 133 | membrane fusion |
| GO:0009410 | 0.01870 | 1.66821 | 14 | 23 | 232 | response to xenobiotic stimulus |
| GO:0031638 | 0.01882 | 2.42963 | 4 | 9 | 65 | zymogen activation |
| GO:0006631 | 0.01886 | 1.50941 | 23 | 34 | 376 | fatty acid metabolic process |
| GO:0015837 | 0.01959 | 1.96184 | 8 | 14 | 122 | amine transport |
| GO:0006633 | 0.01975 | 1.90803 | 8 | 15 | 134 | fatty acid biosynthetic process |
| GO:0055123 | 0.01975 | 1.90803 | 8 | 15 | 134 | digestive system development |
| GO:0044271 | 0.01975 | 1.15742 | 249 | 278 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0002701 | 0.01976 | 3.12516 | 2 | 6 | 35 | negative regulation of production of molecular mediator of immune response |
| GO:0035909 | 0.01976 | 3.12516 | 2 | 6 | 35 | aorta morphogenesis |
| GO:0043114 | 0.01976 | 3.12516 | 2 | 6 | 35 | regulation of vascular permeability |
| GO:0046320 | 0.01976 | 3.12516 | 2 | 6 | 35 | regulation of fatty acid oxidation |
| GO:1904707 | 0.01976 | 3.12516 | 2 | 6 | 35 | positive regulation of vascular smooth muscle cell proliferation |
| GO:0032653 | 0.01983 | 2.57250 | 3 | 8 | 55 | regulation of interleukin-10 production |
| GO:0045773 | 0.01983 | 2.57250 | 3 | 8 | 55 | positive regulation of axon extension |
| GO:0061448 | 0.01990 | 1.58726 | 18 | 27 | 285 | connective tissue development |
| GO:0010771 | 0.01995 | 2.08658 | 6 | 12 | 99 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0060993 | 0.01995 | 2.08658 | 6 | 12 | 99 | kidney morphogenesis |
| GO:0006139 | 0.02020 | 1.14575 | 300 | 331 | 4813 | nucleobase-containing compound metabolic process |
| GO:0003015 | 0.02024 | 1.67546 | 14 | 22 | 221 | heart process |
| GO:0003254 | 0.02030 | 2.78327 | 3 | 7 | 45 | regulation of membrane depolarization |
| GO:0032814 | 0.02030 | 2.78327 | 3 | 7 | 45 | regulation of natural killer cell activation |
| GO:0071526 | 0.02030 | 2.78327 | 3 | 7 | 45 | semaphorin-plexin signaling pathway |
| GO:0090184 | 0.02030 | 2.78327 | 3 | 7 | 45 | positive regulation of kidney development |
| GO:0006026 | 0.02042 | 3.59524 | 2 | 5 | 26 | aminoglycan catabolic process |
| GO:0007263 | 0.02042 | 3.59524 | 2 | 5 | 26 | nitric oxide mediated signal transduction |
| GO:0048799 | 0.02042 | 3.59524 | 2 | 5 | 26 | animal organ maturation |
| GO:0050858 | 0.02042 | 3.59524 | 2 | 5 | 26 | negative regulation of antigen receptor-mediated signaling pathway |
| GO:0055003 | 0.02042 | 3.59524 | 2 | 5 | 26 | cardiac myofibril assembly |
| GO:0070233 | 0.02042 | 3.59524 | 2 | 5 | 26 | negative regulation of T cell apoptotic process |
| GO:0090208 | 0.02042 | 3.59524 | 2 | 5 | 26 | positive regulation of triglyceride metabolic process |
| GO:0019217 | 0.02051 | 2.16059 | 5 | 11 | 88 | regulation of fatty acid metabolic process |
| GO:0051253 | 0.02051 | 1.26437 | 79 | 97 | 1269 | negative regulation of RNA metabolic process |
| GO:1901184 | 0.02063 | 2.38689 | 4 | 9 | 66 | regulation of ERBB signaling pathway |
| GO:1904377 | 0.02063 | 2.38689 | 4 | 9 | 66 | positive regulation of protein localization to cell periphery |
| GO:0045665 | 0.02071 | 1.61298 | 16 | 25 | 260 | negative regulation of neuron differentiation |
| GO:0010958 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of amino acid import across plasma membrane |
| GO:0031620 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of fever generation |
| GO:0031943 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of glucocorticoid metabolic process |
| GO:0032354 | 0.02076 | 6.46661 | 1 | 3 | 10 | response to follicle-stimulating hormone |
| GO:0032621 | 0.02076 | 6.46661 | 1 | 3 | 10 | interleukin-18 production |
| GO:0033689 | 0.02076 | 6.46661 | 1 | 3 | 10 | negative regulation of osteoblast proliferation |
| GO:0035336 | 0.02076 | 6.46661 | 1 | 3 | 10 | long-chain fatty-acyl-CoA metabolic process |
| GO:0040009 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of growth rate |
| GO:0044793 | 0.02076 | 6.46661 | 1 | 3 | 10 | negative regulation by host of viral process |
| GO:0046543 | 0.02076 | 6.46661 | 1 | 3 | 10 | development of secondary female sexual characteristics |
| GO:0060297 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of sarcomere organization |
| GO:0060907 | 0.02076 | 6.46661 | 1 | 3 | 10 | positive regulation of macrophage cytokine production |
| GO:0070673 | 0.02076 | 6.46661 | 1 | 3 | 10 | response to interleukin-18 |
| GO:0071305 | 0.02076 | 6.46661 | 1 | 3 | 10 | cellular response to vitamin D |
| GO:0072203 | 0.02076 | 6.46661 | 1 | 3 | 10 | cell proliferation involved in metanephros development |
| GO:0090269 | 0.02076 | 6.46661 | 1 | 3 | 10 | fibroblast growth factor production |
| GO:0090270 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of fibroblast growth factor production |
| GO:1901724 | 0.02076 | 6.46661 | 1 | 3 | 10 | positive regulation of cell proliferation involved in kidney development |
| GO:1903011 | 0.02076 | 6.46661 | 1 | 3 | 10 | negative regulation of bone development |
| GO:1904468 | 0.02076 | 6.46661 | 1 | 3 | 10 | negative regulation of tumor necrosis factor secretion |
| GO:2000302 | 0.02076 | 6.46661 | 1 | 3 | 10 | positive regulation of synaptic vesicle exocytosis |
| GO:2000318 | 0.02076 | 6.46661 | 1 | 3 | 10 | positive regulation of T-helper 17 type immune response |
| GO:2001179 | 0.02076 | 6.46661 | 1 | 3 | 10 | regulation of interleukin-10 secretion |
| GO:0032088 | 0.02078 | 2.25680 | 5 | 10 | 77 | negative regulation of NF-kappaB transcription factor activity |
| GO:0071347 | 0.02078 | 2.25680 | 5 | 10 | 77 | cellular response to interleukin-1 |
| GO:0032787 | 0.02085 | 1.39827 | 35 | 48 | 570 | monocarboxylic acid metabolic process |
| GO:0051153 | 0.02088 | 1.94375 | 8 | 14 | 123 | regulation of striated muscle cell differentiation |
| GO:0009746 | 0.02100 | 1.74423 | 11 | 19 | 184 | response to hexose |
| GO:0001692 | 0.02136 | 15.08177 | 0 | 2 | 4 | histamine metabolic process |
| GO:0001757 | 0.02136 | 15.08177 | 0 | 2 | 4 | somite specification |
| GO:0001905 | 0.02136 | 15.08177 | 0 | 2 | 4 | activation of membrane attack complex |
| GO:0001969 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of activation of membrane attack complex |
| GO:0002159 | 0.02136 | 15.08177 | 0 | 2 | 4 | desmosome assembly |
| GO:0002351 | 0.02136 | 15.08177 | 0 | 2 | 4 | serotonin production involved in inflammatory response |
| GO:0002424 | 0.02136 | 15.08177 | 0 | 2 | 4 | T cell mediated immune response to tumor cell |
| GO:0002434 | 0.02136 | 15.08177 | 0 | 2 | 4 | immune complex clearance |
| GO:0002442 | 0.02136 | 15.08177 | 0 | 2 | 4 | serotonin secretion involved in inflammatory response |
| GO:0002840 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of T cell mediated immune response to tumor cell |
| GO:0003104 | 0.02136 | 15.08177 | 0 | 2 | 4 | positive regulation of glomerular filtration |
| GO:0006083 | 0.02136 | 15.08177 | 0 | 2 | 4 | acetate metabolic process |
| GO:0015691 | 0.02136 | 15.08177 | 0 | 2 | 4 | cadmium ion transport |
| GO:0016080 | 0.02136 | 15.08177 | 0 | 2 | 4 | synaptic vesicle targeting |
| GO:0021569 | 0.02136 | 15.08177 | 0 | 2 | 4 | rhombomere 3 development |
| GO:0030035 | 0.02136 | 15.08177 | 0 | 2 | 4 | microspike assembly |
| GO:0032290 | 0.02136 | 15.08177 | 0 | 2 | 4 | peripheral nervous system myelin formation |
| GO:0032672 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of interleukin-3 production |
| GO:0032907 | 0.02136 | 15.08177 | 0 | 2 | 4 | transforming growth factor beta3 production |
| GO:0032910 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of transforming growth factor beta3 production |
| GO:0032929 | 0.02136 | 15.08177 | 0 | 2 | 4 | negative regulation of superoxide anion generation |
| GO:0033326 | 0.02136 | 15.08177 | 0 | 2 | 4 | cerebrospinal fluid secretion |
| GO:0034124 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of MyD88-dependent toll-like receptor signaling pathway |
| GO:0035290 | 0.02136 | 15.08177 | 0 | 2 | 4 | trunk segmentation |
| GO:0035799 | 0.02136 | 15.08177 | 0 | 2 | 4 | ureter maturation |
| GO:0036484 | 0.02136 | 15.08177 | 0 | 2 | 4 | trunk neural crest cell migration |
| GO:0036486 | 0.02136 | 15.08177 | 0 | 2 | 4 | ventral trunk neural crest cell migration |
| GO:0038146 | 0.02136 | 15.08177 | 0 | 2 | 4 | chemokine (C-X-C motif) ligand 12 signaling pathway |
| GO:0042097 | 0.02136 | 15.08177 | 0 | 2 | 4 | interleukin-4 biosynthetic process |
| GO:0045402 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of interleukin-4 biosynthetic process |
| GO:0046136 | 0.02136 | 15.08177 | 0 | 2 | 4 | positive regulation of vitamin metabolic process |
| GO:0051665 | 0.02136 | 15.08177 | 0 | 2 | 4 | membrane raft localization |
| GO:0060214 | 0.02136 | 15.08177 | 0 | 2 | 4 | endocardium formation |
| GO:0060528 | 0.02136 | 15.08177 | 0 | 2 | 4 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development |
| GO:0061218 | 0.02136 | 15.08177 | 0 | 2 | 4 | negative regulation of mesonephros development |
| GO:0061789 | 0.02136 | 15.08177 | 0 | 2 | 4 | dense core granule priming |
| GO:0061884 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of mini excitatory postsynaptic potential |
| GO:0070164 | 0.02136 | 15.08177 | 0 | 2 | 4 | negative regulation of adiponectin secretion |
| GO:0070358 | 0.02136 | 15.08177 | 0 | 2 | 4 | actin polymerization-dependent cell motility |
| GO:0070574 | 0.02136 | 15.08177 | 0 | 2 | 4 | cadmium ion transmembrane transport |
| GO:0070947 | 0.02136 | 15.08177 | 0 | 2 | 4 | neutrophil mediated killing of fungus |
| GO:0070949 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of neutrophil mediated killing of symbiont cell |
| GO:0071072 | 0.02136 | 15.08177 | 0 | 2 | 4 | negative regulation of phospholipid biosynthetic process |
| GO:0071724 | 0.02136 | 15.08177 | 0 | 2 | 4 | response to diacyl bacterial lipopeptide |
| GO:0071726 | 0.02136 | 15.08177 | 0 | 2 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0072162 | 0.02136 | 15.08177 | 0 | 2 | 4 | metanephric mesenchymal cell differentiation |
| GO:0072268 | 0.02136 | 15.08177 | 0 | 2 | 4 | pattern specification involved in metanephros development |
| GO:0086017 | 0.02136 | 15.08177 | 0 | 2 | 4 | Purkinje myocyte action potential |
| GO:0097167 | 0.02136 | 15.08177 | 0 | 2 | 4 | circadian regulation of translation |
| GO:0097350 | 0.02136 | 15.08177 | 0 | 2 | 4 | neutrophil clearance |
| GO:0097490 | 0.02136 | 15.08177 | 0 | 2 | 4 | sympathetic neuron projection extension |
| GO:0097491 | 0.02136 | 15.08177 | 0 | 2 | 4 | sympathetic neuron projection guidance |
| GO:0098816 | 0.02136 | 15.08177 | 0 | 2 | 4 | mini excitatory postsynaptic potential |
| GO:1900126 | 0.02136 | 15.08177 | 0 | 2 | 4 | negative regulation of hyaluronan biosynthetic process |
| GO:1901668 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of superoxide dismutase activity |
| GO:1903847 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of aorta morphogenesis |
| GO:1903849 | 0.02136 | 15.08177 | 0 | 2 | 4 | positive regulation of aorta morphogenesis |
| GO:1903903 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of establishment of T cell polarity |
| GO:1903936 | 0.02136 | 15.08177 | 0 | 2 | 4 | cellular response to sodium arsenite |
| GO:2000412 | 0.02136 | 15.08177 | 0 | 2 | 4 | positive regulation of thymocyte migration |
| GO:2000418 | 0.02136 | 15.08177 | 0 | 2 | 4 | positive regulation of eosinophil migration |
| GO:2000437 | 0.02136 | 15.08177 | 0 | 2 | 4 | regulation of monocyte extravasation |
| GO:2000660 | 0.02136 | 15.08177 | 0 | 2 | 4 | negative regulation of interleukin-1-mediated signaling pathway |
| GO:2000667 | 0.02136 | 15.08177 | 0 | 2 | 4 | positive regulation of interleukin-13 secretion |
| GO:0045778 | 0.02143 | 2.06277 | 6 | 12 | 100 | positive regulation of ossification |
| GO:0090174 | 0.02143 | 2.06277 | 6 | 12 | 100 | organelle membrane fusion |
| GO:0001501 | 0.02175 | 1.41031 | 33 | 45 | 530 | skeletal system development |
| GO:0043536 | 0.02191 | 2.51879 | 3 | 8 | 56 | positive regulation of blood vessel endothelial cell migration |
| GO:0060761 | 0.02191 | 2.51879 | 3 | 8 | 56 | negative regulation of response to cytokine stimulus |
| GO:0090303 | 0.02191 | 2.51879 | 3 | 8 | 56 | positive regulation of wound healing |
| GO:0034284 | 0.02209 | 1.73364 | 12 | 19 | 185 | response to monosaccharide |
| GO:0099504 | 0.02218 | 1.65864 | 14 | 22 | 223 | synaptic vesicle cycle |
| GO:0010821 | 0.02228 | 1.87632 | 8 | 15 | 136 | regulation of mitochondrion organization |
| GO:0008202 | 0.02231 | 1.55562 | 19 | 28 | 301 | steroid metabolic process |
| GO:0090596 | 0.02231 | 1.55562 | 19 | 28 | 301 | sensory organ morphogenesis |
| GO:0002861 | 0.02250 | 3.02085 | 2 | 6 | 36 | regulation of inflammatory response to antigenic stimulus |
| GO:0034205 | 0.02250 | 3.02085 | 2 | 6 | 36 | amyloid-beta formation |
| GO:0035886 | 0.02250 | 3.02085 | 2 | 6 | 36 | vascular smooth muscle cell differentiation |
| GO:0042311 | 0.02250 | 3.02085 | 2 | 6 | 36 | vasodilation |
| GO:0045987 | 0.02250 | 3.02085 | 2 | 6 | 36 | positive regulation of smooth muscle contraction |
| GO:0060969 | 0.02250 | 3.02085 | 2 | 6 | 36 | negative regulation of gene silencing |
| GO:1904037 | 0.02250 | 3.02085 | 2 | 6 | 36 | positive regulation of epithelial cell apoptotic process |
| GO:0017144 | 0.02255 | 1.34441 | 45 | 59 | 727 | drug metabolic process |
| GO:0060976 | 0.02255 | 2.22351 | 5 | 10 | 78 | coronary vasculature development |
| GO:0099024 | 0.02258 | 1.70211 | 12 | 20 | 198 | plasma membrane invagination |
| GO:0002524 | 0.02268 | 4.31268 | 1 | 4 | 18 | hypersensitivity |
| GO:0007252 | 0.02268 | 4.31268 | 1 | 4 | 18 | I-kappaB phosphorylation |
| GO:0021783 | 0.02268 | 4.31268 | 1 | 4 | 18 | preganglionic parasympathetic fiber development |
| GO:0030002 | 0.02268 | 4.31268 | 1 | 4 | 18 | cellular anion homeostasis |
| GO:0030320 | 0.02268 | 4.31268 | 1 | 4 | 18 | cellular monovalent inorganic anion homeostasis |
| GO:0030540 | 0.02268 | 4.31268 | 1 | 4 | 18 | female genitalia development |
| GO:0034695 | 0.02268 | 4.31268 | 1 | 4 | 18 | response to prostaglandin E |
| GO:0046321 | 0.02268 | 4.31268 | 1 | 4 | 18 | positive regulation of fatty acid oxidation |
| GO:0046851 | 0.02268 | 4.31268 | 1 | 4 | 18 | negative regulation of bone remodeling |
| GO:0050961 | 0.02268 | 4.31268 | 1 | 4 | 18 | detection of temperature stimulus involved in sensory perception |
| GO:0050965 | 0.02268 | 4.31268 | 1 | 4 | 18 | detection of temperature stimulus involved in sensory perception of pain |
| GO:0060841 | 0.02268 | 4.31268 | 1 | 4 | 18 | venous blood vessel development |
| GO:0071801 | 0.02268 | 4.31268 | 1 | 4 | 18 | regulation of podosome assembly |
| GO:2000319 | 0.02268 | 4.31268 | 1 | 4 | 18 | regulation of T-helper 17 cell differentiation |
| GO:2000810 | 0.02268 | 4.31268 | 1 | 4 | 18 | regulation of bicellular tight junction assembly |
| GO:0006695 | 0.02270 | 2.71178 | 3 | 7 | 46 | cholesterol biosynthetic process |
| GO:0098754 | 0.02270 | 2.71178 | 3 | 7 | 46 | detoxification |
| GO:1902667 | 0.02270 | 2.71178 | 3 | 7 | 46 | regulation of axon guidance |
| GO:0033559 | 0.02299 | 2.03950 | 6 | 12 | 101 | unsaturated fatty acid metabolic process |
| GO:0055024 | 0.02299 | 2.03950 | 6 | 12 | 101 | regulation of cardiac muscle tissue development |
| GO:0006109 | 0.02322 | 1.72318 | 12 | 19 | 186 | regulation of carbohydrate metabolic process |
| GO:0050803 | 0.02343 | 1.57686 | 17 | 26 | 276 | regulation of synapse structure or activity |
| GO:0001952 | 0.02348 | 1.96679 | 7 | 13 | 113 | regulation of cell-matrix adhesion |
| GO:0018107 | 0.02367 | 1.90855 | 8 | 14 | 125 | peptidyl-threonine phosphorylation |
| GO:0032273 | 0.02367 | 1.90855 | 8 | 14 | 125 | positive regulation of protein polymerization |
| GO:0001649 | 0.02368 | 1.69252 | 12 | 20 | 199 | osteoblast differentiation |
| GO:0036037 | 0.02381 | 3.43166 | 2 | 5 | 27 | CD8-positive, alpha-beta T cell activation |
| GO:2000727 | 0.02381 | 3.43166 | 2 | 5 | 27 | positive regulation of cardiac muscle cell differentiation |
| GO:0071774 | 0.02384 | 2.10570 | 6 | 11 | 90 | response to fibroblast growth factor |
| GO:0002067 | 0.02414 | 2.46727 | 4 | 8 | 57 | glandular epithelial cell differentiation |
| GO:0097479 | 0.02439 | 1.71285 | 12 | 19 | 187 | synaptic vesicle localization |
| GO:0043525 | 0.02443 | 2.19118 | 5 | 10 | 79 | positive regulation of neuron apoptotic process |
| GO:0048663 | 0.02443 | 2.19118 | 5 | 10 | 79 | neuron fate commitment |
| GO:0051781 | 0.02443 | 2.19118 | 5 | 10 | 79 | positive regulation of cell division |
| GO:0072330 | 0.02445 | 1.58569 | 16 | 25 | 264 | monocarboxylic acid biosynthetic process |
| GO:0006855 | 0.02461 | 2.30577 | 4 | 9 | 68 | drug transmembrane transport |
| GO:0045669 | 0.02461 | 2.30577 | 4 | 9 | 68 | positive regulation of osteoblast differentiation |
| GO:0022411 | 0.02474 | 1.49400 | 22 | 32 | 357 | cellular component disassembly |
| GO:0034614 | 0.02475 | 1.80742 | 9 | 16 | 150 | cellular response to reactive oxygen species |
| GO:0071322 | 0.02475 | 1.80742 | 9 | 16 | 150 | cellular response to carbohydrate stimulus |
| GO:0008217 | 0.02483 | 1.68304 | 12 | 20 | 200 | regulation of blood pressure |
| GO:0009582 | 0.02515 | 1.89142 | 8 | 14 | 126 | detection of abiotic stimulus |
| GO:1902653 | 0.02528 | 2.64386 | 3 | 7 | 47 | secondary alcohol biosynthetic process |
| GO:0006732 | 0.02541 | 1.51185 | 21 | 30 | 331 | coenzyme metabolic process |
| GO:0002753 | 0.02548 | 2.92327 | 2 | 6 | 37 | cytoplasmic pattern recognition receptor signaling pathway |
| GO:0019934 | 0.02548 | 2.92327 | 2 | 6 | 37 | cGMP-mediated signaling |
| GO:0033260 | 0.02548 | 2.92327 | 2 | 6 | 37 | nuclear DNA replication |
| GO:0045191 | 0.02548 | 2.92327 | 2 | 6 | 37 | regulation of isotype switching |
| GO:0071158 | 0.02548 | 2.92327 | 2 | 6 | 37 | positive regulation of cell cycle arrest |
| GO:0071825 | 0.02548 | 2.92327 | 2 | 6 | 37 | protein-lipid complex subunit organization |
| GO:0030879 | 0.02565 | 1.76280 | 10 | 17 | 163 | mammary gland development |
| GO:0010558 | 0.02588 | 1.23811 | 88 | 106 | 1414 | negative regulation of macromolecule biosynthetic process |
| GO:0000302 | 0.02602 | 1.67366 | 13 | 20 | 201 | response to reactive oxygen species |
| GO:0030111 | 0.02619 | 1.54483 | 18 | 27 | 292 | regulation of Wnt signaling pathway |
| GO:0048489 | 0.02635 | 1.72499 | 11 | 18 | 176 | synaptic vesicle transport |
| GO:0097480 | 0.02635 | 1.72499 | 11 | 18 | 176 | establishment of synaptic vesicle localization |
| GO:0032231 | 0.02636 | 1.99449 | 6 | 12 | 103 | regulation of actin filament bundle assembly |
| GO:0050807 | 0.02650 | 1.57238 | 17 | 25 | 266 | regulation of synapse organization |
| GO:0015909 | 0.02653 | 2.41781 | 4 | 8 | 58 | long-chain fatty acid transport |
| GO:0019730 | 0.02669 | 1.92805 | 7 | 13 | 115 | antimicrobial humoral response |
| GO:0009581 | 0.02671 | 1.87460 | 8 | 14 | 127 | detection of external stimulus |
| GO:0010565 | 0.02671 | 1.87460 | 8 | 14 | 127 | regulation of cellular ketone metabolic process |
| GO:0051592 | 0.02671 | 1.87460 | 8 | 14 | 127 | response to calcium ion |
| GO:0006725 | 0.02675 | 1.13502 | 312 | 342 | 5012 | cellular aromatic compound metabolic process |
| GO:0071407 | 0.02676 | 1.41204 | 30 | 41 | 482 | cellular response to organic cyclic compound |
| GO:0006305 | 0.02679 | 2.26724 | 4 | 9 | 69 | DNA alkylation |
| GO:0006306 | 0.02679 | 2.26724 | 4 | 9 | 69 | DNA methylation |
| GO:2000107 | 0.02679 | 2.26724 | 4 | 9 | 69 | negative regulation of leukocyte apoptotic process |
| GO:0006072 | 0.02725 | 5.65803 | 1 | 3 | 11 | glycerol-3-phosphate metabolic process |
| GO:0006527 | 0.02725 | 5.65803 | 1 | 3 | 11 | arginine catabolic process |
| GO:0015809 | 0.02725 | 5.65803 | 1 | 3 | 11 | arginine transport |
| GO:0017085 | 0.02725 | 5.65803 | 1 | 3 | 11 | response to insecticide |
| GO:0031392 | 0.02725 | 5.65803 | 1 | 3 | 11 | regulation of prostaglandin biosynthetic process |
| GO:0032490 | 0.02725 | 5.65803 | 1 | 3 | 11 | detection of molecule of bacterial origin |
| GO:0035739 | 0.02725 | 5.65803 | 1 | 3 | 11 | CD4-positive, alpha-beta T cell proliferation |
| GO:0042090 | 0.02725 | 5.65803 | 1 | 3 | 11 | interleukin-12 biosynthetic process |
| GO:0043619 | 0.02725 | 5.65803 | 1 | 3 | 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
| GO:0045075 | 0.02725 | 5.65803 | 1 | 3 | 11 | regulation of interleukin-12 biosynthetic process |
| GO:0046007 | 0.02725 | 5.65803 | 1 | 3 | 11 | negative regulation of activated T cell proliferation |
| GO:0048845 | 0.02725 | 5.65803 | 1 | 3 | 11 | venous blood vessel morphogenesis |
| GO:0060600 | 0.02725 | 5.65803 | 1 | 3 | 11 | dichotomous subdivision of an epithelial terminal unit |
| GO:0072178 | 0.02725 | 5.65803 | 1 | 3 | 11 | nephric duct morphogenesis |
| GO:0090043 | 0.02725 | 5.65803 | 1 | 3 | 11 | regulation of tubulin deacetylation |
| GO:0090209 | 0.02725 | 5.65803 | 1 | 3 | 11 | negative regulation of triglyceride metabolic process |
| GO:1901678 | 0.02725 | 5.65803 | 1 | 3 | 11 | iron coordination entity transport |
| GO:1903977 | 0.02725 | 5.65803 | 1 | 3 | 11 | positive regulation of glial cell migration |
| GO:2000343 | 0.02725 | 5.65803 | 1 | 3 | 11 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:2000561 | 0.02725 | 5.65803 | 1 | 3 | 11 | regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:0002043 | 0.02735 | 4.02498 | 1 | 4 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0002643 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of tolerance induction |
| GO:0010544 | 0.02735 | 4.02498 | 1 | 4 | 19 | negative regulation of platelet activation |
| GO:0010818 | 0.02735 | 4.02498 | 1 | 4 | 19 | T cell chemotaxis |
| GO:0031664 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0032695 | 0.02735 | 4.02498 | 1 | 4 | 19 | negative regulation of interleukin-12 production |
| GO:0032823 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of natural killer cell differentiation |
| GO:0035994 | 0.02735 | 4.02498 | 1 | 4 | 19 | response to muscle stretch |
| GO:0042789 | 0.02735 | 4.02498 | 1 | 4 | 19 | mRNA transcription by RNA polymerase II |
| GO:0044794 | 0.02735 | 4.02498 | 1 | 4 | 19 | positive regulation by host of viral process |
| GO:0046886 | 0.02735 | 4.02498 | 1 | 4 | 19 | positive regulation of hormone biosynthetic process |
| GO:0051956 | 0.02735 | 4.02498 | 1 | 4 | 19 | negative regulation of amino acid transport |
| GO:0090030 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of steroid hormone biosynthetic process |
| GO:1902259 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of delayed rectifier potassium channel activity |
| GO:1903975 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of glial cell migration |
| GO:2000345 | 0.02735 | 4.02498 | 1 | 4 | 19 | regulation of hepatocyte proliferation |
| GO:0002360 | 0.02755 | 3.28231 | 2 | 5 | 28 | T cell lineage commitment |
| GO:0030511 | 0.02755 | 3.28231 | 2 | 5 | 28 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032647 | 0.02755 | 3.28231 | 2 | 5 | 28 | regulation of interferon-alpha production |
| GO:0043032 | 0.02755 | 3.28231 | 2 | 5 | 28 | positive regulation of macrophage activation |
| GO:0044003 | 0.02755 | 3.28231 | 2 | 5 | 28 | modification by symbiont of host morphology or physiology |
| GO:1903846 | 0.02755 | 3.28231 | 2 | 5 | 28 | positive regulation of cellular response to transforming growth factor beta stimulus |
| GO:2000178 | 0.02755 | 3.28231 | 2 | 5 | 28 | negative regulation of neural precursor cell proliferation |
| GO:0030838 | 0.02756 | 2.05352 | 6 | 11 | 92 | positive regulation of actin filament polymerization |
| GO:0007157 | 0.02806 | 2.57926 | 3 | 7 | 48 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0030857 | 0.02806 | 2.57926 | 3 | 7 | 48 | negative regulation of epithelial cell differentiation |
| GO:0032892 | 0.02806 | 2.57926 | 3 | 7 | 48 | positive regulation of organic acid transport |
| GO:0044786 | 0.02806 | 2.57926 | 3 | 7 | 48 | cell cycle DNA replication |
| GO:0050435 | 0.02806 | 2.57926 | 3 | 7 | 48 | amyloid-beta metabolic process |
| GO:0090311 | 0.02806 | 2.57926 | 3 | 7 | 48 | regulation of protein deacetylation |
| GO:0090659 | 0.02806 | 2.57926 | 3 | 7 | 48 | walking behavior |
| GO:1903115 | 0.02806 | 2.57926 | 3 | 7 | 48 | regulation of actin filament-based movement |
| GO:2000725 | 0.02806 | 2.57926 | 3 | 7 | 48 | regulation of cardiac muscle cell differentiation |
| GO:1903052 | 0.02841 | 1.90924 | 7 | 13 | 116 | positive regulation of proteolysis involved in cellular protein catabolic process |
| GO:0007179 | 0.02844 | 1.73882 | 10 | 17 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:0032479 | 0.02852 | 2.12926 | 5 | 10 | 81 | regulation of type I interferon production |
| GO:0003230 | 0.02872 | 2.83178 | 2 | 6 | 38 | cardiac atrium development |
| GO:0030513 | 0.02872 | 2.83178 | 2 | 6 | 38 | positive regulation of BMP signaling pathway |
| GO:0042149 | 0.02872 | 2.83178 | 2 | 6 | 38 | cellular response to glucose starvation |
| GO:0045005 | 0.02872 | 2.83178 | 2 | 6 | 38 | DNA-dependent DNA replication maintenance of fidelity |
| GO:0051968 | 0.02872 | 2.83178 | 2 | 6 | 38 | positive regulation of synaptic transmission, glutamatergic |
| GO:0072210 | 0.02872 | 2.83178 | 2 | 6 | 38 | metanephric nephron development |
| GO:0009059 | 0.02885 | 1.14295 | 257 | 284 | 4121 | macromolecule biosynthetic process |
| GO:0098661 | 0.02908 | 2.37030 | 4 | 8 | 59 | inorganic anion transmembrane transport |
| GO:0002090 | 0.02911 | 2.22996 | 4 | 9 | 70 | regulation of receptor internalization |
| GO:1901360 | 0.02922 | 1.13044 | 324 | 354 | 5208 | organic cyclic compound metabolic process |
| GO:0021915 | 0.02955 | 1.67270 | 12 | 19 | 191 | neural tube development |
| GO:2000060 | 0.02956 | 2.02838 | 6 | 11 | 93 | positive regulation of ubiquitin-dependent protein catabolic process |
| GO:0045931 | 0.02992 | 1.72707 | 10 | 17 | 166 | positive regulation of mitotic cell cycle |
| GO:0035282 | 0.03008 | 1.95142 | 7 | 12 | 105 | segmentation |
| GO:0051726 | 0.03027 | 1.27948 | 59 | 74 | 955 | regulation of cell cycle |
| GO:0035050 | 0.03074 | 2.09959 | 5 | 10 | 82 | embryonic heart tube development |
| GO:0046364 | 0.03074 | 2.09959 | 5 | 10 | 82 | monosaccharide biosynthetic process |
| GO:0021545 | 0.03104 | 2.51773 | 3 | 7 | 49 | cranial nerve development |
| GO:0032941 | 0.03104 | 2.51773 | 3 | 7 | 49 | secretion by tissue |
| GO:0035088 | 0.03104 | 2.51773 | 3 | 7 | 49 | establishment or maintenance of apical/basal cell polarity |
| GO:0061245 | 0.03104 | 2.51773 | 3 | 7 | 49 | establishment or maintenance of bipolar cell polarity |
| GO:0010324 | 0.03123 | 1.63717 | 13 | 20 | 205 | membrane invagination |
| GO:2001234 | 0.03141 | 1.59456 | 14 | 22 | 231 | negative regulation of apoptotic signaling pathway |
| GO:0061045 | 0.03156 | 2.19390 | 4 | 9 | 71 | negative regulation of wound healing |
| GO:0002092 | 0.03163 | 3.14540 | 2 | 5 | 29 | positive regulation of receptor internalization |
| GO:0033687 | 0.03163 | 3.14540 | 2 | 5 | 29 | osteoblast proliferation |
| GO:0034629 | 0.03163 | 3.14540 | 2 | 5 | 29 | cellular protein-containing complex localization |
| GO:0071354 | 0.03163 | 3.14540 | 2 | 5 | 29 | cellular response to interleukin-6 |
| GO:0090181 | 0.03163 | 3.14540 | 2 | 5 | 29 | regulation of cholesterol metabolic process |
| GO:0070555 | 0.03167 | 2.00385 | 6 | 11 | 94 | response to interleukin-1 |
| GO:0042982 | 0.03179 | 2.32461 | 4 | 8 | 60 | amyloid precursor protein metabolic process |
| GO:0071156 | 0.03179 | 2.32461 | 4 | 8 | 60 | regulation of cell cycle arrest |
| GO:0022600 | 0.03207 | 1.93057 | 7 | 12 | 106 | digestive system process |
| GO:0046474 | 0.03207 | 1.93057 | 7 | 12 | 106 | glycerophospholipid biosynthetic process |
| GO:0055006 | 0.03207 | 1.93057 | 7 | 12 | 106 | cardiac cell development |
| GO:0046620 | 0.03209 | 1.87271 | 7 | 13 | 118 | regulation of organ growth |
| GO:0060349 | 0.03209 | 1.87271 | 7 | 13 | 118 | bone morphogenesis |
| GO:0031076 | 0.03221 | 2.74585 | 2 | 6 | 39 | embryonic camera-type eye development |
| GO:0098534 | 0.03221 | 2.74585 | 2 | 6 | 39 | centriole assembly |
| GO:1902476 | 0.03221 | 2.74585 | 2 | 6 | 39 | chloride transmembrane transport |
| GO:1902692 | 0.03221 | 2.74585 | 2 | 6 | 39 | regulation of neuroblast proliferation |
| GO:0010467 | 0.03225 | 1.13105 | 300 | 328 | 4814 | gene expression |
| GO:0001946 | 0.03254 | 3.77325 | 1 | 4 | 20 | lymphangiogenesis |
| GO:0002577 | 0.03254 | 3.77325 | 1 | 4 | 20 | regulation of antigen processing and presentation |
| GO:0034143 | 0.03254 | 3.77325 | 1 | 4 | 20 | regulation of toll-like receptor 4 signaling pathway |
| GO:0035855 | 0.03254 | 3.77325 | 1 | 4 | 20 | megakaryocyte development |
| GO:0036336 | 0.03254 | 3.77325 | 1 | 4 | 20 | dendritic cell migration |
| GO:0045649 | 0.03254 | 3.77325 | 1 | 4 | 20 | regulation of macrophage differentiation |
| GO:0046697 | 0.03254 | 3.77325 | 1 | 4 | 20 | decidualization |
| GO:0050434 | 0.03254 | 3.77325 | 1 | 4 | 20 | positive regulation of viral transcription |
| GO:0050910 | 0.03254 | 3.77325 | 1 | 4 | 20 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0050966 | 0.03254 | 3.77325 | 1 | 4 | 20 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:1902993 | 0.03254 | 3.77325 | 1 | 4 | 20 | positive regulation of amyloid precursor protein catabolic process |
| GO:0009267 | 0.03306 | 1.77314 | 9 | 15 | 143 | cellular response to starvation |
| GO:0031333 | 0.03306 | 1.77314 | 9 | 15 | 143 | negative regulation of protein complex assembly |
| GO:1903321 | 0.03308 | 2.07074 | 5 | 10 | 83 | negative regulation of protein modification by small protein conjugation or removal |
| GO:0030218 | 0.03366 | 1.81017 | 8 | 14 | 131 | erythrocyte differentiation |
| GO:0005975 | 0.03373 | 1.36424 | 34 | 45 | 546 | carbohydrate metabolic process |
| GO:0035690 | 0.03383 | 1.44254 | 24 | 33 | 380 | cellular response to drug |
| GO:0016051 | 0.03391 | 1.64380 | 12 | 19 | 194 | carbohydrate biosynthetic process |
| GO:0043280 | 0.03405 | 1.85495 | 7 | 13 | 119 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0050890 | 0.03410 | 1.48037 | 20 | 29 | 326 | cognition |
| GO:0001788 | 0.03414 | 10.05405 | 0 | 2 | 5 | antibody-dependent cellular cytotoxicity |
| GO:0002238 | 0.03414 | 10.05405 | 0 | 2 | 5 | response to molecule of fungal origin |
| GO:0002278 | 0.03414 | 10.05405 | 0 | 2 | 5 | eosinophil activation involved in immune response |
| GO:0002447 | 0.03414 | 10.05405 | 0 | 2 | 5 | eosinophil mediated immunity |
| GO:0002678 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of chronic inflammatory response |
| GO:0003241 | 0.03414 | 10.05405 | 0 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0003376 | 0.03414 | 10.05405 | 0 | 2 | 5 | sphingosine-1-phosphate receptor signaling pathway |
| GO:0006701 | 0.03414 | 10.05405 | 0 | 2 | 5 | progesterone biosynthetic process |
| GO:0006742 | 0.03414 | 10.05405 | 0 | 2 | 5 | NADP catabolic process |
| GO:0006776 | 0.03414 | 10.05405 | 0 | 2 | 5 | vitamin A metabolic process |
| GO:0006868 | 0.03414 | 10.05405 | 0 | 2 | 5 | glutamine transport |
| GO:0009115 | 0.03414 | 10.05405 | 0 | 2 | 5 | xanthine catabolic process |
| GO:0010641 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0015705 | 0.03414 | 10.05405 | 0 | 2 | 5 | iodide transport |
| GO:0015712 | 0.03414 | 10.05405 | 0 | 2 | 5 | hexose phosphate transport |
| GO:0015760 | 0.03414 | 10.05405 | 0 | 2 | 5 | glucose-6-phosphate transport |
| GO:0031284 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of guanylate cyclase activity |
| GO:0031581 | 0.03414 | 10.05405 | 0 | 2 | 5 | hemidesmosome assembly |
| GO:0031632 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0032484 | 0.03414 | 10.05405 | 0 | 2 | 5 | Ral protein signal transduction |
| GO:0032687 | 0.03414 | 10.05405 | 0 | 2 | 5 | negative regulation of interferon-alpha production |
| GO:0032696 | 0.03414 | 10.05405 | 0 | 2 | 5 | negative regulation of interleukin-13 production |
| GO:0035666 | 0.03414 | 10.05405 | 0 | 2 | 5 | TRIF-dependent toll-like receptor signaling pathway |
| GO:0035898 | 0.03414 | 10.05405 | 0 | 2 | 5 | parathyroid hormone secretion |
| GO:0038145 | 0.03414 | 10.05405 | 0 | 2 | 5 | macrophage colony-stimulating factor signaling pathway |
| GO:0042091 | 0.03414 | 10.05405 | 0 | 2 | 5 | interleukin-10 biosynthetic process |
| GO:0043308 | 0.03414 | 10.05405 | 0 | 2 | 5 | eosinophil degranulation |
| GO:0044027 | 0.03414 | 10.05405 | 0 | 2 | 5 | hypermethylation of CpG island |
| GO:0045074 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of interleukin-10 biosynthetic process |
| GO:0051025 | 0.03414 | 10.05405 | 0 | 2 | 5 | negative regulation of immunoglobulin secretion |
| GO:0055118 | 0.03414 | 10.05405 | 0 | 2 | 5 | negative regulation of cardiac muscle contraction |
| GO:0060431 | 0.03414 | 10.05405 | 0 | 2 | 5 | primary lung bud formation |
| GO:0060681 | 0.03414 | 10.05405 | 0 | 2 | 5 | branch elongation involved in ureteric bud branching |
| GO:0060762 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of branching involved in mammary gland duct morphogenesis |
| GO:0070424 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070427 | 0.03414 | 10.05405 | 0 | 2 | 5 | nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0070432 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0072047 | 0.03414 | 10.05405 | 0 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
| GO:0072081 | 0.03414 | 10.05405 | 0 | 2 | 5 | specification of nephron tubule identity |
| GO:0090271 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of fibroblast growth factor production |
| GO:0090370 | 0.03414 | 10.05405 | 0 | 2 | 5 | negative regulation of cholesterol efflux |
| GO:0097742 | 0.03414 | 10.05405 | 0 | 2 | 5 | de novo centriole assembly |
| GO:0098535 | 0.03414 | 10.05405 | 0 | 2 | 5 | de novo centriole assembly involved in multi-ciliated epithelial cell differentiation |
| GO:0099502 | 0.03414 | 10.05405 | 0 | 2 | 5 | calcium-dependent activation of synaptic vesicle fusion |
| GO:1900133 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of renin secretion into blood stream |
| GO:1900149 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of Schwann cell migration |
| GO:1900223 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of amyloid-beta clearance |
| GO:1900825 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of membrane depolarization during cardiac muscle cell action potential |
| GO:1902412 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of mitotic cytokinesis |
| GO:1904347 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of small intestine smooth muscle contraction |
| GO:1904502 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of lipophagy |
| GO:1904504 | 0.03414 | 10.05405 | 0 | 2 | 5 | positive regulation of lipophagy |
| GO:1990770 | 0.03414 | 10.05405 | 0 | 2 | 5 | small intestine smooth muscle contraction |
| GO:2000410 | 0.03414 | 10.05405 | 0 | 2 | 5 | regulation of thymocyte migration |
| GO:2000697 | 0.03414 | 10.05405 | 0 | 2 | 5 | negative regulation of epithelial cell differentiation involved in kidney development |
| GO:0000079 | 0.03416 | 2.15897 | 4 | 9 | 72 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0072171 | 0.03416 | 2.15897 | 4 | 9 | 72 | mesonephric tubule morphogenesis |
| GO:0006275 | 0.03416 | 1.91016 | 7 | 12 | 107 | regulation of DNA replication |
| GO:0035137 | 0.03423 | 2.45907 | 3 | 7 | 50 | hindlimb morphogenesis |
| GO:0050891 | 0.03423 | 2.45907 | 3 | 7 | 50 | multicellular organismal water homeostasis |
| GO:1902373 | 0.03423 | 2.45907 | 3 | 7 | 50 | negative regulation of mRNA catabolic process |
| GO:0042058 | 0.03467 | 2.28064 | 4 | 8 | 61 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0045600 | 0.03467 | 2.28064 | 4 | 8 | 61 | positive regulation of fat cell differentiation |
| GO:0048286 | 0.03467 | 2.28064 | 4 | 8 | 61 | lung alveolus development |
| GO:1905207 | 0.03467 | 2.28064 | 4 | 8 | 61 | regulation of cardiocyte differentiation |
| GO:0021670 | 0.03469 | 5.02913 | 1 | 3 | 12 | lateral ventricle development |
| GO:0032026 | 0.03469 | 5.02913 | 1 | 3 | 12 | response to magnesium ion |
| GO:0032488 | 0.03469 | 5.02913 | 1 | 3 | 12 | Cdc42 protein signal transduction |
| GO:0032725 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0034392 | 0.03469 | 5.02913 | 1 | 3 | 12 | negative regulation of smooth muscle cell apoptotic process |
| GO:0042268 | 0.03469 | 5.02913 | 1 | 3 | 12 | regulation of cytolysis |
| GO:0045080 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of chemokine biosynthetic process |
| GO:0051024 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of immunoglobulin secretion |
| GO:0060068 | 0.03469 | 5.02913 | 1 | 3 | 12 | vagina development |
| GO:0070970 | 0.03469 | 5.02913 | 1 | 3 | 12 | interleukin-2 secretion |
| GO:0071073 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of phospholipid biosynthetic process |
| GO:0071838 | 0.03469 | 5.02913 | 1 | 3 | 12 | cell proliferation in bone marrow |
| GO:0071863 | 0.03469 | 5.02913 | 1 | 3 | 12 | regulation of cell proliferation in bone marrow |
| GO:0072124 | 0.03469 | 5.02913 | 1 | 3 | 12 | regulation of glomerular mesangial cell proliferation |
| GO:0072176 | 0.03469 | 5.02913 | 1 | 3 | 12 | nephric duct development |
| GO:0072683 | 0.03469 | 5.02913 | 1 | 3 | 12 | T cell extravasation |
| GO:0090557 | 0.03469 | 5.02913 | 1 | 3 | 12 | establishment of endothelial intestinal barrier |
| GO:1900272 | 0.03469 | 5.02913 | 1 | 3 | 12 | negative regulation of long-term synaptic potentiation |
| GO:1900426 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of defense response to bacterium |
| GO:1902805 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of synaptic vesicle transport |
| GO:1902946 | 0.03469 | 5.02913 | 1 | 3 | 12 | protein localization to early endosome |
| GO:2000105 | 0.03469 | 5.02913 | 1 | 3 | 12 | positive regulation of DNA-dependent DNA replication |
| GO:0051604 | 0.03515 | 1.49900 | 19 | 27 | 300 | protein maturation |
| GO:0010506 | 0.03534 | 1.55541 | 15 | 23 | 247 | regulation of autophagy |
| GO:0043933 | 0.03552 | 1.18852 | 122 | 141 | 1956 | protein-containing complex subunit organization |
| GO:0044728 | 0.03554 | 2.04266 | 5 | 10 | 84 | DNA methylation or demethylation |
| GO:0000280 | 0.03555 | 1.41974 | 25 | 35 | 409 | nuclear division |
| GO:0035307 | 0.03597 | 2.66496 | 2 | 6 | 40 | positive regulation of protein dephosphorylation |
| GO:0045747 | 0.03597 | 2.66496 | 2 | 6 | 40 | positive regulation of Notch signaling pathway |
| GO:0071542 | 0.03597 | 2.66496 | 2 | 6 | 40 | dopaminergic neuron differentiation |
| GO:1903053 | 0.03597 | 2.66496 | 2 | 6 | 40 | regulation of extracellular matrix organization |
| GO:2000273 | 0.03597 | 2.66496 | 2 | 6 | 40 | positive regulation of signaling receptor activity |
| GO:0002438 | 0.03608 | 3.01944 | 2 | 5 | 30 | acute inflammatory response to antigenic stimulus |
| GO:0010922 | 0.03608 | 3.01944 | 2 | 5 | 30 | positive regulation of phosphatase activity |
| GO:0021602 | 0.03608 | 3.01944 | 2 | 5 | 30 | cranial nerve morphogenesis |
| GO:0022011 | 0.03608 | 3.01944 | 2 | 5 | 30 | myelination in peripheral nervous system |
| GO:0022617 | 0.03608 | 3.01944 | 2 | 5 | 30 | extracellular matrix disassembly |
| GO:0032292 | 0.03608 | 3.01944 | 2 | 5 | 30 | peripheral nervous system axon ensheathment |
| GO:0032607 | 0.03608 | 3.01944 | 2 | 5 | 30 | interferon-alpha production |
| GO:0034110 | 0.03608 | 3.01944 | 2 | 5 | 30 | regulation of homotypic cell-cell adhesion |
| GO:0035640 | 0.03608 | 3.01944 | 2 | 5 | 30 | exploration behavior |
| GO:0044062 | 0.03608 | 3.01944 | 2 | 5 | 30 | regulation of excretion |
| GO:0048714 | 0.03608 | 3.01944 | 2 | 5 | 30 | positive regulation of oligodendrocyte differentiation |
| GO:0060143 | 0.03608 | 3.01944 | 2 | 5 | 30 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0061082 | 0.03608 | 3.01944 | 2 | 5 | 30 | myeloid leukocyte cytokine production |
| GO:0071456 | 0.03620 | 1.95652 | 6 | 11 | 96 | cellular response to hypoxia |
| GO:1903900 | 0.03674 | 1.74570 | 9 | 15 | 145 | regulation of viral life cycle |
| GO:0006094 | 0.03689 | 2.12514 | 5 | 9 | 73 | gluconeogenesis |
| GO:0007422 | 0.03689 | 2.12514 | 5 | 9 | 73 | peripheral nervous system development |
| GO:0031397 | 0.03689 | 2.12514 | 5 | 9 | 73 | negative regulation of protein ubiquitination |
| GO:0051155 | 0.03689 | 2.12514 | 5 | 9 | 73 | positive regulation of striated muscle cell differentiation |
| GO:0045786 | 0.03722 | 1.39286 | 28 | 38 | 452 | negative regulation of cell cycle |
| GO:0018210 | 0.03759 | 1.77959 | 8 | 14 | 133 | peptidyl-threonine modification |
| GO:0046496 | 0.03759 | 1.70496 | 10 | 16 | 158 | nicotinamide nucleotide metabolic process |
| GO:0017145 | 0.03762 | 2.40307 | 3 | 7 | 51 | stem cell division |
| GO:0043618 | 0.03762 | 2.40307 | 3 | 7 | 51 | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0048806 | 0.03762 | 2.40307 | 3 | 7 | 51 | genitalia development |
| GO:0051353 | 0.03762 | 2.40307 | 3 | 7 | 51 | positive regulation of oxidoreductase activity |
| GO:0060428 | 0.03762 | 2.40307 | 3 | 7 | 51 | lung epithelium development |
| GO:0014911 | 0.03772 | 2.23831 | 4 | 8 | 62 | positive regulation of smooth muscle cell migration |
| GO:0034308 | 0.03772 | 2.23831 | 4 | 8 | 62 | primary alcohol metabolic process |
| GO:0032606 | 0.03812 | 2.01533 | 5 | 10 | 85 | type I interferon production |
| GO:1901863 | 0.03812 | 2.01533 | 5 | 10 | 85 | positive regulation of muscle tissue development |
| GO:0006907 | 0.03828 | 3.55113 | 1 | 4 | 21 | pinocytosis |
| GO:0007190 | 0.03828 | 3.55113 | 1 | 4 | 21 | activation of adenylate cyclase activity |
| GO:0010759 | 0.03828 | 3.55113 | 1 | 4 | 21 | positive regulation of macrophage chemotaxis |
| GO:0031065 | 0.03828 | 3.55113 | 1 | 4 | 21 | positive regulation of histone deacetylation |
| GO:0031579 | 0.03828 | 3.55113 | 1 | 4 | 21 | membrane raft organization |
| GO:0034694 | 0.03828 | 3.55113 | 1 | 4 | 21 | response to prostaglandin |
| GO:0036303 | 0.03828 | 3.55113 | 1 | 4 | 21 | lymph vessel morphogenesis |
| GO:0048486 | 0.03828 | 3.55113 | 1 | 4 | 21 | parasympathetic nervous system development |
| GO:0048569 | 0.03828 | 3.55113 | 1 | 4 | 21 | post-embryonic animal organ development |
| GO:0090050 | 0.03828 | 3.55113 | 1 | 4 | 21 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:1901522 | 0.03828 | 3.55113 | 1 | 4 | 21 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:2000193 | 0.03828 | 3.55113 | 1 | 4 | 21 | positive regulation of fatty acid transport |
| GO:2001224 | 0.03828 | 3.55113 | 1 | 4 | 21 | positive regulation of neuron migration |
| GO:0051146 | 0.03840 | 1.47357 | 20 | 28 | 316 | striated muscle cell differentiation |
| GO:0050829 | 0.03862 | 1.87061 | 7 | 12 | 109 | defense response to Gram-negative bacterium |
| GO:0048525 | 0.03863 | 1.93368 | 6 | 11 | 97 | negative regulation of viral process |
| GO:0051052 | 0.03925 | 1.39295 | 27 | 37 | 440 | regulation of DNA metabolic process |
| GO:0019637 | 0.03946 | 1.26127 | 59 | 73 | 954 | organophosphate metabolic process |
| GO:0001678 | 0.03949 | 1.69296 | 10 | 16 | 159 | cellular glucose homeostasis |
| GO:0008543 | 0.03978 | 2.09235 | 5 | 9 | 74 | fibroblast growth factor receptor signaling pathway |
| GO:0010822 | 0.03978 | 2.09235 | 5 | 9 | 74 | positive regulation of mitochondrion organization |
| GO:0050856 | 0.04000 | 2.58870 | 3 | 6 | 41 | regulation of T cell receptor signaling pathway |
| GO:1903672 | 0.04000 | 2.58870 | 3 | 6 | 41 | positive regulation of sprouting angiogenesis |
| GO:2001258 | 0.04000 | 2.58870 | 3 | 6 | 41 | negative regulation of cation channel activity |
| GO:0010770 | 0.04033 | 1.63134 | 12 | 18 | 185 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0050796 | 0.04033 | 1.63134 | 12 | 18 | 185 | regulation of insulin secretion |
| GO:0003281 | 0.04083 | 1.98872 | 5 | 10 | 86 | ventricular septum development |
| GO:0070509 | 0.04083 | 1.98872 | 5 | 10 | 86 | calcium ion import |
| GO:0001556 | 0.04089 | 2.90318 | 2 | 5 | 31 | oocyte maturation |
| GO:0001893 | 0.04089 | 2.90318 | 2 | 5 | 31 | maternal placenta development |
| GO:0002026 | 0.04089 | 2.90318 | 2 | 5 | 31 | regulation of the force of heart contraction |
| GO:0048535 | 0.04089 | 2.90318 | 2 | 5 | 31 | lymph node development |
| GO:0050999 | 0.04089 | 2.90318 | 2 | 5 | 31 | regulation of nitric-oxide synthase activity |
| GO:0055075 | 0.04089 | 2.90318 | 2 | 5 | 31 | potassium ion homeostasis |
| GO:2000144 | 0.04089 | 2.90318 | 2 | 5 | 31 | positive regulation of DNA-templated transcription, initiation |
| GO:0048488 | 0.04094 | 2.19751 | 4 | 8 | 63 | synaptic vesicle endocytosis |
| GO:0140238 | 0.04094 | 2.19751 | 4 | 8 | 63 | presynaptic endocytosis |
| GO:0090100 | 0.04100 | 1.85143 | 7 | 12 | 110 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0048562 | 0.04108 | 1.46327 | 20 | 28 | 318 | embryonic organ morphogenesis |
| GO:0016126 | 0.04123 | 2.34956 | 3 | 7 | 52 | sterol biosynthetic process |
| GO:0016055 | 0.04139 | 1.39306 | 27 | 36 | 428 | Wnt signaling pathway |
| GO:0019362 | 0.04144 | 1.68113 | 10 | 16 | 160 | pyridine nucleotide metabolic process |
| GO:0045892 | 0.04181 | 1.23124 | 73 | 88 | 1177 | negative regulation of transcription, DNA-templated |
| GO:0006261 | 0.04183 | 1.75001 | 8 | 14 | 135 | DNA-dependent DNA replication |
| GO:0006650 | 0.04194 | 1.55865 | 14 | 21 | 225 | glycerophospholipid metabolic process |
| GO:1905475 | 0.04216 | 1.62156 | 12 | 18 | 186 | regulation of protein localization to membrane |
| GO:0007611 | 0.04254 | 1.48091 | 18 | 26 | 292 | learning or memory |
| GO:0042446 | 0.04281 | 2.06055 | 5 | 9 | 75 | hormone biosynthetic process |
| GO:0002371 | 0.04305 | 4.52601 | 1 | 3 | 13 | dendritic cell cytokine production |
| GO:0002674 | 0.04305 | 4.52601 | 1 | 3 | 13 | negative regulation of acute inflammatory response |
| GO:0003093 | 0.04305 | 4.52601 | 1 | 3 | 13 | regulation of glomerular filtration |
| GO:0006670 | 0.04305 | 4.52601 | 1 | 3 | 13 | sphingosine metabolic process |
| GO:0006857 | 0.04305 | 4.52601 | 1 | 3 | 13 | oligopeptide transport |
| GO:0010885 | 0.04305 | 4.52601 | 1 | 3 | 13 | regulation of cholesterol storage |
| GO:0015802 | 0.04305 | 4.52601 | 1 | 3 | 13 | basic amino acid transport |
| GO:0019321 | 0.04305 | 4.52601 | 1 | 3 | 13 | pentose metabolic process |
| GO:0019370 | 0.04305 | 4.52601 | 1 | 3 | 13 | leukotriene biosynthetic process |
| GO:0030240 | 0.04305 | 4.52601 | 1 | 3 | 13 | skeletal muscle thin filament assembly |
| GO:0030948 | 0.04305 | 4.52601 | 1 | 3 | 13 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0031652 | 0.04305 | 4.52601 | 1 | 3 | 13 | positive regulation of heat generation |
| GO:0033262 | 0.04305 | 4.52601 | 1 | 3 | 13 | regulation of nuclear cell cycle DNA replication |
| GO:0035810 | 0.04305 | 4.52601 | 1 | 3 | 13 | positive regulation of urine volume |
| GO:0038065 | 0.04305 | 4.52601 | 1 | 3 | 13 | collagen-activated signaling pathway |
| GO:0038094 | 0.04305 | 4.52601 | 1 | 3 | 13 | Fc-gamma receptor signaling pathway |
| GO:0042482 | 0.04305 | 4.52601 | 1 | 3 | 13 | positive regulation of odontogenesis |
| GO:0045136 | 0.04305 | 4.52601 | 1 | 3 | 13 | development of secondary sexual characteristics |
| GO:0045820 | 0.04305 | 4.52601 | 1 | 3 | 13 | negative regulation of glycolytic process |
| GO:0046642 | 0.04305 | 4.52601 | 1 | 3 | 13 | negative regulation of alpha-beta T cell proliferation |
| GO:0048304 | 0.04305 | 4.52601 | 1 | 3 | 13 | positive regulation of isotype switching to IgG isotypes |
| GO:0052646 | 0.04305 | 4.52601 | 1 | 3 | 13 | alditol phosphate metabolic process |
| GO:0071295 | 0.04305 | 4.52601 | 1 | 3 | 13 | cellular response to vitamin |
| GO:0071380 | 0.04305 | 4.52601 | 1 | 3 | 13 | cellular response to prostaglandin E stimulus |
| GO:0072110 | 0.04305 | 4.52601 | 1 | 3 | 13 | glomerular mesangial cell proliferation |
| GO:0090042 | 0.04305 | 4.52601 | 1 | 3 | 13 | tubulin deacetylation |
| GO:0099159 | 0.04305 | 4.52601 | 1 | 3 | 13 | regulation of modification of postsynaptic structure |
| GO:1900225 | 0.04305 | 4.52601 | 1 | 3 | 13 | regulation of NLRP3 inflammasome complex assembly |
| GO:2001054 | 0.04305 | 4.52601 | 1 | 3 | 13 | negative regulation of mesenchymal cell apoptotic process |
| GO:2001279 | 0.04305 | 4.52601 | 1 | 3 | 13 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0016042 | 0.04326 | 1.46635 | 19 | 27 | 306 | lipid catabolic process |
| GO:2001236 | 0.04347 | 1.66946 | 10 | 16 | 161 | regulation of extrinsic apoptotic signaling pathway |
| GO:0008637 | 0.04347 | 1.83265 | 7 | 12 | 111 | apoptotic mitochondrial changes |
| GO:0198738 | 0.04380 | 1.38586 | 27 | 36 | 430 | cell-cell signaling by wnt |
| GO:0016070 | 0.04383 | 1.13312 | 234 | 258 | 3761 | RNA metabolic process |
| GO:0007605 | 0.04385 | 1.50212 | 17 | 24 | 266 | sensory perception of sound |
| GO:0010564 | 0.04419 | 1.32647 | 36 | 47 | 585 | regulation of cell cycle process |
| GO:0006687 | 0.04430 | 2.51668 | 3 | 6 | 42 | glycosphingolipid metabolic process |
| GO:0030866 | 0.04430 | 2.51668 | 3 | 6 | 42 | cortical actin cytoskeleton organization |
| GO:0048255 | 0.04430 | 2.51668 | 3 | 6 | 42 | mRNA stabilization |
| GO:0048873 | 0.04430 | 2.51668 | 3 | 6 | 42 | homeostasis of number of cells within a tissue |
| GO:1900015 | 0.04430 | 2.51668 | 3 | 6 | 42 | regulation of cytokine production involved in inflammatory response |
| GO:1902742 | 0.04430 | 2.51668 | 3 | 6 | 42 | apoptotic process involved in development |
| GO:0001658 | 0.04434 | 2.15817 | 4 | 8 | 64 | branching involved in ureteric bud morphogenesis |
| GO:0051926 | 0.04434 | 2.15817 | 4 | 8 | 64 | negative regulation of calcium ion transport |
| GO:0005996 | 0.04444 | 1.51442 | 16 | 23 | 253 | monosaccharide metabolic process |
| GO:0002115 | 0.04455 | 3.35369 | 1 | 4 | 22 | store-operated calcium entry |
| GO:0002864 | 0.04455 | 3.35369 | 1 | 4 | 22 | regulation of acute inflammatory response to antigenic stimulus |
| GO:0009404 | 0.04455 | 3.35369 | 1 | 4 | 22 | toxin metabolic process |
| GO:0016048 | 0.04455 | 3.35369 | 1 | 4 | 22 | detection of temperature stimulus |
| GO:0034405 | 0.04455 | 3.35369 | 1 | 4 | 22 | response to fluid shear stress |
| GO:0048857 | 0.04455 | 3.35369 | 1 | 4 | 22 | neural nucleus development |
| GO:0060438 | 0.04455 | 3.35369 | 1 | 4 | 22 | trachea development |
| GO:0060602 | 0.04455 | 3.35369 | 1 | 4 | 22 | branch elongation of an epithelium |
| GO:0101023 | 0.04455 | 3.35369 | 1 | 4 | 22 | vascular endothelial cell proliferation |
| GO:1902307 | 0.04455 | 3.35369 | 1 | 4 | 22 | positive regulation of sodium ion transmembrane transport |
| GO:1904469 | 0.04455 | 3.35369 | 1 | 4 | 22 | positive regulation of tumor necrosis factor secretion |
| GO:1905562 | 0.04455 | 3.35369 | 1 | 4 | 22 | regulation of vascular endothelial cell proliferation |
| GO:2000353 | 0.04455 | 3.35369 | 1 | 4 | 22 | positive regulation of endothelial cell apoptotic process |
| GO:1903507 | 0.04473 | 1.22649 | 74 | 88 | 1181 | negative regulation of nucleic acid-templated transcription |
| GO:0033138 | 0.04518 | 1.77099 | 8 | 13 | 124 | positive regulation of peptidyl-serine phosphorylation |
| GO:1902679 | 0.04549 | 1.22531 | 74 | 88 | 1182 | negative regulation of RNA biosynthetic process |
| GO:0016358 | 0.04556 | 1.46972 | 18 | 26 | 294 | dendrite development |
| GO:0010977 | 0.04590 | 1.62801 | 11 | 17 | 175 | negative regulation of neuron projection development |
| GO:0019229 | 0.04599 | 2.02971 | 5 | 9 | 76 | regulation of vasoconstriction |
| GO:0019319 | 0.04599 | 2.02971 | 5 | 9 | 76 | hexose biosynthetic process |
| GO:1904029 | 0.04599 | 2.02971 | 5 | 9 | 76 | regulation of cyclin-dependent protein kinase activity |
| GO:0006805 | 0.04605 | 1.81424 | 7 | 12 | 112 | xenobiotic metabolic process |
| GO:0006939 | 0.04605 | 1.81424 | 7 | 12 | 112 | smooth muscle contraction |
| GO:0046822 | 0.04605 | 1.81424 | 7 | 12 | 112 | regulation of nucleocytoplasmic transport |
| GO:0051150 | 0.04607 | 2.79552 | 2 | 5 | 32 | regulation of smooth muscle cell differentiation |
| GO:0051180 | 0.04607 | 2.79552 | 2 | 5 | 32 | vitamin transport |
| GO:0051642 | 0.04607 | 2.79552 | 2 | 5 | 32 | centrosome localization |
| GO:0060306 | 0.04607 | 2.79552 | 2 | 5 | 32 | regulation of membrane repolarization |
| GO:0070286 | 0.04607 | 2.79552 | 2 | 5 | 32 | axonemal dynein complex assembly |
| GO:2000191 | 0.04607 | 2.79552 | 2 | 5 | 32 | regulation of fatty acid transport |
| GO:0055013 | 0.04659 | 1.86824 | 6 | 11 | 100 | cardiac muscle cell development |
| GO:0044344 | 0.04664 | 1.93755 | 5 | 10 | 88 | cellular response to fibroblast growth factor stimulus |
| GO:0051606 | 0.04719 | 1.53585 | 14 | 21 | 228 | detection of stimulus |
| GO:0048592 | 0.04799 | 1.61770 | 11 | 17 | 176 | eye morphogenesis |
| GO:0007050 | 0.04881 | 1.70743 | 9 | 14 | 138 | cell cycle arrest |
| GO:0003416 | 0.04889 | 2.44855 | 3 | 6 | 43 | endochondral bone growth |
| GO:0031670 | 0.04889 | 2.44855 | 3 | 6 | 43 | cellular response to nutrient |
| GO:0038202 | 0.04889 | 2.44855 | 3 | 6 | 43 | TORC1 signaling |
| GO:0042771 | 0.04889 | 2.44855 | 3 | 6 | 43 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0045823 | 0.04889 | 2.44855 | 3 | 6 | 43 | positive regulation of heart contraction |
| GO:1901031 | 0.04889 | 2.44855 | 3 | 6 | 43 | regulation of response to reactive oxygen species |
| GO:1903320 | 0.04904 | 1.52839 | 14 | 21 | 229 | regulation of protein modification by small protein conjugation or removal |
| GO:2000648 | 0.04911 | 2.24937 | 3 | 7 | 54 | positive regulation of stem cell proliferation |
| GO:0001705 | 0.04912 | 7.54019 | 0 | 2 | 6 | ectoderm formation |
| GO:0001878 | 0.04912 | 7.54019 | 0 | 2 | 6 | response to yeast |
| GO:0001923 | 0.04912 | 7.54019 | 0 | 2 | 6 | B-1 B cell differentiation |
| GO:0002036 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of L-glutamate import across plasma membrane |
| GO:0002051 | 0.04912 | 7.54019 | 0 | 2 | 6 | osteoblast fate commitment |
| GO:0002248 | 0.04912 | 7.54019 | 0 | 2 | 6 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0002322 | 0.04912 | 7.54019 | 0 | 2 | 6 | B cell proliferation involved in immune response |
| GO:0002677 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of chronic inflammatory response |
| GO:0002826 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of T-helper 1 type immune response |
| GO:0002925 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0003096 | 0.04912 | 7.54019 | 0 | 2 | 6 | renal sodium ion transport |
| GO:0009756 | 0.04912 | 7.54019 | 0 | 2 | 6 | carbohydrate mediated signaling |
| GO:0009757 | 0.04912 | 7.54019 | 0 | 2 | 6 | hexose mediated signaling |
| GO:0010182 | 0.04912 | 7.54019 | 0 | 2 | 6 | sugar mediated signaling pathway |
| GO:0010255 | 0.04912 | 7.54019 | 0 | 2 | 6 | glucose mediated signaling pathway |
| GO:0015074 | 0.04912 | 7.54019 | 0 | 2 | 6 | DNA integration |
| GO:0016554 | 0.04912 | 7.54019 | 0 | 2 | 6 | cytidine to uridine editing |
| GO:0019364 | 0.04912 | 7.54019 | 0 | 2 | 6 | pyridine nucleotide catabolic process |
| GO:0030174 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of DNA-dependent DNA replication initiation |
| GO:0032055 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of translation in response to stress |
| GO:0032237 | 0.04912 | 7.54019 | 0 | 2 | 6 | activation of store-operated calcium channel activity |
| GO:0032741 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of interleukin-18 production |
| GO:0032782 | 0.04912 | 7.54019 | 0 | 2 | 6 | bile acid secretion |
| GO:0034316 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of Arp2/3 complex-mediated actin nucleation |
| GO:0035166 | 0.04912 | 7.54019 | 0 | 2 | 6 | post-embryonic hemopoiesis |
| GO:0035405 | 0.04912 | 7.54019 | 0 | 2 | 6 | histone-threonine phosphorylation |
| GO:0035509 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of myosin-light-chain-phosphatase activity |
| GO:0035633 | 0.04912 | 7.54019 | 0 | 2 | 6 | maintenance of permeability of blood-brain barrier |
| GO:0035655 | 0.04912 | 7.54019 | 0 | 2 | 6 | interleukin-18-mediated signaling pathway |
| GO:0035723 | 0.04912 | 7.54019 | 0 | 2 | 6 | interleukin-15-mediated signaling pathway |
| GO:0035860 | 0.04912 | 7.54019 | 0 | 2 | 6 | glial cell-derived neurotrophic factor receptor signaling pathway |
| GO:0035926 | 0.04912 | 7.54019 | 0 | 2 | 6 | chemokine (C-C motif) ligand 2 secretion |
| GO:0045650 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of macrophage differentiation |
| GO:0046110 | 0.04912 | 7.54019 | 0 | 2 | 6 | xanthine metabolic process |
| GO:0048597 | 0.04912 | 7.54019 | 0 | 2 | 6 | post-embryonic camera-type eye morphogenesis |
| GO:0050705 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of interleukin-1 alpha secretion |
| GO:0051182 | 0.04912 | 7.54019 | 0 | 2 | 6 | coenzyme transport |
| GO:0051771 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of nitric-oxide synthase biosynthetic process |
| GO:0052173 | 0.04912 | 7.54019 | 0 | 2 | 6 | response to defenses of other organism involved in symbiotic interaction |
| GO:0052200 | 0.04912 | 7.54019 | 0 | 2 | 6 | response to host defenses |
| GO:0060331 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of response to interferon-gamma |
| GO:0060336 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0060605 | 0.04912 | 7.54019 | 0 | 2 | 6 | tube lumen cavitation |
| GO:0060662 | 0.04912 | 7.54019 | 0 | 2 | 6 | salivary gland cavitation |
| GO:0060745 | 0.04912 | 7.54019 | 0 | 2 | 6 | mammary gland branching involved in pregnancy |
| GO:0060751 | 0.04912 | 7.54019 | 0 | 2 | 6 | branch elongation involved in mammary gland duct branching |
| GO:0060956 | 0.04912 | 7.54019 | 0 | 2 | 6 | endocardial cell differentiation |
| GO:0061724 | 0.04912 | 7.54019 | 0 | 2 | 6 | lipophagy |
| GO:0070162 | 0.04912 | 7.54019 | 0 | 2 | 6 | adiponectin secretion |
| GO:0070163 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of adiponectin secretion |
| GO:0070245 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of thymocyte apoptotic process |
| GO:0070447 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of oligodendrocyte progenitor proliferation |
| GO:0070948 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of neutrophil mediated cytotoxicity |
| GO:0071224 | 0.04912 | 7.54019 | 0 | 2 | 6 | cellular response to peptidoglycan |
| GO:0071287 | 0.04912 | 7.54019 | 0 | 2 | 6 | cellular response to manganese ion |
| GO:0071350 | 0.04912 | 7.54019 | 0 | 2 | 6 | cellular response to interleukin-15 |
| GO:0075136 | 0.04912 | 7.54019 | 0 | 2 | 6 | response to host |
| GO:0086073 | 0.04912 | 7.54019 | 0 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0090032 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of steroid hormone biosynthetic process |
| GO:0090258 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of mitochondrial fission |
| GO:0098902 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of membrane depolarization during action potential |
| GO:0099576 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
| GO:1900028 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of ruffle assembly |
| GO:1901552 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of endothelial cell development |
| GO:1902075 | 0.04912 | 7.54019 | 0 | 2 | 6 | cellular response to salt |
| GO:1903142 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of establishment of endothelial barrier |
| GO:1903238 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of leukocyte tethering or rolling |
| GO:1903935 | 0.04912 | 7.54019 | 0 | 2 | 6 | response to sodium arsenite |
| GO:1904428 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of tubulin deacetylation |
| GO:1905065 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of vascular smooth muscle cell differentiation |
| GO:1990791 | 0.04912 | 7.54019 | 0 | 2 | 6 | dorsal root ganglion development |
| GO:2000064 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of cortisol biosynthetic process |
| GO:2000348 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of CD40 signaling pathway |
| GO:2000554 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of T-helper 1 cell cytokine production |
| GO:2000556 | 0.04912 | 7.54019 | 0 | 2 | 6 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000659 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of interleukin-1-mediated signaling pathway |
| GO:2000672 | 0.04912 | 7.54019 | 0 | 2 | 6 | negative regulation of motor neuron apoptotic process |
| GO:2000977 | 0.04912 | 7.54019 | 0 | 2 | 6 | regulation of forebrain neuron differentiation |
| GO:0050688 | 0.04933 | 1.99976 | 5 | 9 | 77 | regulation of defense response to virus |
| GO:2001259 | 0.04933 | 1.99976 | 5 | 9 | 77 | positive regulation of cation channel activity |
| GO:0045934 | 0.04944 | 1.20250 | 87 | 102 | 1395 | negative regulation of nucleobase-containing compound metabolic process |
| GO:2000300 | 0.04947 | 1.84740 | 6 | 11 | 101 | regulation of synaptic vesicle exocytosis |
| GO:0000041 | 0.04974 | 1.91294 | 6 | 10 | 89 | transition metal ion transport |
| GO:0031016 | 0.04974 | 1.91294 | 6 | 10 | 89 | pancreas development |
| GO:0030902 | 0.04998 | 1.63539 | 10 | 16 | 164 | hindbrain development |